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SUMMARY
The control of African bovine trypanosomiasis is likely 
to depend, to a large extent, on the use of trypanocidal drugs 
for the foreseeable future. Within the limited armoury of drugs 
currently available, Isometamidium occupies a position of prominence, 
and is probably the most widely used trypanocide. Drug resistance 
is commonly considered to be the major problem associated with the 
use of trypanocides, and therefore a number of aspects of resistance 
of Trypanosoma congolense to Isometamidium were investigated in 
the present study.
Three basic approaches to the assessment of Isometamidium 
sensitivity of strains of T. congolense were explored; tests 
conducted using mice or cattle as hosts, and tests carried out 
using an in vitro system. The mouse sensitivity test was shown 
to have limitations in the degree of correlation between mouse and 
cattle results, while the in vitro approach had the major disadvantage 
that most strains of T. congolense had to undergo a period of adaptation 
to in vitro culture conditions, before any in vitro assessment of 
sensitivity could be made. It was concluded that the method of 
choice was sensitivity tests performed in the definitive host, 
ie cattle, and it was also noted that tests to assess the duration 
of prophylaxis should be carried out in- addition to those to test 
therapeutic activity.
An investigation of the apparent aparasitaemic interval 
following subcurative treatment with Isometamidium of T. congolense 
infections/ 0
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infections in a mouse model suggested that trypanosomes survived 
in the bloodstream in low numbers, rather than in cryptic foci, 
such as has been described for T.b. brucei.
Two aspects of resistance to Isometamidium, studied as 
part of this thesis, were of particular interest. 7irst, deliberate 
attempts to induce changes in sensitivity by repeated subcurative 
treatment, failed to alter significantly the IS’ '.etamidium sensitivities 
of strains of T. congolense, both in mice and goats. Secondly, 
a relatively Isometamidium resistant strain of T. congolense was 
apparently unable to establish an infection in the face of an 
existing infection of a sensitive strain, although in the reverse 
situation the sensitive strain established an infection and suppressed 
the resistant strain. These findings may help to explain the 
apparent scarcity of reported incidences of Isometamidium resistance 
arising in the field.
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CHAPTER ONE
BOVINE TRYPANOSOMIASIS
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INTRODUCTION
The African animal trypanosomjLases are a group of parasitic 
diseases which affect all the economically important livestock 
species. Of particular significance is the impact of tsetse- 
transmitted bovine trypanosomiasis; indeed, some authorities 
consider this to be the single most significant factor responsible 
for the continents relatively poor output of foodstuffs, particularly 
animal protein (Trail, Sones, Jibbo, Durkin, Light and Murray, 1985)*
The potential benefits to be derived from effective control of the 
disease are enormous.
The Organisms
Trypanosomes are parasitic protozoa which inhabit the plasma, 
and, in.the case of some species, other body fluids and tissues, of 
a wide range of animal hosts throughout the world (Mulligan, 1970) •
The majority of trypanosome species are non-pathogenic, but some 
species are the causative organisms of the major disease complex, 
the trypanosomiases. Nagana, surra and dourine occur in domestic 
livestock and trypanosomiasis (sleeping sickness) and Chagas1 disease 
in humans. The organisms belong to the order Kinetoplastidae, 
family Trypanosomatidae and genus Trypanosoma. In general bloodstream 
forms of trypanosomes are motile, unicellular organisms, usually 
spindle shaped, flattened and curved. They possess a single nucleus 
and a single flagellum, the latter being the organ of locomotion.
The portion of the trypanosome which is directed forward during movement 
is conventionally regarded as the anterior end. The flagellum 
emerges at the basal body, posterior to the nucleus, and runs along 
the/
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the outer margin of the pellicle to form an undulating membrane.
In some species there is a free portion of flagellum, in others 
the flagellum terminates at the anterior end. In close proximity 
to the basal body is the kinetoplast, a disc-shaped organelle containing 
DNA. Morphologically important features which can be used to aid 
identification of different species include the position of the 
kinetoplast and presence or absence of a free portion of flagellum 
(Table 1). Species of Trypanosoma have been divided into two sub­
groups, the Salivaria and the Stercoraria, on the basis of the 
site of development of the parasites in the vector species and the 
mode of transmission of infection.
Bloodstream, or trypomastigote, forms are ingested by the 
vector during the course of a blood meal from an infected host.
In the tsetse fly for Salivarian species, or in the arthropod vector 
for Stercorarian species, the trypanosomes undergo a number of 
developmental stages before transforming into metacyclic trypanosomes 
which are the form capable of infecting a new host. Bloodstream 
forms ingested by the vector species transform into epimastigote 
forms, which develop further into infective metacyclic forms.
The Stercorarian species develop entirely in the alimentary tract of 
the vector, with production of metacyclics occurring in the hind 
gut, from where they are voided in the faeces, and bring about 
infection either by contamination of skin abrasions or by oral ingestion 
by the host. This mode of development occurs in the important 
human pathogen T. cruzi.
The trypanosome species responsible for African bovine 
trypanosomiasis belong to the Salivarian sub-group0 The initial 
stages/
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stages of the development of metacyclics may occur in the alimentary 
tract of the vector but development is completed in the mouth parts.
In the case of T. vivax development occurs exclusively in the 
proboscis. Cyclical development, that is the transformation through 
a number of morphological forms before infective metacyclics are 
produced, occurs in the principal vector of the Salivarian trypanosomes, 
species of the genus Glossina, the tsetse flies. Twenty-two 
species of tsetse are known to transmit trypanosomes (Murray,
Morrison and Whitelaw, 1982) and, as each species is adapted to a 
slightly different habitat (Ford, 1971)> the tsetse-transmitted 
trypanosomes have a widespread distribution south of the Sahara. 
Infection of new hosts occurs by inoculation of infective metacyclics 
by an infected tsetse taking a blood meal. Salivarian trypanosomes 
are also capable of being transmitted by mechanical transmission in 
which infected blood is simply transferred from one host to another 
via the mouth parts of a biting fly. With most species cyclical 
transmission is of much greater significance than mechanical, although, 
in the case of T. evansi, an important pathogen particularly of 
camels, transmission is entirely by the mechanical mode (Mulligan,
1970).
Three species of Salivarian trypanosome are implicated in 
tsetse-transmitted bovine trypanosomiasis, of which two are of 
particular importance. Most clinical cases of African bovine 
trypanosomiasis are due to infection of T. congolense or T. vivax 
with the former probably predominating in East Africa and the 
latter in West Africa (Leach and Roberts, 1981). Mixed infections 
of the two species are common and infections involving T. brucei 
brucei are also encountered.
The Disease in Cattle
The course and severity of the disease varies depending 
upon the species and strain of trypanosome and, to some extent, 
on the breed and prior experience of the bovine (Morrison, Murray 
and McIntyre, 1981). Infections due to T. vivax exhibit a 
particularly wide range of clinical manifestations, ranging from 
chronic, low grade infections to those which run an acute course, 
characterised by pyrexia, sustained parasitaemia, massive haemorrhage 
and death, often within two weeks of infection. T. congolense 
infections demonstrate a narrower range of virulence, infections 
ranging from relatively acute to the more usual chronic course.
T.b. brucei usually gives rise to chronic, low grade infections.
The most common course for all three species, however, is 
a chronic condition associated with a series of waves of parasit­
aemia, generally at a relatively low level, with development of 
anaemia, seen as a pallor of the mucous membrane, as a major feature. 
In the early stages of the disease there is intermittent pyrexia 
and the superficial lymph nodes are enlarged. As the disease 
progresses lymph nodes revert to normal or may be reduced in size.
The appetite is usually normal, except for short periods associated 
with pyrexia; animals have been reported which died with food still 
in the mouth. Anaemia develops, its severity dependent on the 
level of parasitaemia experienced, and is accompanied by loss of 
condition. This is especially marked if extensive foraging is 
necessary, as the animals become very weak and are eventually unable 
to stand.
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The anaemia occurs in two distinct phases (Morrison, et al.«
1981). Initially there is increased red cell destruction by 
extravascular phagocytosis (Jennings, Murray and TJrquhart, 1974;
Mamo and Holmes, 1975)* Although bone marrow is responsive the 
erythropoietic response is probably less than the degree of anaemia 
dictates (Dargie, Murray and Murray, 1979)* The role of haemodilution 
is equivocal, and haemorrhage is not usually a symptom except in the 
case of haemorrhagic T. vivax. Treatment of this initial phase 
with trypanocidal drugs generally results in a cure, with the packed 
cell volume (PCV) returning to normal levels. The second phase of 
anaemia which may occur after 4.'to 6 months if the animal survives 
and is not successfully treated, is associated with progressively 
decreasing waves of parasitaemia: sometimes the presence of trypanosomes
cannot be demonstrated. Red blood cell destruction by phagocytosis 
continues and femoral marrow is often inactive (Dargie, et al.t 
1979)« In this second phase the condition usually responds 
poorly to trypanocidal drugs. The aetiology of the anaemia is 
multifactorial, with immune sensitisation of red cells, production of 
haemolysins by trypanosomes, fever and a more active mononuclear 
phagocytic system all having been implicated (Morrison, et al.t'
1981; Herbert and Inglis, 1973)*
The outcome of the chronic disease is often fatal, death 
being caused by congestive heart failure brought about by a combination 
of anaemia, circulatory disturbance associated with increased 
vascular permeability and myocardial damage (Murray, 1974)*
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In some animals the PCV will stabilise at a low level; some 
individuals will die, others become aparasitaemic and the PCV 
gradually revert to normal, although as the duration of the infection 
increases recovery of PCV tends to be slight. Surviving animals 
tend to remain at a low level of productivity, with poor growth rates 
and poor reproductive performances.
The Extent of the Problem
Tsetse-transmitted bovine trypanosomiases have a devastating 
impact over an area of 10 million square kilometres of sub-Saharan 
Africa. Tsetse infest approximately 40% of the habitable land in 
an area embracing 37 countries (PAO/WHO/OIE, 1982); often these 
areas are the best watered and most fertile parts which otherwise 
would be suitable for mixed agricultural development or grazing.
Thus, cattle and also sheep and goats, are excluded from vast tracts 
of tsetse-infested land. In other areas of less severe tsetse 
challenge enormous losses are incurred due to depressed levels of 
productivity - poor growth rates, low fertility, high incidence of 
abortion, long calving intervals, low milk yields, limited work 
potential - of animals exposed to trypanosomiasis. It has been 
estimated that 30% of the 147 million cattle in countries affected 
by tsetse are exposed to the disease (PAO/WHO/OIE, 1982).
Exclusion of cattle from tsetse-infected areas not only denies 
inhabitants of such areas access to livestock products such as 
milk, meat, skins, dung and for small-scale farmers, a saleable 
asset in times of need, but also means that draught power is not 
available. Since it has been estimated that possession of a single 
oxen can increase the food output of a family six-fold, the significance 
of this factor can readily be appreciated (McDowell, 1979)
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Limited utilisation of tsetse-infested areas inevitably results 
in increased pressure on land use in tsetse-free regions. At a 
time of rapidly rising human population in Africa, this can result 
in overgrazing, pasture degradation and ultimately in desertification. 
Effective control of trypanosomiasis, resulting in the development 
of tsetse-infested land for mixed agriculture, would do much to 
relieve this pressure.
Some workers however take the contrary view point that the 
development of tsetse-infected land for grazing is environmentally 
detrimental. Omerod and Rickman (1988) for example, consider 
trypanosomiasis control to be *one of the worst initiators of land 
degradation1. They suggest land cleared of tsetse and rapidly 
stocked with cattle is vulnerable to overgrazing, which can easily 
lead to disruption of the ecological balance of a relatively fragile 
environment.
Methods of Control
Approaches to the control of trypanosomiasis fall into one 
of two basic categories: those in which control of the disease is
attempted by action against the vector and those in which direct 
action is taken against the parasite. Possibly the simplest approach 
to the problem in the past has been to avoid exposing livestock to the 
risk of infection by not keeping them in trypanosomiasis endemic 
areas. However, the extent of the area involved is enormous.
Tsetse infest an area equivalent in size to the whole of the U.S0A 0 
(Trail et al., 1985) and, with current trends in human population 
growth in Africa, the continuation of this approach in the future 
is unlikely to be tenable.
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Vector control
Attempts to control tsetse have taken place for more than 60 
years but despite this, territorial expansion of tsetse infested 
country is occurring throughout the continent (MacLennan, 1980). 
Initially reliance was placed on techniques such as selective bush 
clearance to remove breeding habitats, clearance of vegetation 
from tracts of land to act as barriers to the advance of tsetse and 
removal of wildlife as a source of infected blood meals. When 
synthetic insecticides became available after the Second World War, 
their use became the most commonly employed method of tsetse control. 
Residual insecticides such as DDT, or more recently dieldrin are 
generally applied by hand sprayer to likely tsetse resting sites, 
while non-residual insecticides are usually applied by fixed-wing 
aircraft or occasionally helicopters. Well planned campaigns 
using insecticides have succeeded in the elimination of tsetse from 
sizeable areas, for example, in Nigeria, Zimbabwe, Botswana and 
Zambia (Trail et al.« 1985)« The logistics involved, however, 
are complicated and the cost high. The danger of reinvasion of 
tsetse from adjacent areas is ever-present and, particularly when 
residual insecticides are used, the technique can be criticised on 
ecological grounds.
A number of biological methods of control are at various stages 
of experimental or field evaluation. The sterile insect technique 
(SIT) relies on the fact that a female tsetse mates only once, and 
if the male is sterile, the female will not produce any offspring. 
Sterilisation is achieved by exposure of colony reared males to 
sublethal irradiation or chemical sterilants. Normally the number 
of/
- 1 0  -
of tsetse present in a target area are initially reduced by 
application of a non-residual insecticide, such as endosulphan, 
prior to release of the sterile males. A further requirement 
of the technique is an effective barrier, natural or man-made, 
to prevent reinvasion of tsetse from outside the area. This 
generally takes the form of a zone of sheer-cleared vegetation 
approximately 1 kilometre wide around the target zone. The 
difficulty of initially clearing this barrier and subsequently 
maintaining it is considerable. Disadvantages of SIT are its 
relative sophistication, expense and risk of reinvasion negating 
any benefits gained. The presence of more than one Glossina 
species in most infested areas also complicates this approach.
The use of biological control in the form of tsetse parasites, 
pathogens or predators has not progressed beyond the experimental 
stage.
A relatively simple approach to vector control is the use 
of strategically positioned tsetse traps. Originally traps were 
used mainly for sampling tsetse populations for survey purposes, 
but more recently the potential for using traps as means of tsetse 
control has been investigated. The latest developments in this 
area concern the use of insecticide-treated screens, or targets, 
baited with tsetse attractant odours such as acetone and octanol.
The screen consists of a central rectangle of black cloth flanked 
by netting on either side. The cloth and netting are treated 
with/
- 11 -
with an insecticide such as meltamethrin, and tsetse, attracted 
by the odour plume, are killed when they either alight on the 
black cloth or collide with the netting. A trial conducted in 
the Rifa Triangle, Zimbabwe (Yale, Bursell and Hargrove, 1985) 
was apparently successful in eliminating previously abundant 
G.m. morsitans and G. pallidipes, although Tabanids and Muscids 
remained numerous. The technique has the advantage of being 
ecologically sound, but has yet to be shown to be effective against 
all Glossina species in all ecological zones.
Immunological control and the use of trypanotolerant livestock
A pronounced and rapid immune response follows infection of 
a host with trypanosomes, with humoral antibody being the main 
factor involved (Holmes, 1980). However, the parasites are able- 
to overcome the host!s response largely due to the phenomena of 
antigenic variation.
The pellicular surface of trypanosomes is covered with a 
glycoprotein. This surface is antigenic and by a process of 
repeatedly changing the dominant surface coat, or variable antigen 
type (VAT), the parasites are able to evade the antibody produced 
in response to them (Cross, 1975)• The parasite in effect remains 
one step ahead of the host*s immune response. The classical 
course of parasitaemia in a trypanosome infected animal is one of 
a series of waves of rising and falling parasite numbers. This 
is due to the rapid growth of a trypanosome population possessing
a /
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a certain dominant VAT, the mounting of a successful immune 
response by the host, which is then defeated by the emergence 
of a new dominant VAT0 This sequence of production of antibody 
against a specific VAT and emergence of a new dominant VAT is 
repeated indefinitely. The number of VATs in the repertoire 
of any given tiypanosome strain is unknown but appears to be large. 
In the case of a clone of T. equiperdum. 101 distinct VATs have 
been isolated (Caphem, Giroud, Baltz and Mai tern, 1977)
The development of an effective vaccine is, therefore, 
frustrated by a number of factors. Firstly, to be effective in 
the control of bovine trypanosomiasis, a vaccine must be active 
against T. congolense, T. vivax and ideally T0b. brucei as well. 
Secondly, within each trypanosome species there exists a large, 
but unknown number of antigenically distinct strains (van Meirvenne, 
Magnus and Vervoort, 1977) each with their own repertoire of 
VATs. Thirdly, the problem of VATs compounds an already 
complicated situation. It is relatively easy to produce 
immunological protection against homologous challenge in a 
laboratory environment (Holmes, 1980) but it seems difficult, 
if not impossible, to produce protection against heterologous 
strains or variants. In spite of enormous research effort in 
this area, the likelihood of a field vaccine becoming available 
in the foreseeable future seems slim (Murray and Gray, 1984).
- 13 -
It has long been recognised that there are certain breeds 
of cattle, sheep and goats which are able to survive in tsetse- 
infested regions where other breeds cannot (iLCA, 1979)• These
breeds tend to be confined to West and Central Africa due to a 
combination of historical factors and have been termed *trypanotolerant®0 
Two major breeds of cattle are recognised as being trypanotolerant: 
the N'dama and the West African Shorthorn. The former are 
descended from the humpiess Hamitic Longhorn which arrived in Africa 
around 5>000 B0C0 and the latter are descendents of the humpless 
Hamitic Shorthorn which were imported into Africa around 3,000 B0C0 
Both breeds are classified as Bos taurus types, in contrast to the 
Zebu breeds which are Bos indicus and whose ancestors arrived on 
the continent around 700 A0D0 (Murray et al., 1982).
Pagot (1974) defined trypanotolerance as a ‘racial aptitude 
to maintain good condition and to reproduce while harbouring 
trypanosomes without showing clinical signs of the disease®.
The term * trypanotolerance * is in some ways misleading. The 
trypanotolerance of these breeds is not absolute (Stephen, I966) 
and under some circumstances clinical disease can become manifest.
A range of stress factors such as poor nutrition, overwork, 
intercurrent disease or simply a very high level of challenge 
may result in the breakdown of the trypanotolerance. The breeds 
in question, however, undoubtedly exhibit reduced susceptibility 
to the disease.
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Several misconceptions have become associated with the 
trypanotolerant breeds, including the beliefs that the tolerance 
is an acquired trait and that the breeds are only capable of 
achieving a low level of productivity. Much experimental work, 1 
particularly with N’dama cattle, has shown that trypanotolerance 
is an innate characteristic (Murray et al., 1982). Comparative 
experiments with susceptible Zebu cattle have consistently shown 
that N ’dama exhibit a lower level, prevalence and duration of 
parasitaemia; develop less severe anaemia; have greater survival 
rates and high reproductive performance in the face of challenge, 
whether that challenge was by syringe inoculation or naturally 
and was T. congolense, T. vivax or T.b. brucei (Murray, Murray, 
Wallace, Morrison and McIntyre, 1979)*
The belief that trypanotolerant breeds are of a low 
productivity has arisen in the past due to prejudice against the 
relatively small mature bodyweight of these breeds and lack of 
convincing, comparative performance data. Recent investigations, 
however, have shown that trypanotolerant livestock are more 
productive than was previously thought (ILCA, 1979)*
In spite of their apparent advantages over susceptible 
cattle, the major constraint that limits the contribution 
trypanotolerant cattle can make to the problem of trypanosomiasis 
on a continental scale is the relatively small numbers available. 
Latest population estimates of N ’dama and West African Shorthorn 
are/
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are 3*4 million and 1.8 million respectively, or about 8% of the 
cattle population of the tsetse-infected countries (ILCA, 1979)* 
Recent research suggests that even the trypanotolerant breeds 
can be more productive when maintained under trypanocidal drug 
regimes, although the frequency of treatment needed may be less 
than in the more susceptible breeds (Trail et al.» 1985)*
Trypanocidal drugs
The non-availability of an effective field vaccine, the 
difficulty of effective vector control and the relatively small 
numbers of trypanotolerant cattle currently available means that, 
in the foreseeable future, trypanocidal drugs will have to be relied 
upon to control the animal trypanosomiases.
There are two broad categories of drugs used against 
trypanosomes; those which bring about a sterile cure but have 
little or no residual activity and those which maintain trypanocidal 
levels in the blood or tissues of treated animals for extended 
periods. The former are termed therapeutic or curative and the 
latter prophylactic. Table 2 presents details of chemical class, 
activity and principal manufacturer and trade name for the currently 
available trypanocides used against African bovine trypanosomiases 
(Table 2).
Use of trypanocidal drugs is not without its problems, a 
topic reviewed by Holmes and Scott (1982)0 Initially the cost of 
drugs creates a strain on the foreign exchange reserves of the 
countries affected, a problem exacerbated by the fact that these 
countries tend to be the poorest and least developed nations. 
Effective/
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Effective use of trypanocidal drugs requires close veterinary 
supervision and the monitoring of treated cattle for signs of 
reappearance of trypanosomes. Shortages of trained manpower and 
materials makes such supervision difficult. Many authors consider 
the most significant problems to be that of drug resistance. To 
some extent, resistant strains of trypanosomes have emerged to all 
the trypanocidal drugs which have been, or still are being, used 
in the field. The problem of drug resistance is heightened by 
the small number of different trypanocidal drugs available and also 
the narrow therapeutic ratio of most of these products. No new 
drugs have become available since the introduction of Isometamidium 
in the early sixties. Williamson (1976) attributes this to the 
high cost of developing and marketing a compound for a market 
segment which, to the large pharmaceutical companies, is relatively 
small and which is made up of countries of uncertain economic 
stability, often with small veterinary budgets.
There are several categories of cattle exposed to trypano­
somiasis risk and the desirability and practicability of providing 
effective therapeutic or prophylactic cover varies between these 
categories.
In West Africa it has been a comparatively common practice 
to trek cattle from up-country centres of production to the large 
urban markets on the coast. On route the cattle were often exposed 
to trypanosomiasis risk as they passed through tsetse-infected areas. 
In such a situation a chemoprophylactic treatment given at the start 
of/
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of the trek was an effective method of providing protection.
The period of protection conferred by the prophylactic drug was 
likely to exceed the period of risk, and several workers have 
conducted trials which have demonstrated that Isometamidium is 
effective in this situation (jones-Davies, 1967; Na*Isa, 1969)*
More recently, a shift from trekking animals to transporting 
them more rapidly by lorry, has reduced the trypanosomiasis risk 
associated with this journey (Kilgour and Godfrey, 1978).
Susceptible Zebu cattle migrating into the tsetse belt 
in the dry season to gain access to grazing and water present 
a similar problem. Movement of this type is a common feature 
of cattle husbandry particularly in parts of West Africa. Animals 
exposed to this type of seasonal risk generally receive a prophylactic 
treatment before moving to the tsetse area, which should provide 
protection during their three or four month exposure to risk.
A curative treatment is then usually administered at the end 
of the dry season grazing period to reduce the risk of drug 
resistant strains arising and to prevent the chanpe of trypanosomes 
being transmitted mechanically by biting flies during the wet 
season grazing outside the tsetse belt (Anon, 1979)-
Trypanocidal drug regimes for draught animals and cattle 
under individual ownership in trypanosomiasis endemic areas 
present particular problems. These include monitoring infection 
and ensuring that all animals receive adequate treatment at the 
appropriate interval, with due regard to correct dosage and with 
provision/
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provision to safeguard against emergence of drug resistance.
Bourn and Scott (1978) described a scheme in Ethiopia where 400 
draught oxen were maintained in good health in a tsetse-infested 
area but emphasised the need for good veterinary supervision.
A recent major study, based at Muhaka on the Kenya coast, 
has demonstrated the potential benefit of Isometamidium prophylaxis, 
in terms of decreased infection rates and increased productivity 
even under village conditions (iLCA, 1986; Murray, Trail and 
Maloo, 1987).
It is far easier to provide chemoprophylactic protection 
for cattle maintained in endemic areas on ranches or large farms 
under permanent veterinary supervision. Provision must be made 
for regular monitoring of herds for signs of reinfection; individual 
animals must be ear-tagged to allow reliable identification; 
facilities must be available for handling and weighing animals and 
all animals must be presented for treatment. The trypanocidal 
regime used should be tailor-made to reflect the local challenge 
and, ideally, incorporate a curative drug at regular intervals.
Isometamidium has been successfully used to control 
trypanosomiasis in a number of field trails and commercial situations. 
Thus, Wilson, Le Roux, Paris, Davidson and Gray, (1975) reported 
a trial involving Zebu cattle in a tsetse infested area of Kenya.
Three drug regimes were compared? Isometamidium administered on 
a herd basis when 5% of the herd was diagnosed as trypanosome 
positive; diminazene aceturate administered on the same basis 
and diminazene aceturate given to individuals shown to be clinically 
affected./
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affected. Of the three regimes, Isometamidium prophylaxis was 
demonstrated to give the best economic return. potential emergence 
of resistant strains of trypanosomes was monitored by regular 
collection of isolates from tsetse or untreated control cattle. 
Stabilates were prepared and used to infect test cattle in a tsetse 
free area. Treatment was given 7 - 1 0  days after detection of 
parasites and jugular blood samples were monitored for 100 days.
The absence of trypanosomes during this period was assumed to 
indicate that the isolates were sensitive to the drug under test.
On the basis of this criteria, no drug resistance to either 
Isometamidium or diminazene aceturate was detected.
Logan, Goodwin, Tembely and Craig (1984) compared three 
monthly administration of Isometamidium with individual treatment 
with diminazene aceturate using Zebu-maure cattle in Mali. Luring 
the 21 month study, Isometamidium used prophylactically was shown 
to result in significantly greater weight gain and prevented losses 
more effectively than the diminazene regime, resulting in a herd 
with a greater market value. No evidence of drug resistance was 
encountered.
The results of an analysis of data from Mkwaja Ranch, 
Tanzania (Trail et al., 1985) indicated that a regime based on 
Isometamidium prophylaxis allowed a high level of productivity to 
be achieved. Indirect evidence suggested that even though 
Isometamidium had been used to protect the grade Boran cattle for 
more than 20 years, resistance had not emerged as a problem.
For most of the study period (1973 - 1980), Isometamidium
was/
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was administered on a herd basis at 0.5 mg/kg. The need for 
re treatment was determined by sampling 50 - 4-0 animals in each 
herd (225 - 500acattle), beginning about 1 month after the last 
herd prophylaxis. The sample was biased to include any 
individuals which looked in poor condition. If 2CP/0 of the slides 
in a sample were shown to be trypanosome positive, by thick 
film examination, then the herd was retreated. If less than 2QP/0 
of a sample were positive, then the need for retreatment was judged 
according to a subjective impression of the condition of the herd.
If the herdfs condition was considered to be poor, then the herd 
was retreated. If the herd's condition was judged to be generally 
good, individual trypanosome positive animals were treated with 
diminazene aceturate (Berenil, Hoechst, West Germany) at 5*5 mg/kg.
Use of trypanocidal drugs has increased dramatically in 
Africa in the past 10 years or so, and Tacher (1982) estimated usage 
at 25 million doses per year. He suggests that the use of trypanocidal 
drugs allows development of cattle production in areas where tsetse 
eradication is not currently possible, but, by using drugs, 
conditions could gradually be created under which operations against 
Glossina may eventually be undertaken. This was the original 
objective when Mkwaja Ranch was established in north-eastern 
Tanzania in 1954* It was anticipated that profits accrued from 
the beef ranch could be used to finance a bush clearance programme 
which would lead to tsetse eradication and pasture improvement.
Rapid bush regeneration and less than anticipated profitability 
were/
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were two factors which operated against this objective and 50 years 
later reliance upon trypanocidal drugs is absolute (Ford and 
Blaser, 1971; Trail et al., 1985)•
Development of Brugs Against African Animal Trypanosomiases
The histories of the science of chemotherapy and of the 
development of synthetic trypanocides are closely linked, both 
having their roots in experiments carried out with trypanosomes 
in the early years of the present century.
Crude extracts of vegetable origin and other simple 
substances have long been used to treat a variety of disease; 
inorganic arsenic, for example, has been used since the time 
of Hippocrates. Livingstone, although ignorant of the aetiology 
of the condition, treated a * fly-struck1 mare with potassium 
arsenite during his travels in Africa in the 1840*s (Hawking,
1965)« However, the founding father of chemotherapy as a science 
is generally recognised as being Paul Ehrlich, a German physician.
Ehrlich recognised that in the same way that certain dyes 
were able to stain specific cellular elements, it may be possible 
to identify chemical substances which would specifically unite with, 
and destroy, disease-causing parasites, without at the same time 
destroying the cells of the hostc As early as 1891 Ehrlich showed
that methylene blue, which is specifically absorbed as a stain by 
Plasmodium species, also had a therapeutic action against malaria 
in humans. This observation apparently attracted little interest 
at the time. Interest in chemotherapy was, however, revived by 
the/
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the need to find a method of controlling * tsetse-fly disease1, or 
nagana, which was seriously hindering the development of Africa in the 
late nineteenth and early twentieth century. Bruce (1895) demonstrated 
that the disease was caused by trypanosomes, similar to those seen 
in India, where they caused surra in horses and cattle (Evans, 1880).
Lareran and Mesnil (1902) demonstrated that trypanosomes could be 
maintained in rats by continuous passage thereby providing a convenient 
laboratory model which made it possible to begin the search for 
effective remedies (Hawking, 1965)*
Lingard had shown in 1895 that arsenious oxide had a temporary 
effect on surra. It was, however, toxic and treated animals eventually 
either died or relapsed. Ehrlich investigated hundreds of dyes 
and identified trypan red as being curative for T. equinum infections 
in mice. This work on the aniline dyes, which also led to the 
potent antispirochaetal agent salvarsan which revolutionised the 
treatment of syphilis, is often regarded as the first major breakthrough 
in chemotherapy. Davey (1958), however, suggests that Ehrlich would 
not have made his important discovery were it not for the earlier 
work of Thomas in Liverpool in 1904> who showed atoxyl to be curative 
against T. gambiense infections in mice.
Plimmer and Thompson (1908) first showed potassium antimony 
tartrate (tartar emetic) and its sodium analogue to be active against 
T. b. brucei and T. congolense in laboratory animls. The efficacy 
of tartar emetic was confirmed against T. congolense and T. vivax 
infections in cattle by Bevan (1928) and Curson (1928), but it was 
not active against T. b. brucei. A dose of 1 - 1.5 g per head 
was/
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was given in a 5% aqueous solution and treatment sometimes needed 
repeating daily. Severe local reactions occurred with intramuscular 
or subcutaneous injections, resulting in the need for intravenous 
administration which presented handling problems in relatively wild 
cattle. Despite a mortality rate of 6% in treated cattle, tartar 
emetic continued to be used up until the early 1950*s. This was due 
to the even higher mortality rate of untreated animals and doubt 
as to the efficacy and toxicity of newer compounds (Leach and Roberts, 
1981).
Chemists working on dyes tuffs in the Bayer company during 
the first world war developed the synthetic compound suramin, having 
started with trypan red, trypan blue and African violet and investigating 
ureas of the aminophthalene-sulfonic type (Hawking, 1983)* Initial 
activity was demonstrated against the human-infective trypanosomes 
and later against natural infections of T. evansi in camels (Knowles,
1925) horses and cattle (Edwards, 1926). Suramin was introduced 
under the tradenames Germanin (1921) and Naganol (1923) • Considerably 
later Guimaraes and Lourie (1951) found that suramin and pentamidine 
(a drug used in the prophylaxis of human trypanosomiasis) produced a 
precipitate which reduced the toxicity of pentamidine without reducing 
its prophylactic activity. This finding led to considerable research 
effort and the examination of a wide variety of suramin complexes. 
Although some showed long periods of protection to cattle, local 
toxicity was a considerable problem and the complexes never came 
into general use for cattle.
Research interest in potassium antimony tartrate led to the 
synthesis of an analogous sulfonated pyrocatechol, antimosan, derived 
from trivalent antimony, and also the sodium salt, stibophen.
Antimosan was shown to be active against T. congolense and T. vivax, 
although less so against T. b. brucei (Parkin, 1931; 1935)*
Repeated treatments at intervals of four weeks were, however, required 
at a dose of 3*6 g per 300 - 400 kg bodyweight.
Interest was also shown in the strylquinolines, some of 
which were found to have trypanocidal activity, particularly against 
the Trypanozoon subgenus (Browning, Cohen, Ellingworth and Gilbransen,
1926). The compounds, however, were found to be retained in the 
body for long periods and gave rise to local systemic toxicity, and 
did not act rapidly against trypanosomes.
Jensch (1937) reported a 4-aminoquinoline derivative, 
surfen C, with activity against T. congolense. Field trials in 
cattle demonstrated the drug to be toxic; Le Roux (1936) reported 
some animals dying of shock within minutes of treatment and also severe 
local reactions in surviving cattle. However, modification of the 
surfen C molecule, by chemists at Imperial Chemical Industries (iCl) 
in Britain, led to the synthesis of the quinapyramines (Barrett,
Curd and Hepworth, 1953)* Field trials by Davey (1950) demonstrated 
quinapyramine dimethosulphate to be active against T. congolense.
T. vivax and T.b. brucei. Although introduced as a therapeutic 
drug in the early 19501s, quinapyramine dimethosulphate also had some 
prophylactic activity. Some authorities consider that this may 
have/
have been disadvantageous, and could have been a factor in the 
extensive field resistance which developed to the product (Davey,
1958). Quinapyramine chloride is much less soluble than the dimetho­
sulphate and although subcutaneous injection resulted in the 
formation of a depot from which the drug was slowly released, the 
blood level attained was too low to be curative (Curd and Davey,
1950). A mixture of the two salts was, therefore, marketed under 
the name Antrycide Prosalt, initially as three parts dimethosulphate 
and four parts chloride, and then later, in 1958, as Prosalt RF 
with a half as much chloride. The latter formulation was cheaper 
to produce and was shown to be equally effective, providing three 
months protection to cattle in low tsetse challenge and two months 
in medium challenge situations (Davey, 1958). The revised formulation
also resulted in less severe local reactions. Antrycide was withdrawn
from the market in 1977» in the face of considerable field resistance. 
Quinapyramine was re-introduced, however, in 1984 under the tradename 
Trypacide (May and Baker) principally for the treatment and prevention 
T. evansi infections in camels and equines.
Browning, Morgan, Robb and Walls (1938) reported activity 
against the Trypanozoon subgenus by phenidium chloride. Although 
this activity was subsequently confirmed in the field, the solubility 
of the compound*was low and its therapeutic index narrow. The 
finding, however, focused attention on the phenanthridines, and soon 
another member of this group, dimidium bromide, was shown to be 
active against T. congolense in a field trial by Carmichael and Bell
(1944)./
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(1944). The drug was used for mass treatment campaigns in East 
and Central Africa, but unfortunately resistance was widespread 
by 1952, and the use of higher doses resulted in the development 
of photosensitization in cattle (Randall and Beveridge, 1946).
Watkins and Woolfe (1952) reported the synthesis of a 
new aminophenathridine compound, derived from dimidium. Homidium 
bromide was shown to be as effective as dimidium, but less toxic 
(Ford, Wilmshurst and Karib, 1953a; 1953b) and with limited 
prophylactic activity (Leach, Karib, Ford and Wilmshurst, 1955). 
Synthesis was achieved by the substitution of an ethyl for a methyl- 
group on the quaternary nitrogen heteroatom of dimidium. Wragg 
(1955) 5 working at May and Baker, patented the chloride salt which 
had the advantage over homidium bromide of solubility in cold water. 
Homidium bromide was introduced as Ethidium (originally Boots Pure 
Drug Company; most recently Cameo Ltd) and homidium chloride was 
marketed under the tradename Novidium by May and Baker. Mass 
treatment with homidium however, resulted in widespread development 
of resistant strains.
The introduction of homidium and quinapyramine in the 1950®s 
meant that for the first time safe, mass treatment of cattle was 
possible. The number of trypanocidal treatments administered 
annually rose dramatically. In Kenya, for example, from 45>000 
in 1951/52 to 641,000 in 1957/58 (Wilson, i960). One of the major 
factors implicated in the decision to set up, in 1954, Mkwaja Ranch 
in an area of severe trypanosomiasis challenge in north-east 
Tanzania/
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Tanzania, was the availability of Antrycide Prosalt which allowed, 
for the first time, susceptible cattle to be maintained in tsetse- 
infected areas (Ford and Blaser, 1971
Interest in the diamidines originated from the observation 
that insulin, by lowering blood sugar levels, reduced the rate of 
replication of trypanosomes in vivo. Synthalin, a synthetic 
compound with hypoglycaemic activity, was also found to be trypanocidal 
in vivo (Jansco and Jansco, 1935). Lourie and Yorke (1937) 
investigated the activity of synthalin further and showed that it 
had trypanocidal activity in vitro. This demonstrated that synthalin 
was having a direct action on trypanosomes, not acting simply by 
reducing the amount of glucose available from the host. Synthetic 
activity then focused on the diamidines, and led to the synthesis 
of pentamine, and a number of experimental compounds; phenamidine, 
propamidine, stilbamidine and M & B 2242 (Williamson, 1970).
Research chemists at Hoechst, West Germany, reported a new aromatic 
diamidine, diminazene aceturate (Berenil) (Bauer, 1955; Fussganger, 
1955; Jensch, 1958). Jensch (1958) describes the development 
of diminazene aceturate from a systematic dissection of the surfen 
C molecule. It is also noteworthy that the diminazene aceturate 
molecule bears a close resemblance to M & B 2242, with only 
substitution of a triazine bridge for the aminotriazine ring of 
the latter compound. Berenil was rapidly taken into general use 
in the field, increasing from 2,000 doses in 1957 to 190,000 in 
1961 in Kenya (Fairclough, 19&3)> and virtually replaced quinapyramine 
and/
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and homidium in northern Nigeria (MacLennan, 1968). Limited 
stability of aqueous solutions led the manufacturers to add 
phenyldimethyl pyrazolone (antipyrine) as a stabilizer from 1959 
onwards (Fairclough, 1963). Diminazene aceturate is also 
effective against babesiosis, which is an additional advantage of 
this product. Early hopes, however, that the short period of 
activity and rapid rate of excretion of this drug would avoid 
the development of resistant strains of trypanosomes have not been 
realised.
Watkins and Woolfe (1956) of the Boots company reported 
the synthesis of pyrithidium bromide, by the substitution of the 
pyramidyl moiety of quinapyramine into a phenanthridine which 
resembled phenidium. This compound, marketed as Prothidium, 
was shown to have therapeutic and prophylactic action (Watkins, 
1958) although Leach and El Karib (i960) reported it to be less 
effective than quinapyramine, and also reported possible problems 
relating to systemic toxicity in cattle. Resistance rapidly 
developed to the drug when it came into general use. The product 
was withdrawn from the market in 1985*
Wragg, Washbourne, Brown and Hill (1958) described a new 
trypanocide formed by preparing the p-amidinophenylodiazoamino 
derivative of homidium chloride. This derivative was chosen 
because of the structural relationship the product would have to 
diminazene aceturate. The coupling reaction resulted in the 
formation of two isomers. Favourable results from the testing 
of these isomers resulted in an extensive investigation of 
structure/activity relationships of similar isomers, from which 
the/
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Figure 1. Structure of isometamidium (8-(m-amidinophenyldiazoamino)- 
• 3-aJnino-5-©thyl-6-phenylphenanthridinium chloride hydro­
chloride).
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the most promising product emerged as a mixture of two isomers which 
were m-amidino derivatives. This mixture of isomers was given the 
common name metamidium. Subsequently the red isomer present in 
metamidium, isometamidium chloride, was shown to be the more active 
of the two, and its chemical structure was described by Berg (1960) 
(Figure 1), After successful field trials isometamidium chloride 
was marketed in 1961 by May and Baker under the tradename Samorin, 
and subsequently it has also been marketed in francophone countries 
as Trypamidium (Specia, now Rhone-Merieux, France). The commercially 
available products Samorin and Trypamidium are not pure isometamidium 
chloride. They contain approximately 70% isometamidium chloride, 
with 20% of a purple isomer and 10% of a bis-compound (Hutchinson, 
1981)* In this thesis the term Isometamidium is taken to mean the 
commercially available product, and not pure isometamidium chloride.
A problem with the use of Isometamidium is that of local 
toxicity, particularly at the higher doses. Hope-Cawdery and Simmons 
(1964) experimented with formulations of Isometamidium in a high- 
viscosity base, but the results were disappointing. Several workers 
have experimented with Isometamidium-dextran complexes. James 
(1978) reported extended prophylaxis and reduced local toxicity in 
rodents. Aliu and Sannusi (1979) reported enhanced prophylaxis in 
preliminary experiments with rodents. They showed that subcutaneous 
administration of Isometamidium-dextran resulted in the formation 
of a small nodule at the site of injection, although no severe local 
reaction accompanied either subcutaneous or intramuscular injection. 
No/
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No advantage was demonstrated in the ability to cure infections; 
both Isometamidium and the dextran-complex failed to prevent the 
development of relapse infections when used at the 0.5 mg/kg dose 
level against a T. vivax challenge. Use of Isometamidium-dextran 
complexes has not progressed beyond the experimental stage.
Future Prospects for the Development of New Trypanocides
Up until the early 1960*s several pharmaceutical companies 
were actively involved in the search for novel trypanocides.
Programmes of lead-orientated chemical synthesis were carried out, 
and large numbers of compounds were fed into screening programmes.
From the early 1960!s however, the pharmaceutical companies have 
tended to reduce drastically or cease, their activities in this field.
The reasons for this are complex, but include the escalating cost of 
developing new products - partly due to the increasingly rigorous 
registration requirements, the break-up of the old colonial territories 
and lack of confidence in the political and economic stability of the 
new independent countries. To the large multinational pharmaceutical 
companies the trypanocide market is not always an attractive one.
The countries worst affected by the trypanosomiases are often the 
least-developed, poorest nations, with low and erratic veterinary 
budgets. To develop a new trypanocide in the prevailing economic 
environment would be particularly unfavourable. Even if the considerable 
development costs could be met and a product emerged which met all 
the registration requirements in the various intended markets, the 
financial rewards to the pharmaceutical company would be slight, 
because, to begin with at least, the product would be held in reserve
by/
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by government veterinary services for use only when conventional 
trypanocides had failed. So, although a novel trypanocide, which 
could be used as an effective sanative in the face of resistance to 
the currently available products, would be of great value in the 
field, the profitability of such a product would be low.
Considerably cheaper and therefore more attractive to industry, 
is the development of improved formulations of, and new delivery 
systems for, existing products. Nearly all products currently 
used have, undesirable local and systemic toxic side-effects.
If the duration of prophylaxis achieved by a single administration 
could be lengthened, this also would be beneficial.
New Formulations of Isometamidium
Several possible approaches to new formulations of Isomet­
amidium have been, or are being investigated. As stated earlier, 
dextran complexes have been examined, and although some authors 
reported reduced toxicity and enhanced prophylaxis, they did not 
progress beyond the experimental stage.
Another possibility currently being field tested in Zimbabwe 
is the incorporation of Isometamidium into liposomes. Liposomes 
are concentric shells of phospholipid bilayer membranes with 
aqueous interstices (Marr, 1984), which are prepared by emulsifying, 
under suitable conditions, phospholipids and other lipids in the 
presence of the compound which it is desired to trap within the 
lipid spheruleso The use of liposome delivery systems was 
developed for the chemotherapy of leishmaniasis. It is known 
that liposomes injected into the bloodstream are taken up by the 
reticulo-endothelial/
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reticulo-endothelial system. Since intracellular forms of 
leishmania live predominately within the cells of this system it 
seems an ideal means of selectively delivering the drug to those 
cells in which the parasite occurs. The same is not true for 
trypanosomes, which in the case of T. congolense and T. vivax 
inhabit the bloodstream but do not invade the blood cells, and 
in the case of T.b. brucei also occur in extravascular tissues. 
Liposomes also have some intrinsic drawbacks. It has been 
suggested that they have some adverse pharmacological effects 
themselves (Alving, Steck, Chapman, Waits, Hendricks, Swartz and 
Hansen, 1978)> and there may be problems of stability at extremes 
of temperature and humidity. The economics of liposomal delivery 
systems may also be unfavourable.
It has recently been suggested that isometamidium may be 
metabolized by the bovine to a metabolite of greater trypanocidal 
activity than the starting material (Borowy, personal communication) • 
The successful isolation and identification of such a metabolite, 
or metabolites, could give rise to a new trypanocide which may have 
advantages over isometamidium,e.g. enhanced activity, reduced 
toxicity.
Slow-release technologies are finding applications in 
many areas of veterinary and human medicine. A project has 
recently been initiated under the auspices of the EAO/lAEA to 
investigate possible slow-release formulations for the currently 
available trypanocides. Approaches being considered include 
trapping trypanocidal molecules in polymeric matrices, incorporating 
trypanocidal/
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trypanocidal molecules into the structures of polymers and the use 
of slow-release glasses. By such techniques it may be possible 
to achieve extended periods of protection from compounds with 
prophylactic activity, and it may be feasable to use slow-release 
formations of curative drugs, e.g. diminazene aceturate, as 
prophylactics.
New Approaches to the Development of Trypanocides
The current situation then is one of a small and decreasing 
number of products being available for the prevention and treatment 
of nagana. This situation is exacerbated by the origin of these 
compounds from what Williamson (1976) has described as 'cannabilization 
synthesis', whereby a moiety of one compound is incorporated into 
another, giving rise to, not surprisingly, a high level of cross­
resistance between products.
Against this unpromising background some potentially 
valuable new leads have emerged over the last two decades;.
During this time there has tended to be a shift in both the 
location of, and the approach to, the quest for new trypanocides.
For 60 years or so the search for novel trypanocides was conducted 
by a process of 'intelligent empiricism', with large-scale screening 
of possible products. This was largely carried out by pharmaceutical 
companies in Britain and Germany - both countries with considerable 
colonial interest in Africa. From the early 1960's a shift has 
occurred whereby the bulk of trypanocidal research now takes place 
in academic institutes. A more rational approach has been pursued
W
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in that basic research into trypanosome biochemistry has been 
carried out. This has led to the identification of a number 
of trypanosome-unique metabolic pathways, not found in the host. 
Clearly such pathways are vulnerable to attack by suitable 
inhibitors.
Drug Resistance
The phenomenon of resistance was probably first recognised 
by Kossiakoff (1887), who noted that by exposure to gradually 
increasing concentrations of the antiseptics boric or mercuric 
acid, bacteria could survive in concentrations which previously 
had been toxic. Franke and Rohl, working in Ehrlich1 s laboratory, 
were the first to observe the development of resistance to drugs 
in the course of treatment of the host. They noted that whereas, 
initially, treatment of T.b. brucei infected mice with parafuchsin 
resulted in the temporary disappearance of the parasites, treatment 
of the relapse infection and subsequent relapse infections led to 
a gradual loss of response. Significantly, they also subinoculated 
their relapse strains into new hosts, and demonstrated that the 
resultant infections also failed to respond to treatment with 
parafuchsin (Ehrlich, 1907)* Browning (1907) demonstrated that the 
dyes trypan red and trypan blue could also give rise to resistant 
strains, and since then drug resistant strains have been demonstrated 
for all the economically important trypanosome species and over 
the full range of trypanocidal drugs (Schillinger, 1984)•
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Drug resistance has been defined as 'the ability of a former 
drug exposed trypanosome strain to survive, despite the administration 
of a drug given in doses equal to or higher than usually recommended* 
(Schillinger, 1984). Trypanosomes also exhibit natural tolerance, 
or natural resistance, to certain trypanocides, which is not 
dependant on prior drug exposure (Leach and Roberts, 198t).
For example, T. simiae is naturally tolerant of most trypanocides.
The fact that strains of T. congolense resistant to diminazene 
aceturate were difficult to produce in the laboratory, and yet 
diminazene aceturate resistant strains were isolated in the field 
within 10 months of the trypanocide first being used was considered 
by Jones-Lavies (1968) to be evidence of the natural occurrence 
of strains resistant to diminazene aceturate, rather than due to 
the emergence of resistance as a consequence of under dosing.
The above definition fails to embrace examples in the literature 
of drug resistance apparently occurring spontaneously, without 
prior exposure to the trypanocide to which resistance arose (Eagle 
and Magnusson, 1944)* The situation is also complicated by cross­
resistance, that is when a strain of trypanosome which is resistant 
to one trypanocide is also resistant to a second trypanocide, even 
though it may never have been exposed to the latter.
Much of the early work on resistance and cross-resistance 
in trypanosome infections of cattle was carried out by Whiteside 
in Kenya during the 1950’s, using strains of T. congolense and T. 
vivax (Whiteside, 1960; 1962). Early work had produced conflicting
results where, for example, in some experiments strains resistant 
to/
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to quinapyramine were shown to be cross-resistant to phenanthridines, 
while in other experiments cross-resistance was not demonstrated, 
Whiteside was able to show that much of this confusion was due 
to differences in the degree of resistance exhibited by the strains.
He reported that resistant strains could be produced in the 
laboratory by exposure of infected cattle to repeated subcurative 
trypanocide dosages. The degree of resistance produced appeared 
to increase as the number of such exposures increased. Thus,
Whiteside showed that whereas a strain of T. congolense made 
resistant to four times the minimum curative dose (MCD) of 
quinapyramine was sensitive to normal doses of either homidium 
or diminazene aceturate, if the level of resistance was increased 
further, cross-resistance to diminazene aceturate could be demonstrated. 
Whiteside, therefore, investigated cross-resistance by preparing 
in cattle strains of T. congolense which were highly resistant 
to each of the then available trypanocidal drugs, and tested each 
resistant strain against all the other trypanocides, thereby 
building up a table of cross-resistance.
Hopes that cross-resistance could be simply related to 
chemical structure were not entirely realised so, although cross- 
resistance could be demonstrated between the phenanthridines homidium, 
prothidium and metamidium, high doses of metamidium could still 
be effective against strains directly resistant to homidium. 
Cross-resistance was also demonstrated between chemically unrelated 
drugs, e.g. homidium and quinapyramine, Cross-resistance can 
also/
- 37 -
also occur in one direction only, e.g. strains resistant to diminazene 
aceturate showed no cross-resistance to quinapyramine, whereas cross­
resistance can be demonstrated in the reverse direction.
Development of drug resistant strains in the laboratory
The ease with which drug-resistant trypanosomes can be produced 
in the laboratory varies considerably between strain and species 
of trypanosome, host species and trypanocidal drugs. The method 
generally used to produce resistant strains is to expose a 
population of trypanosomes to subcurative drug concentrations.
This can either be done by allowing an infection to relapse to repeated 
subcurative treatment, or by rapid passage of trypanosomes through 
a series of drug-treated animals. Whiteside (1962) suggested that, 
while drug-resistant strains of T. congolense are relatively difficult 
to produce in mice, in cattle, except for diminazene aceturate, 
Resistance never fails to develop with astonishing rapidity*. His 
method was to treat an infected steer with three to six successive 
subcurative treatments, and he reported that this resulted in a level 
of drug resistance 40 - 80 times the mediam curative dose (cD^q) 
for the initial strain. For example, a strain of T. congolense 
originally susceptible to 0.2 mg/kg pyrithidium was made resistant to 
2.0 mg/kg by three successive treatments at 0.1,;0.1 and 0.5 mg/kg.
Other workers have not found the production of resistant strains to 
be so easy. Stephen (19&3) failed to produce resistance to homidium 
in a strain of T. vivax by a process of subcurative treatment and 
cyclical passage through Glossina palpalis0 Folkers (1966) detected 
no/
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no decrease in sensitivity following repeated use of Isometamidium 
at the low dosage of 0.25 mg/kg? in naturally infected cattle in 
Nigeria.
Several authors have suggested that resistant strains emerge 
more rapidly in the absence of an immune response in the host. An 
advantage of the rapid passage method of producing resistant strains 
in the laboratory may be that it avoids the effect of the host*s immune 
response (Jansco and Jansco, 1935; Schnitzer, Lafferty and Buck,
1946).
Limited work on cloned and natural populations of trypanosomes 
has produced equivocal results. Oehler (1913) found that resistance 
to salvarsan developed as quickly in a cloned population of T.b. 
brucei as in a normal population, although Prowazek (1913) noted 
some differences in sensitivity of cloned and normal populations 
of T.b. rhodesiense and T. equiperdum.
In some cases it does not seem possible to produce resistance 
directly by exposure of a normal trypanosome population to drug, but 
a strain already resistant to one drug can sometimes be readily induced 
to become resistant to another. For example, strains of T.b. brucei 
resistant to tartar emetic could not be produced directly, but were 
readily produced from atoxyl-resistant strains.
A decrease in sensitivity has apparently been brought about 
by a single exposure to drug, both in the laboratory and field, but 
usually multiple exposures are required. Bovet and Montezin 
(1937) demonstrated a marked decrease in sensitivity after a single 
dose/
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dose of 3-hyd.oxymethyl-4-aminophenylarsonic acid, and Wilson (1949) 
found resistant strains of T. congolense and To vivax after a single 
dose of quinapyramine.
In spite of inadequate culture techniques in the past, drug 
resistance has been produced in vitro. Inability to maintain blood 
stream forms for extended periods was overcome by exposing T.b. 
rhodesiense to gradually increasing drug concentrations in vitro 
for 50 minute periods, with alternating passages through mice. By 
this method no decrease in sensitivity was observed during the first 
four passages, but, thereafter resistance developed rapidly (Yorke, 
Murgatroyd and Hawking, 1931)• Recent developments in the in 
vitro culture of trypanosomes, allowing the maintenance of bloodstream 
forms of T. congolense, T. vivax and T.b. brucei. open up new 
possibilities in this area.
Development of Resistance in the Field
Bayer introduced suramin, under the tradename Germanin, in 
1923 and within a few years the first clinical consequences of drug 
resistance were encountered (Knowles, 1927). Resistance to the cattle 
trypanocides dimidium, quinapyramine and homidium emerged soon after 
their introduction, and more recently resistance has been encountered 
to both diminazene aceturate and isometamidium. It is not known 
how drug resistance arises in the field, although it is generally 
thought to occur as a result of underdosing, which can occur for a 
number of reasons: under estimation of bodyweight, error in
preparation/
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preparation of drug for injection or in the calculation of the correct 
dosage, solutions of drug kept for too long before use leading to 
loss of potency, use of counterfeit product - e.g. potassium 
permanganate fradulently substituted for Novidium in Nigeria.
Exposure to high tzypanosome challenge is also considered to be 
equivalent to underdosing by some authors (Whiteside, 1J62),
It is a widely held belief, often repeated in the literature, 
that trypanocides having prophylactic activity are more likely to 
induce drug resistance than those with only curative activity. This 
is based on the theory that, following treatment with a trypanocidal 
drug, there eventually comes a critical point when the level of drug 
in the blood and tissues is sufficiently high to induce resistance, 
but not high enough to prevent infection. Those drugs with 
prophylactic activity are considered to have a longer 1 critical 
period* than curative drugs, which are more rapidly excreted. 
Diminazene aceturate was originally held up as evidence of this 
hypothesis, it being thought that resistance to Berenil did not occur. 
However, although resistance to diminazene aceturate proved difficult 
to bring about in the laboratory, in the early 1960*s the first 
cases of resistance in the field were reported from West Africa 
(jones-Davies, 1967; Na*Isa, 19&7)> niore recently resistance 
has also been reported in East Africa (Mtfambu and Mayende, 1971)*
Well documented cases of resistance to Isometamidium, a drug with 
pronounced prophylactic activity, are relatively few in number, 
which/
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which fails to confirm this hypothesis. Evidence from Eolkers 
(1966) and the Mkwaja Ranch, Tanzania (Trail et al., 1985) 
suggests that exposure to sub-curative levels of isometamidium in 
the field does not necessarily lead to the emergence of resistant 
strains. A prophylactic regime based on Isometamidium has been 
in operation at Mkwaja Ranch, Tanzania, for more than 20 years.
The need for retreatment was assessed by the detection of trypanosomes 
in the blood of a proportion of the herd, and, therefore, some animals 
must have had blood and tissue levels of isometamidium below the 
effective level, which is precisely the situation which is classically 
thought to ensure the development of resistant strains. There is, 
however, no evidence that resistant strains have emerged.
Mechanisms for the Development of Resistance
Drug resistance in micro-organisms is associated with either 
a change in the permeability of the organism to the drug in question, 
or a quantitative or qualitative alteration to a metabolic pathway, 
or inactivation of the drug. In some bacteria the biochemical 
basis of drug resistance is well understood. Resistance to penicillin 
is due to production by resistant organisms of an enzyme, p-lactamase, 
which inactivates penicillin by acting on the p-lactam ring.
Recently this form of resistance has been overcome by the commercial 
production of p-lactamase inhibitors. The situation with trypanosomes 
is less clear. Mechanisms by which drug resistance could occur 
include section mutation and adaptation.
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Hawking (1963a) suggests that a population of trypanosomes 
consists of individuals which exhibit a range of sensitivities 
to any given trypanocide, with the range of drug sensitivities 
describing a normal distribution. Exposure of that population to 
a subcurative drug concentration should result in the elimination 
of sensitive individuals, and to the selection of those individuals 
with drug sensitivities greater than the drug concentration used.
This selection would lead to a downward shift in the sensitivity 
of the population. In practice, although repeated or even single 
exposure to a subcurative drug concentration can lead to a shift 
in sensitivity, particularly in large animal hosts, this is not 
always the case. If mice are infected with a strain of T. congolense. 
treated with a subcurative dose of Isometamidium which brings about 
temporary aparasitaemia followed by relapse, and are then retreated 
at the same dose rate, the second treatment again tends to cause 
a temporary aparasitaemia with subsequent relapse. If a simple 
selection mechanism was operating one might expect the first treatment 
to eliminate the majority of sensitive individuals in the population, 
leaving the most resistant tail of the distribution curve to 
replicate unhindered by the, perhaps, more viable sensitive 
trypanosomes. Repeat treatment with the same dose would then 
be expected to have little or no effect. A possible explanation 
for the observed response is that trypanosomes occupy drug inaccessible 
sites. Although such sites have been demonstrated for T.b. brucei 
in mice (Jennings, Whitelaw, Holmes, ChizyukaandUrquhart, 1979)> they have 
rarely been demonstrated for T. congolense which is generally 
regarded as a strict haemoparasite (Losos, Paris, Wilson and Par,
197?),/
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1973)> except for the initial replication of metacyclic forms 
in the connective tissue at the site of the bite of an infected 
tsetse (Luckins and Gray, 1978; 1979)* There are, however,
two reports in the literature which describe cerebral involvement 
of T. congolense. Haase, Bernard and Guidot (1981) infected 
four cattle with T. congolense. then T. vivax and finally T0b. 
brucei. and then treated them with diminazene aceturate. When 
no trypanosomes could be detected in the peripheral blood the 
cattle were killed and blood and organ macerates were subinoculated 
into rats. In the case of one Zebu, for which sub inoculation of 
blood failed to result in the transfer of infection, subinoculation 
with brain homogenate resulted in the establishment of a T. congolense 
infection in the recipient rat. Masake, Nantulya, Akol and Musoke 
(1984) detected T. congolense in the cerebrospinal fluid of a 
goat which had an intercurrent, chronic T.b. brucei infection.
In both cases it is possible that the presence of T. b. brucei "
resulted in damage to the blood-brain barrier, facilitating the 
entry of T. congolense.
Development of resistance generally proceeds by step-wise 
decreased in sensitivity, possibly indicating a series of mutations 
having a cumulative effect. The rate at which resistance develops 
would then depend on the rate at which mutation occurred.
Characteristics of Resistant Strains
Stability, infectivity and insect transmissibility
The stability of drug resistant strains may be an important 
factor in the spread of resistance. Stability in the absence 
of drug has been shown to vary with the strain and species of 
trypanosome, mode of transmission and drug. At one extreme Fulton 
and Grant (1955) describe an atoxyl resistant strain of T. rhodesiense 
still resistant 24 years after its last exposure to this drug and 
maintained by serial passage. At the other end of the scale,
Unsworth (1954) describes a strain of T. congolense resistant to 
quinapyramine which showed a rapid decline in resistance after 
just 65 days.
Stability of drug resistance may be related to the mechanism 
by which resistance arose. If exposure to drug has been brought 
about by an adaptation, e.g. increased activity of an inducible 
enzyme enabling the organism to survive at higher drug concentration, 
then removal of the drug may result in a rapid return to pre­
exposure sensitivity levels. If on the other hand, resistance 
was due to mutation, then removal of drug may be less important.
Loss of resistance would then be dependant upon the rate of back 
mutation, and the relative competitive advantage of mutant and 
wild type individuals.
Several workers have demonstrated that resistant strains 
can be transmitted cyclically by tsetse flies in a laboratory 
environment, and that strains transmitted under such conditions 
are usually stable. Yorke, Murgatroyd and Hawking (1933) and 
Murgatroyd/
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Murgatroyd and Yorke (1937) demonstrated that tryparsamide resistance 
of T.b. brucei was unaffected by transmission through G. morsitans 
or G. nalpalis. and Van Hoof and Henrard (1934) made a similar 
observation with a strain of T.b. gambiense. Similarly the 
quinapyramine resistance of a strain of T. vivax was unaffected 
by transmission through G. palpalis. Gray and Roberts (1971) 
transmitted a drug resistant strain of T. vivax through antelope 
and cattle by cyclical transmission. Resistance to diminazene 
aceturate (7.0 mg/kg) and quinapyramine sulphate (5.0 mg/kg) was 
retained for 7 months in tsetse and antelope, and 29 months in 
tsetse and cattle. Nyeko, Ssenyonga, Golder and Otieno (in press) 
detected no change in sensitivity of an Isometamidium resistant 
strain of T. congolense after 12 cyclical passages, although a 
slight, statistically significant reduction was detected with 
the same strain after 15 needle passages in mice.
There are numerous examples in the literature of cyclical 
transmission of drug resistant strains in the field (Fiennes,
1953> Williamson and Stephen, 1960; Jones-Davies, 1968). Studies 
of the stability of resistant strains in the field in the absence 
of drug have produced conflicting results. Fiennes (1953) 
isolated quinapyramine resistant strains of T. vivax and T. congolense 
in an area from which all drug treated cattle had been removed 
5 - 7 months previously. Jones-Davies (1968) reported homidium 
resistant strains of T. congolense in tsetse flies in Nigeria, 
despite homidium having been withdrawn from use in the area two 
years earlier, to be replaced with diminazene aceturate. Other 
workers have found that resistant strains of T. vivax and To
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congolense tend to disappear from tsetse, 6 - 9  months after 
cattle are removed and the use of the drug in question suspended 
(Whiteside, i960).
Viability of resistant strains
If continued exposure of trypanosomes to subcurative drug 
concentrations • inevitably leads to the development of resistant 
strains, the problem of drug resistance might be expected to be 
more widespread than is the case. Prophylactic drugs, such as 
Isometamidium, are often used such that a proportion of the animals 
at risk are allowed to become reinfected, or to relapse, before 
repeat prophylaxis is carried out on a herd basis. This means 
that trypanosomes are regularly being exposed to subcurative drug 
concentrations as blood and tissue levels decline towards the end 
of the prophylactic period. As previously described, this was 
the basis on which prophylactic cover was provided for up to 12,000 
cattle at Mkwaja Ranch, Tanzania for over 20 years from the 
introduction of Isometamidium on the ranch in 1963 (Trail et al.t 
1985)* During this period no problems of drug resistance were 
encountered, and although diminazene aceturate was occasionally 
used in some animals it was not used in a regulated manner as a 
1 sanative1. The classical theories of the development of drug- 
resistant strains predict that in the conditions described, in 
an area of very high trypanosome challenge, resistant strains would 
have readily emerged.
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At Galana Ranch, Kenya, during 1984/85> an outbreak of 
acute, haemorrhagic T. vivax occurred for which Isometamidium 
prophylaxis was ineffective (Rottcher and Schillinger, 1985 5 
Njogu and Heath, 1986). Experimental herds of cattle were 
established in the area soon after, and despite weekly monitoring, 
no further evidence of drug resistance was subsequently detected.
One explanation for these observations is that some drug 
resistant strains of trypanosomes cannot successfully complete 
with strains of normal sensitivity. This could be because the 
resistant individuals replicate more slowly than normal individuals, 
and so eventually the latter simply overgrow the former (Hawking, 
1963a).
Reduced growth rate of drug resistant, as compared to 
parent strains has been reported for both bacteria (Mayr-Harting, 
1955^ and Plasmodium galinaceum (Bishop and McConnachie, 1950)* 
Limited investigation using mixtures of resistant and normal strains 
suggest that, for some strains at least, the resistant strains 
may be at a competitive disadvantage compared to a normal strain. 
Both a salvarsen resistant strain of T. gambiense in mice (Oehler, 
1914) and an oxophenarsine resistant strain of T. equinerdum 
in rats (Cantrell, 1958) disappeared in the presence of intercurrent 
infections of normal sensitivity.
Drug uptake
One possible mechanism for reduced sensitivity of drug 
resistant strains of t r y p a n o s o m e s  is reduced uptake of drug.
Several workers have demonstrated that resistant strains take up 
drug more slowly than sensitive strains. Taking advantage of 
the/
/
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the fluorescent properties of the drug, Hawking and Smiles (194*1) 
looked at fluorescence of T. equiperdium after in vitro treatment 
with diamidinostilhene, and predicted that resistant strains would 
exhibit less fluorescence than sensitive ones. Fulton and Grant 
0955) compared uptake of stilbamidine, and showed that the resistant 
strains absorbed less drug than the normal strain. Damper and 
Patton (1976) used ^H-labelled pentamidine to demonstrate a 
lower rate of pentamidine transport in drug resistant T.b. brucei 
strains compared to a strain of normal sensitivity, and also in 
T.b. rhodesiense which is naturally less sensitive to pentamidine 
than T.b. brucei.
Course of parasitaemia
Several authors have compared the course of parasitaemia 
of drug-resistant and sensitive strains. Tobie and Brand (1953) 
working with arsenic-resistant T. b. gambiense described a pattern 
of infection in rats infected with normal strains associated with 
continuous parasitaemia, compared with a predominance of intermittent 
relapsing parasitaemias in rats infected with resistant strains. 
Williamson and Stephen (i960) concluded from work on the development 
of resistant strains in rodents that an increase in resistance 
was manifest by a decrease in the period from subcurative treatment 
to subsequent relapse infection, and proposed a test for drug 
resistance based on this observation.
Stephen (1962) noted that breakthrough infections occurring 
towards the end of the protection period afforded by prophylactic 
drugs were often of a scanty and sporadic nature, particularly 
for/
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for T. congolense, with trypanosomes appearing at irregular intervals 
and in very low numbers. In cases where the relapse infection 
was T. vivax, however, parasites were present in moderately large 
numbers and appeared at quite regular intervals. Similarly with 
T. simiae infections in pigs, Stephen and Gray (i960) reported 
that breakthrough and relapse infections tended to be mild, and 
parasitaemias were usually, although not always scanty.
Hill (1962) investigated the nature of breakthrough strains 
of T. congolense in mice after treatment with experimental 
phenanthridines, and described a low grade, chronic relapsing 
course which was quite different from the acute or subacute course 
of the parent strain in untreated mice.
Pathogenicity
In experiments using wild caught tsetse as the source of 
infection, Stephen (i960) suggested that there was evidence that 
the trypanosomes occurring in breakthrough infections were less 
pathogenic than the trypanosomes infecting control animals that 
had not received a prophylactic drug. Cattle with breakthrough 
infections of T. congolense gained weight, did not become anaemic 
and did not die. Where the breakthrough infection was T. vivax 
two out of three cattle lost weight and developed a moderate anaemia 
although none died. In contrast three control animals that 
received no prophylactic drug died of mixed T. vivax/T. congolense 
infections.
In T. simiae infections in pigs, although the parasitaemias 
of breakthrough infections tended to be scanty, the trypanosomes 
causing/
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causing those infections had not lost their pathogenicity (Stephen 
and Gray, i960). Hill (1962) also reported that the low grade 
chronic infections he obtained with breakthrough T. congolense 
infections in mice were not due to reduced virulence of the strains. 
He demonstrated this by subinoculating mice with breakthough 
strains, and found the number of days to mortality was the same 
as the parent strain. He considered the difference in character 
of the breakthrough strains was probably due to the combined 
action of the drug and the Immune system of the host. Recent 
experiments in cattle, however, have failed to demonstrate a 
detectable immune response in animals protected by Isometamidium 
prophylaxis (Whitelaw, Bell, Holmes, Moloo, Hirumi, Urquhart and 
Murray, 1986).
Resistance to Isometamidium
Relatively few reports have appeared in the literature 
regarding resistance, or reduced sensitivity, to Isometamidium.
Lewis and Thomson (1974) mention two earlier reports of strains 
of T. vivax and T. congolense that were resistant to 0.25 and 0.5 
mg/kg Isometamidium. The reports they cite, dated ^^GrJ and 1970, 
are both annual reports of the Branch of Tsetse and Trypanosomiasis 
Control, Ministry of Agriculture, Rhodesia (Zimbabwe). The 19^7 
report seems to contain the earliest reference to resistance 
arising to Isometamidium in the field. Lewis and Thomson (1974) 
report a strain of T. congolense isolated from the Masumo and 
Logolo Valley region of Rhodesia where chemoprophylaxis had been 
in use since 1958. Initially quinapyramine prosalt was used 
with/
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with diminazene aceturate as a sanative. Isometamidium was 
first used in 1962/3, and replaced quinapyramine, due to resistance 
becoming a problem, in 1987*
Treatment was administered every 12 weeks at 1 mg/kg 
Isometamidium, with an extended period of 16 weeks when oxen 
were required for ploughing. Approximately 2,300 cattle were 
maintained in the area, which was within the flybelt. Up to 
2.5% of animals failed to be presented for treatment. In 1968/69 
no sanatives were employed, but the use of diminazene aceturate 
was reintroduced in 1970, 3*5 mg/kg being administered every 6 
months, 4 weeks prior to a routine Isometamidium treatment.
From 1970 onwards there was evidence that a reduced period 
of protection was being achieved. In March 1972 strains of T. 
congolense were isolated from infected animals and stabilates 
prepared for storage in liquid nitrogen. Two isolates were used 
to infect two trypanosome naive bovines, which were maintained 
outside the tsetse-infested area. Bovine 1 developed patent 
parasitaemia 23 days post-infection and was treated with 1 mg/kg 
Isometamidium. A relapse infection was detected 50 days post­
treatment, after which treatment was repeated at the same dose, 
resulting in a 150 day parasite-free period. Bovine 2 became 
parasitaemic 21 days post-infection, and relapsed 48 days after 
treatment at 1 mg/kg. Repeat treatment at 1 mg/kg resulted in 
a relapse infection 83 days post-treatment. Treatment at 2 mg/kg 
resulted in a 150 day parasite free period. It was concluded that
resistance of a strain of T. congolense to 1 mg/kg Isometamidium 
had been demonstrated after the drug had been used for prophylactic 
protection for 4 years.
Gitatha (1981) reports the isolation of a strain of 
T. congolense from the Shimba Hills Settlement Scheme, Kwale 
District, Coast Province, Kenya, which demonstrated resistance 
to quinapyramine, diminazene aceturate, homidium chloride and 
bromide and Isometamidium. The results of an Isometamidium 
sensitivity test in cattle were variable: of 5 animals infected
with the strain, two were cured at 0.5 mg/kg, one at 2.0 mg/kg 
and two at 4*0 mg/kg. Although quinapyramine methyl sulphate and 
prosalt, homidium bromide and diminazene aceturate were all used 
in the Shimba Hill Scheme between 1958 and 1971 > Isometamidium has 
never been used. Irregular treatment of cattle in the scheme, with 
up to 50% not being presented for treatment on some occasions, is 
thought to have led to the development of multiple drug-resistance, 
and it is speculated that resistance to Isometamidium has arisen due 
to cross-resistance from the development of resistance to quinapyramine. 
An unusual feature was resistance to both diminazene aceturate and 
Isometamidium, two trypanocides normally considered to be an effective 
•sanative pair1.
Bourn and Scott (1978) describe the use of Isometamidium 
in an agricultural development scheme in the Angar Valley, a tsetse 
infested area of Ethiopia. Initially diminazene aceturate was 
used to protect the draught oxen at a dosage of 3*5 mg/kg.
However, in January 1973> an infection rate of 92% was detected,
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27 days post-treatment and so the move was made to a prophylactic 
drug, Isometamidium. The dosage was 1 mg/kg with repeat treatments 
scheduled every 8 weeks. In fact, the second treatment was given 
89 days after the first, and 36 days after the third treatment 66% 
of the oxen were found to he infected, the majority with T. congolense. 
Emergence of Isometamidium resistance was suspected, and further 
evidence was obtained when it was shown in mice that T. congolense 
isolates from Augar Gutin were resistant to the phenanthridine drug 
homidium bromide (Scott and Pegram, 1974)* It is significant, 
however, that despite the proven existence of phenanthridine-resistant 
trypanosomes, the work oxen in the area remained in good condition. 
Isometamidium continued to be used until January, 1974> after which 
diminazene aceturate and Isometamidium were used alternately for 
approximately 9 month periods, in an attempt to control development 
of drug resistant strains.
Kupper and Wolters (1983) investigated drug resistance 
in a feedlot in northern Ivory Coast. Many of the slaughter cattle 
in the Ivory Coast originate from Mali or Upper Volta (Burkina Easo) 
and are fattened in the Ivory Coast. Cattle are treated with 
trypanocides at the point of entry, and then in the case of cattle 
destined for the feedlot at Fencessendongon, are trekked through 
tsetse-infested country for 2 - 3  weeks. Cattle arriving at the 
feedlot generally became infected within 2 - 4  weeks of arrival, 
although tsetse are reported to be scarce. Diminazene aceturate 
had been used at 3*5 and 5.0 mg/kg, but within 8 days 4&/o of 
treated cattle had become reinfected with T. vivax and/or T. 
congolense./
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congolense. A trial was therefore carried out in cattle to 
investigate drug efficacy. The results are difficult to interpret 
in the form presented, and are complicated by the late arrival 
of Isometamidium for inclusion in the trial. Rapid reinfection 
was demonstrated, however, following treatment at up to 1 mg/kg 
Isometamidium. The breakthrough infections were also resistant 
to homidium chloride at 1 mg/kg. Diminazene aceturate at 7 mg/kg 
eliminated trypanosomes for 28 days, and is concluded to be the 
drug of choice in this location. It is noted that swellings and 
abcesses occurred at the site of injection of Isometamidium, 
suggesting poor injection technique, and this may have influenced 
absorption of drug.
Pinder and Authie (1984) report the appearance of 
Isometamidium resistant T. congolense in cattle in Upper Volta 
(Burkina Paso). The reappearance of patent parasitaemia, mainly 
T. congolense, as early as two weeks after treatment with 
Isometamidium at 1 mg/kg suggested the existence of resistant 
strains. This was investigated using mouse sensitivity tests. 
Strains were also available from the areas in question, which had 
been isolated two or more years earlier, prior to the widespread 
use of the drug. The mouse tests showed that most T. congolense 
stocks isolated in 1982/83 were 4 - 8  times less sensitive to 
Isometamidium than those which had been isolated in 1979/80.
Authie (1984) also reported that some of the strains shown to 
be resistant to Isometamidium were also resistant to diminazene 
aceturate.
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Relapse Not Due to Resistance
When a therapeutic drug fails to achieve a sterile cure, 
or a prophylactic drug fails to confer the expected duration of 
protection, and after the possibility of accidental or fradulent 
underdosing has been eliminated, the usual conclusion is that a 
drug resistant strain of trypanosome has been encountered. There 
are, however, other explanations. Jennings and coworkers (1979) 
have demonstrated the importance of * privileged sites® in experimental 
infection of T.b. brucei in mice, that is locations in the body 
which trypanosomes can invade, but which are inaccessible to drugs.
In a series of experiments, they showed that the ability of diminazene 
aceturate to cure T.b. brucei infections in mice was related to the 
delay from infection to treatment. Treatment at 3 days post-infection 
resulted in a 100% cure rate, but if treatment was withheld until 
days 14 or 21, many mice went on to develop relapse infections. 
Carefully controlled organ transfer experiments demonstrated that 
the location of the cryptic trypanosome focus responsible for the 
relapse infection was the brain.
In the case of a prophylactic drug, even if trypanosomes 
could gain access to drug inaccessible sites, this should not affect 
the prophylactic period. In the curative situation it is envisaged 
that trypanosomes re-emerge from the privileged sites, and as soon 
as the trypanocide concentration decreased below the effective 
level, re-emerging trypanosomes can proliferate and become detectable. 
Trypanosomes re-emerging in an animal protected by a trypanocide 
with/
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with prophylactic activity should still succumb. Jennings1 work 
was with T.b. brucei, a trypanosome known for its ability to 
invade tissue as well as blood. T. congolense, however, is 
generally regarded as strictly vascular. Evidence for extra- 
vascular development of T. congolense has, until recently, been 
limited to reports of short-term development at the site of an infected 
tsetse bite, i.e. the chancre (Luckins and Gray, 1978)*
Masake et_al., (1984)> however, have demonstrated T. congolense 
in the cerebrospinal fluid of Boran steers inoculated with mixed 
T. brucei /congolense infections, but not in animals infected only 
with T. congolense. The authors point out that since mixed 
infections are commonly encountered in the field, invasion of the 
central nervous system poses a problem for chemotherapy since the 
drugs currently available do not penetrate the blood-brain barrier.
MacLennan (1973) has demonstrated a period of aparasitaemia 
in cattle infected with T. vivax and treated with diminazene aceturate, 
during which subinoculation of blood into naive cattle feiiled to 
result in the establishment of infection in recipients, suggesting 
the existence of a site inaccessible to drug. Haase et al (1981) 
demonstrated that homogenates of brain tissue obtained from cattle 
which had been infected with T. congolense and treated with diminazene 
aceturate, resulted in the establishment of infection in recipient 
rats, whereas subinoculation of blood failed to do so.
A further possibility to explain relapse infections is due 
to the presence of species of trypanosome naturally insensitive to 
the trypanocide in use. For example, it has been suggested that 
some/
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some cases attributed to drug resistant T. congolense may have been 
due to T. simiae infections. T. simiae is naturally insensitive 
to the range of currently available tzypanocides, and also is 
indistinguishable from T. congolense morphologically. The two 
species can, however, be distinguished by the course of infection 
in pigs. T. simiae runs a rapid, fatal course in pigs, whereas 
T. congolense has a more chronic course. It is, therefore, 
desirable that suspected drug resistant strains of T. congolense 
are inoculated into pigs to eliminate this possibility, until such 
times as more convenient diagnostic techniques become available, 
such as species-specific DNA probes.
The control of African bovine trypanosomiasis is likely to 
remain heavily dependent on a small number of trypanocidal drugs 
for the foreseeable future. It is therefore important that those 
drugs which are available are used to the best effect, and that 
appropriate steps are taken to limit the development of drug resistant 
strains. Effective methods of monitoring the drug sensitivities of 
field isolates of trypanosomes are an important element in the overall 
trypanosomiasis control strategy. This thesis is therefore primarily 
concerned with the evaluation of several methods, both in vivo and 
in vitro, of assessing the Isometamidium sensitivities of strains of 
T. congolense. Experiments are also described relating to attempts 
to produce Isometamidium resistant strains of T. congolense in mice 
and goats, and to the relative viability of Isometamidium sensitive 
and resistant strains of T. congolense.
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CHAPTER TWO
GENERAL MATERIALS AND METHODS
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Experimental Animals
Mice: For most of the experiments described in this thesis,
female CD1 strain mice, 6 to 8 weeks old at the beginning of 
each experiment were used (Charles River, England). Exceptions 
were the mouse sensitivity tests performed concurrently with 
the cattle sensitivity test (pp. 85-95) for which female randomr- 
bred Swiss mice, 20 - 50 g bodyweight, were used. For routine 
sub inoculation of cattle blood during this experiment, outbred 
mice from the Kenya Trypanosomiasis Research Institute (KETRl) 
closed colony were used.
The mice used as donors for the study of the aparasitaemic 
interval following subcurative treatment, were CD1 ex-breeder 
females. These larger mice were used because of the need to 
obtain daily 0.1 ml blood samples for sub inoculation.
All mice were maintained under standard laboratory conditions.
Goats: Castrated male, British cross-bred goats were
obtained from a commercial source, at 6 to 18 months of age.
Prior to infection, goats were treated with an anthelmintic (Panacur, 
Hoechst, W. Germany), long acting oxytetracycline (Terramycin 
LA injectable solution, Pfizer, England) to prevent respiratory 
infections and an ectoparasitic dusting powder (Louse Powder,
Cooper Animal Health, England) • Goats were kept in fly-proof 
housing and maintained on a diet of hay, ad libitum, supplemented 
with concentrates • (0.5 kgy d, 506 Ewbol Store Lamb Finisher Pellets, 
BOCM Silcock LTD., England) and occasionally small quantities of 
cabbage./
cabbage. Water, rock-salt and a mineral lick (Super Chelated 
Rockies, Tythebam Ltd., England) were always available.
Cattle: Trypanosome-naive, Boran steers, originally
obtained from a tsetse-free region of Kenya were housed in indivual 
stalls in fly-proof accommodation at KETRI. Cattle were maintained 
on a diet of hay, ad libitum, supplemented with concentrates 
(Ranchcubes, Unga Feeds Ltd., Kenya) at the rate of approximately 
0.5 kg per head per day. Water and a mineral lick (MacLick, Twiga 
Chemicals Ltd., Kenya) were always available. Prior to the start 
of an experiments, cattle were treated with an anthelmintic (Nilzan, 
Wellcome Kenya Ltd., Kenya) and, as a precaution against tick- 
borne disease, cattle were sprayed with an acaricide (Delnav, 
Wellcome Kenya Ltd.,) once a week. One steer in the first phase 
of the experiment developed muscular dystrophy. All cattle in the 
second phase of the experiment were therefore treated with an 
injectable selenium/vitamin E preparation (Bystosel, Intervet, 
England) prior to the start of the experiment.
Trypanosomes
The following strains of trypanosomes were used in the 
experiments described in this thesis:
T. congolense KETRI 2880 (ILRAD 2856), a derivative of an 
isolate (Banankeledage/85/CRTA/67) prepared from a steer in Burkina 
Faso, and reported to be partially sensitive to Isometamidium at 
4 mg/kg in mice (Pinder and Authie, 1984)* The isolate was 
passaged eight times in rodents before being stabilated as KETRI 
2880.
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T1__congolense KETRI 2885 (ILRA.D 5055), a derivative of an 
isolate made from a steer maintained under Isometamidium prophylaxis 
at Muhaka, Coast Province, Kenya. The primary isolate was 
passaged in a goat and then further passaged nine times in rodents 
before being treated with Isometamidium at 2 mg/kg. The relapse 
infection was passaged twice in rodents before being stabilated as 
KETRI 2885.
T±_congolense KETRI 2885 (il Nat. 5*1)> a doubly cloned 
derivative of an isolate originally made from a lion in Serengeti 
National Park (Geigy and Kauffman, 1973; Nantulya, Musoke,
Rurangirwa and Moloo, 1984), known to be sensitive to 0.5 mg/kg 
Isometamidium in mice (Whitelaw, Bell, Holmes, Moloo, Hirumi,
Urquhart and Murray, 1986).
T. congolense 12/1, originally obtained from Professor Lumsden, 
London School of Hygiene and Tropical Medicine, and passaged in 
mice, some of which had been treated with suramin (20 mg/kg).
T. congolense 82/1. originally obtained from Professor 
Vickerman, University of Glasgow (TC 1). The strain had been 
passaged in rodents and exposed to suramin (20 mg/kg)during some 
passages.
Cryopreservation of T. congolense
Trypanosomes for cryopreservation were harvested from mice 
or rats close to the first parasitaemic peak, by cardiac puncture 
under terminal anaesthesia. The volume of infected blood collected 
was then measured and 10% (v/v) glycerol was added dropwise. The 
blood/
Table 3 Composition of PBS and ESG buffers
PBS
Disodium hydrogen phophate
Na HPO (anhydrous) 13.48 g
2 4
or if dodecahydrate 34.01 g
Sodium hydrogen phosphate
NaH PO . 2H 0 0.78 g
2 4 2
Sodium Chloride
NaCl 4.25 g
made up to 1 litre with distilled water and used as 6 volumes PBS 
to 4 volumes distilled water. pH 8.0.
ESG
Sodium Chloride 
NaCl
Potassium dihydrogen orphophosphate
KH PO 
2 4
EDTA
Glucose
Indicator *
Distilled water
adjust pH to 7.4 with NaOH
* Indicator: lg phenol red
4g NaCl
distilled water to 500 ml.
8.0 g
0.3 g
2.0 g
2.0 g
5 ml 
1000 ml
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blood/glycerol emulsion was well mixed using a glass rod, and left 
to equilibriate for 5 minutes on ice, after which it was either 
placed in screw-top plastic vials, or was taken up in glass capillary 
tubes which were then flame sealed. The vials, or capillary 
tubes packed into screw-top plastic tubes, were suspended in the 
vapour phase of a liquid nitrogen Dewar flask, gradually lowering 
the containers closer to the liquid nitrogen surface. Finally 5 
to 24 hours later, the stabilates were stored in liquid nitrogen. 
Preparation of Inocula
Cryopreserved trypanosomes were rapidly thawed either by
rolling the plastic vial between the fingers, or plunging capillary
tubes into water. Thawed, infected blood was diluted with
approximately 1 ml of phosphate buffered saline (PBS, see Table 3 *
EDTA-saline-glucose buffer (E3G) was substituted for PBS in the
cattle/mouse sensitivity experiments), and the trypanosome density
estimated using a haemocytometer.
5For mice, 1 x 10 trypanosomes was the standard infective 
inoculum, administered in a volume of 0.2 ml PBS by intraperitoneal 
(ip) inoculation using a 25g, 5/8" needle, into the left side of 
the body to avoid the spleen. When intravenous (iv) inoculation 
was required, mice were anaesthetized (Hypnorm, Pfizer, England) 
approximately 15 minutes before inoculation, and were placed under 
heat lamps to ensure vasodilation. Intravenous inoculation was 
carried out using a 25g, 5/8" needle and syringe, into a tail-vein. 
The vein was occluded to raise the vessel and a volume of 0.2 ml of 
inoculum injected.
- 6 5  -
For cattle and goats the standard, infective inoculum was
51 x 10 trypanosomes administered in a volume of 4 ml PBS, by iv 
inoculation into the jugular vein.
Trypanocidal Treatment
Mice were treated with Isometamidium by ip injection.
The selected dose was administered at the rate of 0.1 ml Isomet­
amidium solution per 10 g bodyweight. A dose of x mg/kg was 
prepared by weighing x mg of Isometamidium, and making up to 10 ml 
with distilled water. If x < 10 mg, then the final concentration 
was achieved by serial dilution.
Goats were treated by deep intramuscular injection into 
the quadricep femoris muscle of the hind leg, using a 20 g, 1" 
needle and syringe. Successive treatments were administered alter­
nately into the left and right leg.
Cattle were treated by deep intramuscular injection into 
the middle third of the neck. When the injection volume exceeded 
1$ ml, the dose was divided between the left and right sides.
For ruminants the Isometamidium concentration used varied 
with the dose administered. In goats, dosages up to 0.2 mg/kg 
were prepared at 0.25% (w/v) solutions using distilled water. 
Dosages of 0.5 mg/kg were prepared as 1% (w/v) solutions, while 
dosages of 1 .0 mg/kg and above were prepared as 2% (w/v) solutions. 
All Isometamidium solutions were used within our hour of 
preparation.
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Trypanosome Detection Methods 
Mice
Wet-film: mice were bled by venesection at the tip of the
tail, and collecting a drop of blood on to a microscope slide.
The blood was covered by a coverslip (7 x 22 mm) and examined 
at x 400. Twenty microscope fields were examined and the number 
of trypanosomes counted was converted to trypanosomes per ml of 
blood by the method of Herbert and Lumsden (1976).
Capillary concentration: mice were bled by tail venesection 
and 50 jil of blood was collected using a micropipetter (Volac,
England). The blood was dispensed into a well of a microtitre 
plate, 50 |ol of diluent added (9% glycerol (v/v); 9% magnessium
sulphate (w/v); 0.1% THIS buffer (w/v), pH 8.0; phenol red 1:100,000
in distilled water) and mixed. The microti tre plates were kept 
at room temperature and 15 minutes later samples were taken up in 
plain capillary tubes, sealed at one end (Crystaseal, Hawksley,
England) and centrifuged using a micro-haematocrit centrifuge (Hawksley, 
England) for 2 minutes. The capillary tubes were then cut, such 
that the retained portion contained approximately 1 mm of red blood 
cells, the buffy coat and the plasma. The red cells, buffy coat 
and approximately 10 mm of plasma were expelled on to a microscope 
slide, mixed and examined at x 400. Approximately 200 microscope 
fields, over the entire preparation, were searched for trypanosomes.
Goats
A jugular blood sample was obtained using a heparinised 
evacuated blood collection tube (75 x 13 mm Vacutainer, Becton 
Dickinson,/
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Dickinson, England). Blood samples were placed on a rotary 
mixer for at least 5 minutes to ensure homogenous samples were 
obtained, and then plain capillary tubes were filled, sealed at 
one end with Crystaseal, and centrifuged for 5 minutes using 
a micro-haematocrit centrifuge. Examination of the buffy coat 
was carried out as described above.
Cattle
A peripheral blood sample was obtained by puncturing a 
marginal ear-vein with a sterile lancet, and collecting blood 
directly into a heparinised capillary tube, which was then sealed 
at one end with modelling clay. Samples were then processed 
as described above.
Packed Cell Volume
Packed cell volume (PCV) was determined using a jugular 
blood sample, prior to examination of the buffy coat in goats, or 
by a similar procedure, but using a specially collected jugular 
sample, for cattle. Blood samples were centrifuged in a micro- 
haematocrit centrifuge for 5 minutes and PCV*s read using a 
microhaematocrit reader (Hawksley, England).
Rectal Temperature
Rectal temperatures were measured in goats and cattle at 
approximately 09.00 hours, using a standard clinical thermometer. 
Euthanasia
Mice and rats were killed by inducation of deep anaesthesia 
using trichloroethylene (Trilene, ICI, England) followed by 
cervical dislocation.
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Goats were killed by overdosing with pentobarbitone 
(Euthatal, May and Baker, England), administered by rapid injection 
into the jugular vein.
At the end of an experiment cattle were generally cured 
by chemotherapy (isometamidium or diminazene aceturate) and then 
disposed of to commercial outlets for slaughter.
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CHAPTER THREE 
In vivo Approaches to the Assessment of Isometamidium
Sensitivities of Strains T. congolense
68 -
INTRODUCTION
Drug resistance is usually suspected in the field when 
either a prophylactic drug has apparently failed to confer the 
expected period of protection, or a curative drug has failed to 
achieve a sterile cure. The existence of drug resistant strains 
of trypanosomes, though important, is only one of many possible 
explanations for such failures. The animals may have been under­
dosed because bodyweight was underestimated. Very often weigh 
crates are not available, and in any case groups of cattle are often 
treated with a standard dose. Larger than average animals are, 
therefore, at particular risk from underdosing. The drug may 
have been prepared incorrectly or kept too long before use,, or 
exposed to too high temperatures, leading to loss of potency. It 
may have been administered incorrectly; for example the trypanocide 
homidium chloride (Novidium, May and Baker, England) is supplied 
in tablet form, and it is intended that it should be broken up, 
dissolved in water and administered by deep intramuscular injection. 
Cattle owners in the north of Kenya favour this product, finding 
it more convenient than trypanocides in powder form, but have been 
known to misuse it by inserting whole tablets into bovine orifices 
or even placing tablets in incisions made in the neck which are then 
held in place by acacia thorn sutures (J. Waitumbi, personal 
communication). The material used may not have been trypanocide 
at all, but some similar looking material fradulently passed off 
as/
- 69 -
as the authentic product: potassium permanganate has been made
into tablets, embossed with the name Novidium and offered for sale 
in authentic looking packaging in Nigeria (E.WoGo Crouch, personal 
communication). Individual animals may have missed treatment, by 
failing to be presented for treatment, by escaping from the collecting 
pens, or crush, or accidental ommision.
There is also the possibility of relapse due to re-emergence 
from drug inaccessbile sites (see p. 55)* Misdiagnosis of the original 
problem may explain the apparent failure of the trypanocides to 
have an effect: conditions such as liverfluke, heartwater or even
starvation may be implicated (Jones-Davies and Eolkers, 1966).
The presence of mixed infections of trypanosome species or incorrectly 
identified species may also confuse the situation.
To prove that drug resistant trypanosomes are, in fact, 
involved then it is necessary to first discount these and other 
possibilities, and secondly to demonstrate the response of the 
trypanosomes involved to treatment under carefully controlled 
conditions. Ideally this should be carried out in the host species 
of interest, ie in Bos indicus cattle for strains isolated from 
East African zebu. Although this approach would allow a high 
degree of confidence in the results obtained, it would be very expensive 
in terms of animals, space, facilities and resources; prohibitively 
so for routine examination of field isolates. Most strains of 
T. congolense can be established and maintained in rodent hosts, 
and mice are most often used for trypanocide sensitivity testing.
Mice clearly offer considerable advantages in terms of ease of handling 
and/
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and overall economy, and because it is possible to use larger 
numbers of animals in a mouse test, experiments of superior 
experimental design can be carried out in terms of the number of 
treatment groups and number of replicates. There is also the 
advantage that whereas parasitaemias of -T. congolense in cattle 
tend to be low-grade, parasitaemias in mice tend to be higher; and, 
therefore, more easily detected: simple examination of blood wet-
film preparations can be used in place of the more sophisticated 
concentration techniques which may be needed for cattle.
Drug resistant strains of T. vivax present a different 
problem because the vast majority of strains will not infect rodents. 
Williamson and Stephen (i960) reported that sheep were easily 
infected with tsetse-borne T. vivax. and, being more economical to 
use than cattle, were'well suited to drug sensitivity investigations. 
Ilemobade, Leeflang, Buys and Blotkamp (1975) used a local breed 
of sheep for the isolation and assessment of the homidium sensitivity 
of isolates of T. vivax collected from cattle in Nigeria, but noted 
that exotic or cross-bred cattle were more readily infected than 
local breeds of sheep or goats. On the other hand, Schoenefeld, 
Rottcher, Schillinger and Gorton (1986) considered that small 
ruminants, even if splenectomized, were not suitable hosts because 
of their capacity to control parasitaemia and they concluded that 
drug sensitivities of T. vivax should be investigated in the bovine. 
Birug sensitivity studies of T. vivax are, therefore, of necessity 
relatively difficult and expensive to conduct.
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A drug sensitivity test, whether conducted in laboratory 
or large animal hosts, requires a uniform batch of trypanosome- 
naive animals free from intercurrent disease. Infection with 
the strain of interest is usually effected by needle challenge using 
a standard sized inoculum. Groups of experimental animals are 
then treated at a predetermined stage of parasitaemia with one 
of a range of drug levels, or are left untreated as infection 
controls. After treatment the animals are monitored for a period 
of time long enough to be reasonably sure that all potential relapse 
infections have occurred. The two drug dosages identified in 
sensitivity tests are conventionally the lowest drug dose which 
will temporarily clear an infection (ie reduce the parasitaemia 
below the limit of detection of the method employed) from the blood 
of all, or a proportion, of the test groups, and secondly, the 
lowest dose which will achieve a sterile cure in all, or a proportion, 
of the test group. The terms minimum effective dose (MED) and 
minimum curative dose (MOD) are used to describe these two para­
meters. Different workers report varying proportions of test animals 
in their MOD and MED values, largely reflecting different experimental 
design. Hawking (1963a), for example, reported EDqq and ^go 
values, ie the minimum dosage having the appropriate response in 
at least 80% of the test group, while Authie (1984) reported ED^^ 
values. The proportions selected seem to be less due to a 
consideration of statistical significance, but for convenience 
with regard to group size: Hawking tended to use five animals per
treatment group, so that 80% represents four out of five responses, 
while/
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while Authie used four animals per group. A dose which will 
bring about temporary clearance of trypanosomes from the blood is 
of no real practical significance, but is more readily determined 
than a curative dose.
The results of a mouse sensitivity test are only of 
value if they can be related in a predictable manner to the results 
achieved in cattle. There are obvious differences between the 
two species: a 10,000 fold difference in bodyweight and different
routes of drug administration, usually intraperitoneal in the 
former, intramuscular or subcutaneous in the latter. The pharma­
cokinetics and metabolism of the drug may vary between the two 
species and host-parasite relationships may also differ.
Surprisingly little effort has gone into evaluating the 
mouse sensitivity test. Hawking (1965a) published comparative 
cattle and mouse sensitivity data for a number of strains of T. 
congolense and a range of trypanocides, although his work predated 
the availability of Isometamidium. The experimental design of
his experiments can be criticized on the grounds that whereas 
the cattle work was carried out by Whiteside in Kenya, the mouse 
work was performed in London. Between the two sets of sensitivity 
tests the strains of T. congolense used were subjected to numerous 
bovine and murine passages. Hawking cautiously concluded that 
mice results will give a ’broad indication of the probably response 
of a strain in cattle’.
Several workers have adopted different approaches to 
assessing drug sensitivity in vivo, or have modified the basic 
drug/
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drug sensitivity test. Jones-Davies and Folkers (1966) transported 
trypanosome-naive calves by lorry to treatment camps in Nigeria, 
and subinoculated them with blood collected from cattle presented 
for treatment. Large numbers of subinoculations were carried 
out simultaneously - up to 80 in one calf - although the site 
of the subcutaneous inoculations were varied over the body.
Calves were then transported back to the laboratory and 24 hours 
later treated with 1 mg/kg homidium chloride (Novidium). Treated 
animals were then monitored for relapse infections, during which 
time they were deliberately maintained on a low plane of nutrition. 
The appearance of relapse infections in a calf was taken to be 
evidence of the existence of homidium resistant strains in one 
or more of the cattle from which blood had been subinoculated.
They had previously shown that experimental cattle could be treated 
during the prepatent period, ie the period between infection and 
first detection of trypanosomes in the blood, and that it was not 
necessary to wait until parasitaemia had been established.
Williamson and Stephen (i960) had observed that in rodents 
the development of drug resistant strains was manifest by a decrease 
in the time taken for a relapse infection to develop following 
subcurative treatment. They went on to develop a test for 
homidium sensitivity of strains of T. vivax based on this observation. 
The method involved feeding laboratory-reared tsetse on cattle 
naturally infected with the trypanosome strain under investigation, 
transferring the infected flies back to the laboratory and allowing 
them/
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them to feed on a trypanosome-naive sheep. When the sheep became
parasitaemic, clean tsetse flies were allowed to feed, and were
then used to infect a new batch of sheep. When trypanosomes
had been observed on four consecutive mornings, treatment was
carried out with a low (0.1 mg/kg) dose of homidium. The number
of days from treatment to detection of a relapse infection was
taken as an index of the homidium sensitivity of the strain under
investigation: the longer the aparasitaemic intervals, the more
sensitive the strain. Sheep were used as the host rather than
cattle for reasons of economy.
Dukes,(1985) developed a mouse sensitivity test for T.b.
brucei designed to overcome the complications of, firstly, sequestration
by trypanosomes in drug inaccessible sites and, secondly, host
immune response. In his test, sub-lethally irradiated mice were
5
infected by the intravenous route with approximately 1 x 10 
trypanosomes. Three hours later they were treated with one of 
a graded series of drug levels. Parasitaemias were monitored 
quantitatively by the rapid matching/counting method of Herbert and
Lumsden (1976). ^og^ Parasa’kaemaas (loS-jQ 'tryPanosomes Per ml)
were then plotted against time, and the number of trypanosomes which 
notionally survived treatment and contributed to the relapse 
infection could be assessed. Thus, for a range of drug treated 
groups and an untreated control group a series of parallel lines 
would be obtained. The log-jQ of the percentage of trypanosomes 
present at t = 0 for each treatment group, related to the untreated 
control could then be calculated (log S) and be plotted against
10 1^0/
log^Q drug dose (log^D). For each strain tested a straight 
line was obtained, and the intercept with log^S = 0 .1, ie the 
dose required to achieve 99*9% suppression of trypanosome numbers 
at t = 0, could be derived. This value, designated the DSq ^, 
was the basis by which the relative sensitivities of different 
T.b. brucei strains were compared.
Erommel and Barber (1987) prepared drug resistant clones 
of T.b. rhodesiense and T.b. brucei from sensitive parent clones 
by passaging trypanosomes through irradiated mice treated with 
increasing concentrations of drug. They redefined MED as the 
minimum amount of drug required to cure mice infected with the 
sensitive clone, and introduced the term maximum ineffective dose 
(MID), which they defined as as the maximum amount of drug which 
had no effect on the population doubling time of the resistant 
clone during the 24 hour period following administration of drug 
in irradiated mice infected 36 hours previously. They calculated 
the resistance value (EV) as the ratio of MID to MED. EV values 
increase with relative resistance. The method is limited in 
application to studies involving laboratory derived resistant 
stocks. There is some risk of confusion since MED is conventionally 
considered to be the minimum dose which bring about temporary 
clearance of circulating trypanosomes with subsequent relapse.
Currently, assay methods sensitive enough to detect 
circulating concentrations of Isometamidium are not available.
In the case of malaria, drug resistance is not considered proven 
until/
until plasma drug concentrations have been determined. When 
a reliable, sensitive assay procedure for Isometamidium becomes 
available, a simple definition of, and test for drug resistance, 
could be the demonstration of trypanosomes in a blood sample in 
the presence of a defined serum or plasma Isometamidium concentration.
Isometamidium Sensitivities of Two Strains of T. congolense 
Introduction
The Isometamidium sensitivites of two strains of T. 
congolense, namely 82/1 and 12/1, were assessed using two different 
techniques in mice:
- ip infection and treatment at first parasitaemic peak,
- iv infection and treatment 3 hours post-infection.
The first is a standard method of carrying out sensitivity 
tests in mice similar to that adopted by Hawking (1963a), and the 
second is adapted from Dukes (1985). The latter method was specific­
ally developed for T.b. brucei and was intended to overcome the 
complications of parasites penetrating drug-inaccessible sites and 
the effects of the host*s immune response. The results obtained 
by the two methods were compared.
Methods
Method 1: A batch of mice were infected ip with 0.2 ml of
5
trypanosome suspension containing approximately 5 x 10 trypanosomes 
per ml, and the resulting parasitaemias monitored until the number 
of parasites was estimated to be > log^Q 7 . 0 per ml blood, using 
the rapid matching method (Herbert and Lumsden, 1976). Mice were 
then/
allocated to treatment groups, four per group, and treated ip with
one of a range of Isometamidium dosages, or left untreated as infection
controls.
Method 2: Groups of mice were anaesthetized to facilitate
infection by iv inoculation into the tail vein. Approximately
5
0 . 2 ml of trypanosome suspension containing 5 x 10 trypanosomes
5per ml in PBS was inoculated, giving an inoculum of about 1 x 10 
trypanosomes per mouse. Three hours post-infection, groups of 
five mice were treated with one of a range of Isometamidium dosages 
administered by ip injection, or were left untreated as infection 
controls.
In both cases parasitaemias were monitored by examination 
of tailblood wet-films, initially three times a week, decreasing 
to twice a week from day 21 post-treatment until termination of 
the experiment at day 100.
Results
T. congolense 12/1: For mice infected by ip inoculation
with T. congolense 12/1, treatment with Isometamidium at 0.001 
mg/kg at the first parasitaemic peak had no effect. No mice 
were cured and all mice remained continuously parasitaemic.
All four mice treated at 0.01 mg/kg experienced temporary 
remission of infection, with relapse infections first being detected 
between days 9 and- 11 post-treatment. The MED was therefore 0.01 
mg/kg.
Treatment at 0.1 mg/kg (the MOD) resulted in cures in all 
four mice.
For mice infected by iv inoculation with T. congolense 
12/1, treatment 3 hours later with 0.001 mg/kg Isometamidium had 
no effect. No mice were cured at this dosage and the prepatent 
period was no different to the untreated, infection control mice.
Treatment at 0.01 mg/kg resulted in two of 10 mice being cured, 
and extended prepatent periods in the remaining eight mice.
Pour out of five mice were cured at 0.025 mg/kg (the CDqq 
value) and also at 0 .0 5 and 0 .075 mg/kg.
All five mice treated at 0.1 mg/kg (the MOD) and higher 
dosages were cured, ie never developed parasitaemia.
T. congolense 82/1* For mice infected by ip inoculation with 
T. congolense 82/1 and treated at the first parasitaemic peak, 
dosages up to 0 o1 mg/kg ho-d no effect.
Pour out of five mice treated at 1 mg/kg (EDqq) experienced 
temporary remission of infection, and one of the five mice was 
cured.
All mice treated at 2 mg/kg (MOD) and above were cured.
Por mice infected by iv inoculation with T. congolense 
82/1 and treated 5 hours later with Isometamidium, treatment at 
dosages up to 0.1 mg/kg had no effect. Prepatent periods were 
similar to untreated, infection control mice.
Treatment at 0.25 mg/kg resulted in slightly extended 
prepatent periods: mice treated at this dosage were parasitaemic
by day 8 compared to day 3 - 5  for infection control mice.
Treatment at 0.5 mg’/kg resulted in a further extension in 
the prepatent period and two out of five mice were cured.
Table 4« Comparison of Isometamidium sensitivity data for T.congolense 12/1 
and 82/1, using two techniques (mg/kg).
ED80 MED CD80 MCD
T.congolense
strain: +3hr 1st +3hr 1st +3 hr 1st +3hr 1st
peak peak peak peak
12/1 - - - O.bl 0.025 - 0.1 0.1
82/1 - 1.0 - 1.0 2.0 2.0
Three out of five mice treated at 0.75 mg/kg were cured, 
nine out of ten mice treated at 1.0 mg/kg (CDqq) were cured and 
all mice treated at 2.0 mg/kg (MOD) and above were cured.
Irrespective of the method used the MCI) values determined 
for the strains were the same. T. congolense 12/1 was 20 times 
more sensitive than T. congolense 82/1 based on a comparison of 
MOD1 s. The results of the sensitivity test are shown in Table 4 • 
Discussion
The two methods used to assess Isometamidium sensitivities 
have produced the same values for both the strains used. The 
method of Duke, whereby treatment is administered 3 hours after iv 
infection, was developed for use with T.b. brucei and was intended 
to minimise the influence of trypanosome penetration of drug 
inaccessible sites. The existence of cryptic foci have been 
demonstrated for T.b. brucei infections in mice, where the brain has 
been shown to be the source of the relapse infection (Jennings 
et al. t 1979) • T. congolense is however generally regarded as 
strictly vacular (Losos et al., 1975) and the fact that the two 
methods both produced the same MOD values suggests that drug inaccessible 
sites were not a factor in this experiment.
Treatment at the first parasitaemic peak has a number of 
practical advantages over treatment at 3 hours. Infection by the 
ip route is considerably easier in mice than the iv inoculation 
required by the latter method. The presence of infection can also 
be demonstrated . prior to treatment: with treatment at 3 hours
post-infection there is always the possibility that the mice did not 
receive an infective inoculum.
Investigation of the Effect of the Number of Trypanosomes in the 
Initial Inoculum on the Assessment of Isorneta.mi dlum Sensitivity 
of a Strain of T. congolense
Introduction
Walker and Opiyo (1973) investigated the effect of the 
number of trypanosomes in the initial infective inoculum, on the 
curative dose of experimental T.b. brucei and T.b. rhodesiense
infections in mice. Their method was to treat mice 2 days after
6 5 4 3infection with 10 , 10 , 10 or 10 trypanosomes. They reported
that for a range of trypanocidal drugs, including Isometamidium,
the MOD was markedly affected by the number of trypanosomes
inoculated. It was therefore decided to investigate the effect
of the number of parasites inoculated on drug sensitivity parameters
of a strain of T. congolense. using the iv inoculation and treatment
at 3 hours post-infection method.
Methods
A stock suspension of T. congolense 12/1 was prepared from 
cryopreserved stabilate and the trypanosome density estimated by
duplicate counts using a haemocytometer. Serial dilutions were
6 5 4 3
then prepared containing 5 x 10 , 5 x 10 , 5 x 10 and 5 x 10
trypanosomes per ml EBS0 Groups of five mice were anaesthetized
and then infected by iv inoculation into the tail vein with 0.2 ml
of inoculum. Three hours post-infection each group was treated
with one of a range of Isometamidium dosages by ip injection, or
left untreated as infection controls. Parasitaemias were monitored
by examination of tail-blood wet-films, initially three times a
week. Observation was continued for 100 days.
Table 5« Isometamidium sensitivity tests using a range of inital inocula.
Isometamidium
mg/kg
Initial inoclum (trypanasomes per mouse)
3
1 x 10
4
1 x 10
5
1 x 10
6
1 x 10
*
0.01 4/5 2/5 0/5 0/5
0.025 5/5 4/5 4/5 0/5
0.050 5/5 5/5 4/5 1/5
0.075 5/5 5/5 4/5 5/5
0.1 5/5 5/5 5/5 4/5
0.5 5/5 5/5 5/5 5/5
*
number of mice cured/number of mice infected
Results
The prepatent period of untreated mice was found to he
dependent on the size of the initial inoculum. With an initial
3inoculation of 1 x 10 trypanosomes, one of five mice did not become
parasitaemic, while in the remaining four mice parasites were
first detected in a mean of 9.B ± 1 .5 days post-infection.
When the inoculum was increased to 1 x 10^ parasites this period
5decreased to a mean of 8 . 0 ± 2 . 2 days, for 1 x 10 parasites it
6was 6 .6 ± 0 . 9 days and for 1 x 10 , 1 .2 ± 0 . 4 days.
Three out of five infection control mice inoculated with
61 x 10 trypanosomes died during the initial 55 day post-infection.
5One mouse infected with 1 x 1 0  died, and there were no mortalities 
4 5in the 1 x 10 or 1 x 10 trypanosomes per mouse groups.
The number of mice cured in each experimental group is 
*
3shown in Table 5 • With an initial inoculum of 1 x 10 trypanosomes, 
four out of five mice were cured at a dosage of 0.01 mg/kg Isometamidium, 
and all mice were cured at dosages of 0 .025 mg/kg or above.
With an initial inoculum of 1 x 10^ trypanosomes two out 
of five mice were cured at 0.01 mg/kg, four out of five were cured 
at 0.025 nig/kg, and all mice were cured at dosages of 0 .05 nig/kg 
and above.
A dose of 0.01 mg/kg failed to cure any mice infected with
51 x 10 trypanosomes. Pour out of five mice were cured at dosages 
of 0.025, 0.05 or 0.075 mg/kg. Dosages of 0.1 mg/kg or above 
cured all mice.
£
With an initial inoculum of 1 x 10 trypanosomes, dosages 
up to 0.025 mg/kg were ineffective. Only one out of five mice 
was/
- 82 -
was cured at 0.05 mg/kg. All five mice were cured at 0.075 
and 0.5 mg/kg, although only four out of five were cured at 
0.1 mg/kg.
Discussion
In the present experiment the MOD was shown to be dependent
on the size of the initial inoculum. The MOD determined for the
strain of T. congolense used varied from 0.025 mg/kg Isometamidium
3following an initial inoculum of 1 x 10 trypanosomes, to 0.1
mg/kg after an initial inoculum of 1 x 10^ trypanosomes. Although
6all mice infected with 1 x 1 0  trypanosomes were cured after 
treatment at 0 .075 mg/kg or 0.5 mg/kg, only four out of five were 
cured at 0.1 mg/kg. Thus, there was a range of at least a factor 
of four in the value of MCD*s determined for the different size 
inocula.
This result is similar to the observations of Walker and 
Opiyo (1973) who worked with T.b. brucei and T.b. rhodesiense.
The reasons for the above findings are unclear. Davey 
(1958)9 who also reported similar findings in T.b. rhodesiense 
infections in rodents, ie that the curative dose was dependent upon 
the number of trypanosomes present at the time of treatment, considered 
the possibility that the drug was absorbed by the trypanosomes.
Gilbert, Curtis and Newton (1979) used ^C-labelled homidium 
bromide in calves infected with T. congolense, and reported that 
one hour after intramuscular injection, when the amount of radio­
activity in the blood reached a peak, 80% of that radioactivity 
was/
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was bound to trypanosomes. However, the tissue and blood levels, 
and excretion of radioactivity followed a similar course in 
infected and uninfected calves, suggesting that trypanosomes 
did not metabolise homidium.
It is also of interest that Whiteside (1962) was puzzled 
by his observation that the period of protection afforded by a 
prophylactic drug appeared to be dependent upon the degree of 
trypanosome challenge, and in particular queried how the number 
of trypanosomes entering the host could affect the duration of 
prophylaxis. More recently, Whitelaw et al., (1986) found no 
differences in the duration of prophylaxis of cattle treated with 
Isometamidium, and challenged either singly or repeatedly with 
trypanosome infectdd tsetse flies, or titrated doses of in vitro 
derived metacyclic T. congolense. The finding that the level 
of metacyclic challenge did not influence the duration of prophylaxis, 
was later confirmed by Peregrine, Ogunyemi, Whitelaw, Holmes, Moloo, 
Hirumi, Urquhart and Murray (in press).
The present experiment suggests that trypanosomes take up 
and metabolise Isometamidium, and thereby reduce effective plasma 
levels. It is difficult however to reconcile the marked differences 
in the efficacy of Isometamidium dosages with the range of inocula 
used to infect the mice. The difference in the biomass of the 
various levels of inocula used, would appear to be insignificant 
in comparison to the biomass of the mouse. This suggests a highly 
selective uptake of Isometamidium by the trypanosomes, as has pre­
viously been suggested by Gilbert et al., (1979) working with 
radiolabelled homidium (vide supra).
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There are two practical implications of these findings. 
First, to permit comparisons to be made between drug sensitivity 
tests in which treatment is administered soon after infection, 
it is clearly of considerable importance that similar numbers cf 
trypanosomes are inoculated into mice, and probably other species, 
used in such tests. Secondly, that in field situations animals 
infected with higher levels of parasitaemia may require higher 
doses of drug than animals with lower parasitaemias.
Assessment of Sensitivity of Trypanosoma congolense to Isometamidium
Chloride: A Comparison of Tests Using Cattle and Mice
Introduction
Although mice are often routinely used to assess drug 
sensitivities of strains of trypanosomes, including T. congolense. 
there have been few attempts to correlate the results of such 
tests, to those obtained with the use species. Hawking!s (1963a) 
work in this area, using strains of T. congolense in mice and 
cattle was flawed by the numerous bovine and murine passages the 
strains went through between being tested in cattle in Kenya and 
mice in London. It was therefore decided to carry out 
simultaneous mouse and cattle Isometamidium sensitivity tests 
using a number of strains of T. congolense of differing Isometamidium 
sensitivities.
Materials and Methods
Experimental animals
Trypanosome-naive, Boran steers, and female random-bred 
Swiss mice were used for the drug sensitivity experiments. Female 
outbred mice, obtained from the KETRI closed colony, were used 
for routine subinoculation of cattle blood.
Trypanosomes
The three strains of trypanosomes used in this experiment 
were obtained as cryopreserved stabilates. Prior to use the 
strains were expanded in sub-lethally irradiated rats, and then 
stored as stabilates in liquid nitrogen until required. The 
strains were: T. congolense KETRI 2880, 2883 and 2885.
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Methods
Cattle and mice were each infected with approximately
51 x 10 trypanosomes, the former by intravenous inoculation and the 
latter by intraperitoneal inoculation (ip). After infection 
cattle parasitaemias were monitored three times a week by the buffy 
coat method (Paris, Murray and Mcodimba 1982), but with direct 
rather than phase-contrast illumination, and using a peripheral 
blood sample collected from a marginal ear-vein. Packed cell 
volume (PCV), determined from a jugular blood sample, and rectal 
temperature were also recorded three times a week, and bodyweight 
recorded once a week. Mice were monitored by examination of 
tail-blood wet-films. In addition, at 2 weekly intervals, jugular 
blood samples were collected from all cattle judged trypanosome- 
negative by the buffy coat method and 0.5 ml aliquots were inoculated 
into mice (three per steer). After subinoculation mice were 
monitored by tail-blood wet-film examination for 8 weeks. Wo 
infections were detected by subinoculation of blood that were not 
also detected by the buffy coat technique, although in some cases 
infections were detected earlier by subinoculation.
For both cattle and mice, treatment with Isometamidium 
was administered at first detection of trypanosomes at the dose 
rates shown in Table 6. Initially 10 cattle were infected with 
each strain; three cattle were subsequently treated by deep intra­
muscular injection in the middle third of the neck, at each of 
0.1, 0.5 or 1.0 mg/kg bodyweight, while one animal was left untreated 
as an infection control. In the case of KETRI 2885 for which 
0.1 mg/kg Isometamidium proved to be curative, two further cattle 
were/
Table 6. Allocation of experimental animals to treatment groups (number of 
animals per group)
Isometamidium
mg/kg
Cattle Mice
T.congolense KETRI •> T.congolense KETRI;
2885 2883 2880 2885 2883 2880
0 1 1 1 5 5 5
0.001 1 5
0.01 1 5
0.1 3 3 3 5 5
0.5 4 3 3 5 5
1.0 3 3 3 5 5 5
2.0 2 5 5 5
5.0 5 5 5
10.0 5 5 5
20.0 5 5 5
were infected and treated at either 0.01 or 0.001 m^/kg, and 
an additional steer was also infected with KETRI 2880 and treated 
at 2 mg/kg.
When the PCV of the infection control steers declined to 
17%, they were withdrawn from the experiment and treated with 
diminazene aceturate (Berenil, Hoechst, W. Germany) initially at 
3 .5 increasing the dosage in increments of 3*5 mg/kg when
relapse infections were encountered.
For all cattle in which relapse infections occurred after 
initial treatment with Isometamidium, parasitaemias were monitored 
for 7 days, and then the cattle were retreated with the same 
Isometamidium dose. When a second relapse infection occurred, 
cattle were again monitored for 7 days and then treated with 
diminazene aceturate. An exception was the steer infected with 
KETRI 2880 and treated at 1 mg/kg Isometamidium, which relapsed 
twice to this dose (Steer 895)* This animal was then treated
at 2 mg/kg Isometamidium.
Mice were treated at one of a range of Isometamidium doses 
up to 20 mg/kg by ip injection, with five mice in each treatment 
group. The parameters EDqq and CDqq were determined for mice, 
that is the minimum dose which brought about either temporary clearance 
of circulating trypanosomes ( E D q q ), or a permanent cure ( C D q q ), 
in at least 80 per cent of mice, i.e. four out of five. In the 
case of KETRI 2880 the assessment of ED0q was complicated by 
characteristic remission of infection, even in untreated mice, 
following the first parasitaemic peak. The EDqq value for KETRI 
2880 was therefore taken to be the minimum dose which resulted 
in/
in temporary clearance of circulating trypanosomes in four or 
more mice, of at least twice the mean duration observed in the 
infection controls.
Cattle and mice were monitored for at least a 100 day 
post-treatment observation period.
hue to limited cattle accommodation, the experiment was 
carried out in two phases. Initially cattle and mice were 
infected with T. congolense KETRI 2885. Later new batches of 
cattle were infected with either T. congolense KETRI 2880 or 
KETRI 2885. One steer infected with T. congolense KETRI 2885 
and treated at 0.5 mg/kg Isometamidium was included in the second 
batch as a control, so that the relative sensitivities of the 
three strains could be compared in the same conditions, at the 
same time.
Results
Prepatent period
Por KETRI 2885 "the mean prepatent periods (± Sh), following 
needle challenge, were 7 (± 0) days in cattle and 5 (± .0) days in 
mice; for KETRI 2885, 7.1 (±0.5) and 5.9 (± 0*5) days and for 
KETRI 2880, 10.6 (± 0.7) and 9*5 (± 1»4) days, respectively.
Virulence and pathogenicity
Sixty per cent (5/5) of mice infected with either KETRI 
2885 or 2880 which received no treatment, died during a 100 day 
observation period. All mice (5/5) infected with KETRI 2885 and 
left untreated died, with a mean number of days to death of 28.6 
(± 22.6). heaths of mice which were infected with KETRI 2885 
or/
Table 7 * Responses of T.congolense-infected cattle to treatment with
Isometamidium
Strain
Effect of treatment (number of cattle)
c
CureDose
mg/kg
Number in 
treatment 
group
a
No effect
b
Temporary
clearance
2885 1.0 3 0 0 3
0.5 4 0 0 4
0.1 3 0 0 3
0.01 1 0 0 1
0.001 1 0 0 1
0 1 1 0 0
2883 1.0 3 0 0 3
0.5 3 0 0 3
0.1 3 1 2 0
0 1 1 0 0
2880 2.0 2 0 0 2
1.0 3 0 3 0
0.5 3 0 3 0
0.1 3 1 2 0
0 1 1 0 0
a
Animals remained parasitaeraic after treatment.
b
Parasitaemia dropped below limit of detection following treatment, but 
trypanosomes reappeared during observation period.
c
Trypanosomes disappeared from the circulation following treatment and
did not reappear during a 100 day observation period.
or 2880 tended to be after a more chronic infection with mean 
numbers of days to death of 72.7 (± 19«6) and 84.3 (± 6.0), 
respectively.
Infection control cattle were prevented from dying by inteiv 
vention with diminazene aceturate when their PCV had dropped to 
17%. PCV values at infection were similar for all three cattle 
(33 - 34%)* In the case of the KETRI 2880 infection control the 
PCV had declined to 17%> 33 days after infection. For the KETRI 
2883 infection control this point had been reached 34 days 
post-infection and for the KETRI 2885 infection control, 38 days 
post-infection.
Responses to treatment with Isometamidium
Cattle; The responses of cattle infected with the three 
strains of T. congolense and treated with Isometamidium, are shown 
in Table 7* Cattle infected with KETRI 2885 were cured by 
treatment at 0.001 mg/kg Isometamidium, the lowest dose used.
KETRI 2883 was temporarily cleared from the circulation of 
two out of three cattle treated at 0.1 mg/kg. All cattle treated 
at 0.5 or 1.0 mg/kg were permanently cured.
No cattle infected with KETRI 2880 and treated with a single 
injection of Isometamidium at doses up to 1 mg/kg were cured, although 
two out of three steers treated at 0.1 mg/kg and all three treated 
at 0.5 or 1.0 mg/kg experienced temporary remission of infection.
Cattle which either relapsed after initial treatment with 
Isometamidium, or for which initial treatment had no effect, were 
retreated at the same dose (Table 8 ).
Table 8. Aparasitaemic intervals in cattle following treatment with
Isometamidium.
Days to relapse
Steer Dose First mean Repeat mean
number mg/kg treatment treatment
KETRI 2883
899 0.1 0 ) 7 )
902 0.1 14 ) 8.3 9 ) 9.3
893 0.1 11 ) 12 )
;?o.5 >100
KETRI 2880
803 0.1 0 ) 0 )
884 0.1 3 ) 2.3 0 ) 0
881 0.1 4 ) 0 )
877 0.5 21 ) 16 )
818 0.5 13 15.7 14 ) 15.7
801 0.5 13 17 )
819 1.0 37 >100
895 1.0 19 ) 44.3 72
870 1.0 77 >100
895 2.0 >100
805 2.0 >100
Two out of three cattle infected with KETRI 2883 and treated 
at 0.1 mg/kg experienced a temporary clearance of circulating 
trypanosomes, and all three were temporarily cleared by repeat 
treatment at the same dose.
Although KETRI 2880 was temporarily cleared from the 
circulation of two out of three cattle treated at 0.1 mg/kg, 
repeat treatment at the same dose had no effect. Repeat treatment 
at the same dose for cattle initially treated at 0.5 mg/kg again 
resulted in temporary aparasitaemia. Of the three cattle originally 
treated at 1.0 mg/kg, one steer relapsed to repeat treatment at the 
same dose while the remaining two steers did not relapse during a 
100 day post-retreatment observation period. The steer which relapsed 
twice after treatment at 1.0 mg/kg was then treated at 2 mg/kg, and 
did not relapse during the following 100 days. An additional 
steer infected with KETRI 2880 and treated at 2 mg/kg was also 
cured, corroborating this observation.
These results indicated that the MOD for KETRI 2885 was 
less than or equal to 0.001 mg/kg Isometamidium, for KETRI 2883 
was 0.5 mg/kg and for KETRI 2880 was 2 mg/kg.
The intervals from treatment to relapse for KETRI 2880 and
2883 in cattle are shown in Table 8. Cattle infected with 
KETRI 2883 and treated with Isometamidium at a dose of 0.1 mg/kg 
relapsed in a mean of 8.3 days, and after retreatment at the same 
dose in a mean of 9«3 days.
For KETRI 2880 the mean number of days to relapse following
treatment at 0.1 mg/kg was 2.3 days. Retreatment at the same
dose/
Table 9»^esPonses °f T.congolense-infected mice to treatment with 
Isometamidium (5 mice per treatment group).
Strain
Effect
Dose
mg/kg
of treatment
a
No effect
(number of mice)
b
Temporary
clearance
c
Cure
2885 >0.1 0 0 5
0.1 0 0 5
0.01 0 4 1
0.001 5 0 0
0 5 0 0
2883 20.0 1 0 4
10.0 0 1 4
5.0 1 1 3
2.0 0 5 0
1.0 3 2 0
0.5 4 1 0
0.1 5 0 0
0 5 0 0
2880 20.0 0 1 4
10.0 0 4 1
5.0 0 5 0
2.0 0 5 0
1.0 3 2 0
0 0 4 1
a
Animals remained parasitaemic after treatment.
b
Parasitaemia dropped below limit of detection following treatment, but 
trypanosomes reappeared during observation period.
c
Trypanosomes disappeared from the circulation following treatment and
did not reappear during a 100 day observation period.
Table 10. Comparison of mouse ED and CD with cattle MCD values (mg/kg)
80 80
Strain ED80 CD80 MCD
mouse mouse cattle Ratio Ratio
A B C A:C B:C
2885 0.01 0.1 ^  0.001 ^ 1 0  ^100
2880 2 20 2 1 10
2883 2 10 0.5 4 20
dose had no effect. Mean number of days to relapse after both 
treatment and retreatment at 0.5 mg/kg was 15*7 days. Cattle treated 
at 1.0 mg/kg relapsed after a widely varying timespan (19 - 77 days 
post-treatment) with a mean of 44*3 days. Only one steer retreated 
at 1 mg/kg relapsed (day 72), and this animal remained aparasitaemic 
during a 100 day observation period following treatment at 2 mg/kg.
Mice; The responses of mice infected with one of the three 
strains of T. congolense and then treated with one of a range of 
Isometamidium dosages are shown in Table 9 • For KETRI 2885 the 
EDqq was 0*01 nig/kg Isometamidium and the CDqq value was 0.1 mg/kg.
For KETRI 2885 and 2880 the corresponding values were 2 and 10 
mg/kg and 2 and 20 mg/kg, respectively.
Comparison of mouse FDqq or CDqq an -^ Cattle MOD values
Mice EDqo and CDqq values and cattle MCD values are compared 
in Table 10. The ratios in both cases show a wide range of 
variation ( > 10 fold) between the three different strains.
Responses to diminazene aceturate
Cattle which relapsed twice to their designated Isometamidium 
dosage, and also the untreated infection control animals when their PCV 
had dropped to 17%, were treated with diminazene aceturate. Treatment 
was initially attempted at 5*5 nig/kg, increasing the dosage in incre­
ments of 5.5 mg/kg if further relapse infections were encountered. 
Relapse infections were monitored for 7 days before treatment was 
attempted at a higher dose.
KETRI 2885: Four cattle infected with KETRI 2885 (three
initially treated at 0.1 mg/kg Isometamidium, and the infection 
control), were treated with diminazene aceturate. All cattle 
relapsed to treatment at 5*5> 7.0 and 10.5 mg/kg diminazene 
aceturate,/
aceturate, at mean intervals from treatment of 7«5 (± 1*0),'14*3 
(± 5.5) and 17#0 (± 6.0) days respectively. At the time the 
experiment was terminated - up to 55 days after treatment - no 
cattle had relapsed to treatment at 1 4 .0 mg/kg.
KETRI 2880; Seven cattle infected with KETRI 2880 (three 
initially treated at 0.1 mg/kg Isometamidium; three initially 
treated at 0.5 ms/kg Isometamidium, and the infection control) 
were treated with diminazene aceturate. All cattle relapsed 
following treatment at 5-5 and. 7*0 mg/kg diminazene aceturate, 
at mean intervals from treatment of 1 5 .3 (± 4 *5) and 28.1 ( ± 1 1.9) 
days respectively. At the time the experiment was terminated, 
no cattle had relapsed to 1 0 .5 mg/kg; for five of the seven cattle 
this was in excess of 100 days from date of treatment.
Discussion
The three strains of T. congolense used in this experiment 
covered a wide range of sensitivities to the prophylactic drug 
Isometamidium, with a difference of at least 2000 fold in the cattle 
curative doses between the least and most sensitive strains.
Thus KETRI 2885 was extremely sensitive to Isometamidium with a 
dose of 0.001 mg/kg proving to be curative in cattle, while KETRI 
2880, the least sensitive strains, could be cured by treatment at 
less than the maximum tolerated dose.
Hawking (1965a) cautiously concluded that 'tests in mice 
apparently give a broad indication of the probable response of a 
strain in cattle1. Pinder and Authie (1984) suggested that his 
results showed a close relationship between mouse effective dose 
and cattle curative dose, with mouse curative doses being at least 
10 times those for cattle.
The results of the present experiment show that there 
is considerable variation between strains in the relationship 
between mouse effective dose and cattle results. Thus while 
for KETRI 2880 and 2883 the mouse EDqq values were close to 
cattle MCD values, there was at least a 10 fold difference in 
the two values for KETRI 2885. Similarly while mouse CDqq values 
for KETRI 2880 and 2883 were approximately 10 times cattle MCD 
values, in the case of KETRI 2885 there was a difference of at 
least 100 times between the values for the two species. Based 
on these comparisons it is concluded that although the result 
of a mouse test may give a broad indication of the sensitivity of 
a strain, it cannot be reliably used to predict curative doses for 
cattle.
Mouse sensitivity tests can also be criticized-on the grounds 
that they cannot be employed to investigate the sensitivity of 
strains of T. vivax and that not all cattle isolates of T. congolense 
are rodent infective. The variable infectivity of strains of 
T. congolense to rodents may be related to the morphological 
type of trypanosomes present (Godfrey, 1961) - greater rodent 
infectivity being associated with the longer dimorphon-type rather 
than the shorter congolense-type - and also, as has been reported 
for T. vivax. to the stage of infection in the donor (Desowitz and 
Watson, 1951)•
Besides the obvious difference in bodysize between cattle 
and mice, there may also be differences in the pharmacokinetics 
and/
Table 11. Comparison of curative dose and subcurative treatment to relapse 
interval for cattle (treated at 0.1 mg/kg Isometamidium) and mice 
(treated at 2 mg/kg Isometamidium).
Strain
2885
Cattle
MCD Aparasitaeraic 
interval (0.1 mg/kg)
Mice
CD80 Aparasitaemic 
interval (2mg/kg)
4 . 0.001 >100 0.1 >100
2883 0.5 8.3 10 8.8
2880 2.0 2.3 20 6.0
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and metabolism of trypanocidal drugs in the two species. Furthermore, 
even using the same stabilate for infection, the trypanosome population 
which becomes established in cattle may differ from that in mice.
One, or more, of these factors may explain the observed differences 
in Isometamidium dose rates required to cure infections in the two 
species. The lack of correlation between drug sensitivity values 
determined in the two species for different strains of T. congolense 
could also be related to differences in parasite biology. For 
example, the propensity of a strain to sequester in drug inaccessible 
sites in one or other of the host species, or the relative susceptibility 
of a strain to bovine or murine products of drug metabolism.
If mouse sensitivity tests cannot be relied upon to predict 
curative dose rates of Isometamidium for cattle, then other approaches 
need to be investigated. Williamson and Stephen (i960) developed 
a method using sheep, to assess the sensitivity of strains of T. vivax 
to homidium, based on the interval from subcurative treatment to 
subsequent relapse (see pp.73/4)• The interval from subcurative 
treatment to relapse was taken as an index of the degree of homidium 
resistance: the shorter the interval., the more resistant the strain.
A good indication of the relative sensitivities of the three strains 
of T. congolense used in the present study could be obtained by a 
similar approach, but using needle challenge in place of the tsetse 
challenge used by Williamson and Stephen (i960) (Table 11). For 
both cattle and mice, the subcurative treatment to relapse interval 
was shorter for the more resistant strain.
- 95 -
In cattle, both KERRI 2880 and 2883 were resistant to diminazene 
aceturate, the former at dose rates up to 7 mg/kg and the latter 
at dose rates up to 10.5 mg/kg. Until recently (Authie, 1984) 
there has been no evidence of cross-resistance between Isometamidium 
and diminazene, and the two drugs have been regarded as a ‘sanative 
pair* (Whiteside, i960). Finelle (1974) recommended the alternate 
use of Isometamidium and diminazene, and, prompted by fears of drug 
resistance, the management of Mkwaja Ranch in Tanzania adopted a 
regime based on the alternate use of Isometamidium and diminazene 
aceturate in 1980 (Trail et al., 1985). In the present experiment 
KETRI 2880 has been shown to be resistant to the manufacturer^ 
recommended doses of both Isometamidium (0.5 - 1.0 mg/kg) and diminazene 
aceturate (3*5 - 7.0 mg/kg). The occurrence of strains of this 
type clearly has serious implications for the effective control of 
trypanosomiasis by trypanocidal drugs, and emphasises the need for 
reliable techniques for the assessment of sensitivity.
CHAPTER FOUR 
AN in vitro APPROACH TO THE ASSESSMENT
OF ISOMETAMIDIUM SENSITIVITIES
INTRODUCTION
The use of in vitro techniques for Salivarian trypanosomes 
has, until recently, been limited by inadequate culture techniques. 
Although most mammalian and lower vertebrate trypanosomes can be 
easily grown in vitro using relatively simple biphasic media, the 
African trypanosome species proved to be more difficult (Baker,
1970). Originally in vitro culture techniques were developed as 
methods for diagnosing sub-patent infections. This approach could 
be used for the Trypanozoon sub-group, and less reliably for T. 
congolense. However*, since most Trypanozoon species readily infect 
laboratory animals, the in vitro technique was most applicable to 
suspected T.b. gambiense infections. This species is non-infective 
to most laboratory animals, except young Cerocopithecus sppc 
monkeys (vervet), although Heisch, Killick-Kendrick, Dorrell 
and Marsden (1968), demonstrated that T.b. gambiense will also 
develop when injected into the testes of rabbits.
Early attempts to use in vitro cultured trypanosomes for 
biochemical or drug-related investigations, relied upon two basic 
approaches. Short duration incubations at 37°C of trypomastigote 
forms harvested from infected animal hosts, or longer duration 
experiments, usually conducted at 26°C. The usefulness of the latter 
was limited by the fact that, under the conditions used, bloodstream 
form (trypomastigote) trypanosomes transformed to forms morphologically 
and biochemically resembling insect mid-gut forms, which were not 
animal infective.
Short duration in vitro incubations of T. congolense or 
T.b. brucei isolates, in bovine serum containing 0, 1 or 2 pg/ml 
diminazene aceturate were carried out by Van Hoeve and Grainge (19.66) 
to assess drug sensitivity. Trypanosomes were incubated at 37°C 
for 7 hours in serum, with or without diminazene aceturate, before 
being inoculated into mice for assessment of infectivity,,
Yorke, Adams and Murgatroyd (1929) developed a medium which 
enabled them to maintain trypanosomes in vitro at 37°C for 24 hours. 
Using this medium they produced drug-resistant T.b. rhodesiense 
by a procedure of 60 minute in vitro exposures to gradually increasing 
drug concentrations, alternating with passaging in mice (Yorke, 
Murgatroyd and Hawking, 1931)•
Attempts at longer term in vitro culture, generally at 
26°C, resulted in transformation to procyclic forms. Hawking 
(1963) noted that these culture forms were much less sensitive 
to trypanocidal drugs than the same strains in laboratory animals.
For example, for two strains of T. congolense the highest concen­
tration of Isometamidium used in vitro (0.1 mg/ml) proved to be 
inactive, although in mice the strains were sensitive at a calculated 
blood concentration 500,000 times smaller. Hawking (1963) suggests 
that the insensitivity of these culture forms is due to the possession 
of alternative metabolic pathways. The culture forms can be 
maintained in more simple media than bloodstream forms because they 
may possess these additional metabolic pathways and, therefore, the 
specific enzymes blocked by a trypanocide can be bypassed.
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Hirumi, Doyle and Hirumi (1977) investigated 96 combinations 
of culture conditions for T.b. brucei, the most successful of which 
proved to be EEMI 1640 medium, supplemented with 20% foetal bovine 
serum in the presence of a monolayer of fibroblast-like cells acting 
as a feeder layer, and maintained at 37°C. Under these conditions, 
for the first time. T.b. brucei isolated from infected rodents could 
be maintained and propogated in vitro, without transformation to 
insect mid-gut forms. In vitro derived trypanosomes retained the 
morphology, biochemistry, specific surface antigens and animal 
infectivity characteristic of bloodstream forms0
In vitro culture of T.b. brucei was further refined by the 
development of a cell-free system using a semi-defined media (Baltz, 
Giroud and Crockett, 1985)* The presence of 2-mercaptoethanol 
was found to be essential for growth. Eliminating the need for 
a feeder layer considerably simplifies in vitro culture of T0b0 brucei, 
and is of particular benefit in biochemical and drug-related studies.
Prior to 1984* in vitro culture of T. congolense was limited 
to non-infective procyclic and epimastigote forms, other forms 
which retained animal infectivity for limited periods only, and 
metacyclic-like forms (Hirumi and Hirumi, 1984). However, Hirumi 
and Hirumi (1984) described a system for the continuous cultivation 
of animal infective bloodstream forms of T. congolense. The system 
comprised a monolayer of bovine aorta endothelial (EAE) cells and 
Hepes-buffered RPMI 1640 medium supplemented with adult and foetal 
goat serum. Cultures were maintained at 37°C in a C0£ gassed, 
humidified incubator. Trypanosomes propogated using this method 
were/
were morphologically indistinguishable from trypomastigotes from 
animal hosts, were covered with an electron-opaque surface coat 
and were animal infective.
Baltz et al., (1985) considered that trypanosomes pass 
through three stages in becoming established in vitro: an
initiation phase, an adaptation phase and finally a maintenance 
phase. Of the 14 strains of T. equiperdum, T.b. evansi, T.b. brucei, 
T.b. rhodesiense and T.b. gambiense investigated, 10 were successfully 
established in culture, eight adapting to culture very rapidly.
These workers recognised, however, that particularly for those strains 
which experienced a severe decrease in numbers of trypanosomes during 
the initiation phase, the population established was probably due 
to selection of variants that could adapt to the prevailing culture 
conditions, and may not be representative of the trypanosomes in the 
original inoculum.
Ross, Gray, Taylor and Luckins (1985) successfully initiated 
four cloned stocks of T. congolense, of West African origin, into 
culture. Only with one stock could bloodstream forms be introduced 
directly on to BAE cell monolayer. For the other three stocks, 
initiation was achieved by the use of bovine dermal explants.
Only very small proportions of the trypanosomes in the inoculum 
adapted to growth in the conditions employed at 28°C, again 
suggesting that a sub-population may have been established in vitro, 
not necessarily representative of the starting material. In 
contrast, Hirumi and Hirumi (1984) established a strain of 
T. congolense in culture, with 25% of the inoculum adapting to the 
conditions used and, therefore, possibly representing a less drastic 
selection procedure.
Borowy, Fink and Hirumi (1985) used an in vitro system 
incorporating a bovine fibroblast feeder layer to assess the effect 
of a number of trypanocides on a strain of T.b. brucei. Concentrations 
identified as effective were within the range of drug, concentrations. 
estimated to be in body fluids of animals receiving curative doses.
This was in contrast to earlier workers, for example Hawking (19&3) 
who found that drug concentrations much greater than used in vivo 
were required in vitro. This difference may be because Hawking was 
using culture form (procyclic) trypanosomes, while Borowy and 
co-workers were using trypomastigotes, or it may relate to the fact 
that in Borowy1 s assay actively multiplying populations were used 
and the trypanocides used may specifically act on these organisms. 
Adaptation to in vitro, Culture
Prior to carrying out in vitro -sensitivity tests, it was 
necessary to adapt the three strains of T. congolense previously 
used in the cattle/mouse Isometamidium sensitivity experiment, to 
in vitro culture.
T. congolense KE3TR.I 2885 were harvested from a mouse near 
to the first parasitaemic peak and introduced directly on to a BAE 
feeder layer. Using Eagles1 minimum essential medium (MEM) with 
Hepes buffer (25 mM) supplemented with 20% calf serum (CS), and 
maintained in a 5% COg gassed incubator at 37°C, trypanosomes 
survived and actively replicated for at least 7 days. This was 
in accordance with observations made at the laboratories of ILRAD 
(Nairobi, Kenya) (personal communication, A. Peregrine). It was 
therefore/
Fig.2. Adaptation of T.congolense via insect raid-gut forms.
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therefore decided to use bloodstream forms of T. congolense KETRI 
2885 isolated from infected mice in subsequent in vitro drug 
experiments, thereby avoiding the need to produce an in vitro 
adapted population.
T. congolense KETRI 2880 and KETRI 2885 proved to be less 
amenable to in vitro culture than T. congolense KETRI 2885. When 
bloodstream forms of either of these strains were introduced directly 
on to BAE feeder layer, all trypanosomes eventually died.
Successful adaptation to in vitro culture was eventually achieved 
by a process involving transformation through the insect mid-gut 
forms. The procedure used is depicted in Figure 2. Initially 
trypanosomes were harvested from a mouse with a high parasitaemia 
within a few days of infection, and separated from blood components 
by sterile minature anion exchange chromatography (Lanham and
7Godfrey, 1970). Approximately 1 - 2 x 10 trypanosomes were then 
introduced into culture flasks without BAE feeder layer, using 
MEM supplemented with 20% foetal calf serum (ECS) and maintained 
at 28°C. These conditions induced the transformation of bloodstream 
forms to procyclic forms. Continued maintenance in these conditions, 
with changes of media every 2 - 5  days, resulted in the appearance 
of small bundles of epimastigote forms which adhered to the base 
of the flask. Proliferation of epimastigote bundles eventually 
led to the appearance of metacyclic forms, which were then separated 
from the epimastigote forms by miniature anion exchange chromato­
graphy. Metacyclic forms were then introduced on to BAE feeder 
layer with MEM supplemented with 20% ECS and maintained at 28°C.
This/
This resulted in the transformation of metacyclics to forms which 
resembled bloodstream forms and which were mouse infective.
These in vitro derived bloodstream foams were then further passaged 
under similar conditions and were harvested as required for in vitro 
drug experiments. The adaptation procedure was particularly 
difficult for T. congolense KETRI 2883, and. took 3 months to 
complete the sequence from the initial separation of trypanosomes 
from mouse blood to final transformation of metacyclics to in 
vitro adapted bloodstream forms.
The Effect of Isometamidium on the Glucose Utilisation Bate of 
Bovine Aorta Endothelial Cell Feeder Layer 
Introduction
In vitro culture of bloodstream forms of T. congolense t 
is currently dependent on systems incorporating a monolayer of 
BAE coating the base of the culture vessel. Although cell-free 
systems have been developed for the Trypanozoon sub-group, such 
systems have not yet been successfully developed for T. congolense. 
The monolayer of BAE cells, or feeder layer as it is often referred 
to, is believed to have a number of functions*
supply of essential nutrients not provided by the medium, 
and which the trypanosomes cannot synthesize themselves:
removal of toxic metabolites produced by trypanosomes, e.g. 
peroxides. (Until recently trypanosomes were thought to be 
deficient in enzymes involved in the removal of peroxide.
Recent research however suggests that although glutathione 
peroxidase/
peroxidase and catalyse are absent, or present only in trace amounts, 
trypanothione peroxidase plays a role in the removal of peroxide, 
at least in T.b. brucei (Eairlamb and Henderson, 1987)*):
provides a suitable surface for the trypanosomes to attach 
by their flagella.
Interpretation of in vitro experiments involving trypanocidal 
drugs is complicated by the presence of the BAE feeder layer.
It is possible that any observed effect of a drug on trypanosomes 
is due to an indirect effect mediated via the feeder layer, rather 
than a direct effect on the trypanosomes themselves. If the 
concentration of drug used advserely affects the cells making up 
the feeder layer, this could impair its ability to support 
trypanosome growth. It was therefore decided to investigate the 
effect of a range of Isometamidium concentrations on the metabolism 
of the BAE feeder layer. The metabolic rate of feeder layer cells 
was estimated by measurement of the rate of disappearance of glucose 
over a 48 hour incubation period.
Methods
Wells of tissue culture plates (Nunc, Denmark) were seeded 
with BAE cells and were maintained at 37°C using MEM supplemented 
with 20% CS, until the feeder layer was confluent, usually in 
4 - 5  days. The overlying media was then removed from each well 
and was replaced with 990 [il MEM supplemented with 20% CS and. 10 jjI 
of the appropriate Isometamidium solution, to provide a final 
Isometamidium concentration in the well of 100, 30, 10, 3> 1 or 0 jjg/ml. 
Isometamidium solutions were prepared in sterile distilled water 
and filter sterilized. Tissue culture plates were then maintained 
at/
Table 12. Effect of Isometamidium on glucose concentration after 48 hours 
incubation.
Isometamidium
concentration
(|ig/ml)
n
Glucose 
concentration 
After 48 hours 
(mmo1/1)
Glucose
disappearanc
rate
(mmol/l/48hr
i No feeder layer 0 4 5.9(0.4)* -
ii Feeder layer 0 5 3.6(0.3) 2.3
iii 1 4 3.3(0.2)a 2.6
iv 3 5 3.3(0.4)a 2.6
V 10 5 3.7(0.3)a 2.2
vi 30 5 3.5(0.5)a 2.4
vii 100 5 4.3(0.4)b 1.6
* mean and (S.D.)
a Not signifantly different from group ii 
b Significantly different from group ii (p <£. 0.05) 
n number of wells per concentration
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at 28°C for 48 hours in a 5% 00^ gassed incubator, after which 
the media overlying the feeder layer was sampled and the glucose 
concentration estimated using a commercial glucose kit (Sigma 
Diagnostics, procedure 45) based upon the hexokinase method.
Control wells consisting of 990 pi media with 10 pi of ' ■ 
distilled water, but without feeder layer were also incubated 
for 48 hours prior to estimation of glucose concentrations.
Five replicate wells were set up for each Isometamidium 
concentration. Glucose disappearance was calculated from the 
difference in glucose concentrations of the media without feeder 
layer and the test wells with feeder layer.
Results
The mean glucose concentration measured after the 48 hour 
incubation period, and the mean glucose disappearance rate for 
each Isometamidium concentration is shown in Table 12. A Student 
t-test was carried out to compare the glucose concentration measured 
for each Isometamidium concentration with the untreated feeder 
layer wells. The glucose concentration of wells treated at 
1, 3> 10 or 50 pg/ml Isometamidium was not significantly different 
from the untreated BAE wells. The glucose concentration in the 
wells treated at 100 pg/ml was significantly different (p < 0.05)> 
indicating that 100 pg/ml Isometamidium had caused a significantly 
decreased rate of glucose utilisation.
Discussion
This experiment indicates that Isometamidium concentrations 
up to 30 pg/ml do not adversely affect BAE cell metabolism, as 
determined by glucose utilisation rates. This suggests that, 
up/
up to this concentration, any observed effects of drugs on 
trypanosome survival or replication rates are due to direct 
effects on the trypanosomes, and are not mediated via an indirect 
effect on the feeder layer. However at a dose of 100 pg/ml 
Isometamidium the BAE feeder layer is adversely affected, and 
therefore the maximum concentration that should be used in this 
in vitro system is 30 pg/ml.
Borowy et al., (1985) noted that an Isometamidium 
concentration of 100 pg/ml also destroyed foetal bovine fibroblast 
feeder layers, although at 10 pg/ml feeder layer cells were 
unaffected.
In vitro Isometamidium Sensitivity Testing of Strains of T^_congolense
Methods
The in vitro drug experiments were based on the methods
developed by Borowy et al., (1985) for T.b. brucei. His method
involved incubating trypanosomes in the presence of a foetal
bovine fibroblast feeder layer, using 24 well tissue culture plates.
5Approximately 1 x 10 in vitro derived trypanosomes were introduced 
on to confluent feeder layers. Each well contained 1 ml of medium 
and drug was added in a volume of 10 (il to maintain the osmolarity 
of the medium. The effect of the drug was assessed at intervals 
of up to 58 hours, by sampling the wells and making counts of 
trypanosomes using a haemocytometer. Waithaka, Borowy, Gettinby
and Hirumi (1986) expressed the in vitro activity of trypanocidal 
drugs as the concentration required to inhibit growth by C^P/o 
compared to untreated controls (IC^q).
For T. congolense in the present study this method was 
adapted by using BAE cell feeder layer and MEM supplemented with 
20% CS0 Trypanosomes were maintained exposed to a range of
Isometamidium concentrations for 48 hour periods. Several different 
modifications to the basic method were investigated.
Basic method: The central eight wells of a 24 well tissue
culture plate were seeded with BAE cells, and were maintained in 
a 5% COg gassed incubator at 57°C using MEM supplemented with 2CP/o 
FCS. When a confluent feeder layer had been achieved, usually 
in 4 - 5 days, the overlying medium was removed and replaced 
with/
with 1 ml of MEM supplemented with 20% CSQ Trypanosomes were
harvested from a tissue culture flask with a heavy population of
healthy motile trypanosomes on the feeder layer, by vigorous
pipetting, and a sample of trypanosome suspension was counted using
a haemocytometer. The volume of trypanosome suspension required 
5
to contain 5 x 10 trypanosomes could then be calculated. This
volume, plus an additional 10 pi, was then removed from each well.
A stock solution of Isometamidium (10 mg/ml) was prepared using
sterile distilled water and filter sterilized using a 0.2 pm membrane
filter (Plow Laboratories, W. Germany), and a range of Isometamidium
concentrations were prepared by serial dilution using sterile
distilled water, such that the final Isometamidium concentration
required in each well could be achieved by the addition of 10 pi
5of solution. Approximately 1 x 10 trypanosomes were then added 
to each well, and the contents of each well mixed by gentle pipetting. 
The tissue culture plates were incubated at 28°C for 48 hours, in 
a 5% COg gassed incubator.
This basic procedure was varied in some situations <
Por T. congolense KETRI 2885 trypanosomes were harvested from 
parasitaemic mouse blood and not from in vitro culture. Trypanosomes 
were seperated from blood components by differential centrifugation.
In this process a mouse with a parasitaemia close to the first 
parasitaemic peak was bled by cardiac puncture, taking aseptic 
precautions. Approximately 1 ml of heparinised blood was added 
to 10 ml MEM in a sterile plastic universal bottle and centrifuged 
in a refrigerated centrifuge (40 g, 10 minutes) to sediment the 
red/
red blood cells. The supernatant was carefully decanted and 
centrifuged (100 g, 10 minutes) to sediment the trypanosomes.
The supernatant was discarded and the pelleted trypanosomes 
resuspended in a few ml of MEM supplemented with 20% 0So If 
necessary the first centrifugation step was repeated, although 
the presence of a few red blood cells did not seem to adversely 
affect the in vitro culture. In vitro drug tests for T. 
congolense KETRI 2885 were conducted at 57°C, while those for 
T. congolense KETRI 2880 and KETRI 2885 were carried out at 28°C.
For the latter two strains, 28°C was the temperature at which 
the adaptation and subsequent maintenance of in vitro cultures 
was carried out.
Different periods of incubation of trypanosomes in the 
presence of the BAE feeder layer, prior to the addition of Isometamidium 
to the wells, were also used. Thus, Isometamidium was added 
after 0, 4 or 24 hours incubation. In the latter case, the 
medium was changed prior to the addition of Isometamidium.
Enumeration methods
Borowy* s method involved removal of samples of medium and 
trypanosomes by gentle pipetting, and then counting trypanosome 
densities using a haemocy tome ter. It was however thought that 
this approach might be unsuitable for T. congolense which attaches 
to the feeder layer by the flagellum, because it was possible 
that different strains would be more or less readily detached, 
thereby distorting the results. Also, since dead or dying trypano­
somes were likely to be more easily detached from the feeder 
layer/
layer than healthy trypanosomes, this might also influence the 
results. Initially therefore a method was devised which relied 
upon a direct estimate of numbers of trypanosomes still attached 
to the feeder layer, using an inverted microscope (X200). In 
wells containing the higher drug concentrations, where relatively 
few trypanosomes survived after 48 hours incubation, the number 
of trypanosomes in each of three microscope fields near to the 
centre of each well are counted. In those wells in which the 
number of trypanosomes per field was too high to count, an eye­
piece graticule made up of 25 squares was used. The number of 
trypanosomes in each of five squares, one at each comer and one 
in the centre, of each of three microscope fields was counted.
The five squares together were estimated to represent one eighth 
of the total microscope field, and therefore the total number of 
trypanosomes per field was estimated by multiplying the total 
number of trypanosomes counted in the five squares by eight.
The number of trypanosomes per field of drug treated wells was 
related to the untreated wells, and the percentage inhibition 
calculated:
x 100
(Mean No.tryp's per weH ) con-tro]i “ (Mean No.tryp*s per well)^ ^
(Mean No.tryp's per well)control _  "
= % inhibition
The disadvantages of this method were that it was time 
consuming and that the results were vulnerable to uneven distribution 
of trypanosomes throughout the well. Clumping of trypanosomes 
also made counting difficult. It was therefore decided to-try 
removing/
Table 13* Effect of 48 hour incubations with Isometamidium on T.congolense 
2885.
Isometamidium concentration (|ig/ml)
Test number n 0.03 0.01 0
1 3 0 Few
individuals Heavy
2 3 Few
individuals Heavy Very heavy
i
trypanosomes from the feeder layer by vigorous pipetting, and then 
estimating trypanosome densities by haemocytometer counts. It 
was found that although the different strains of trypanosomes did 
attach to the feeder layer with differing degrees of firmness, 
vigorous pipetting removed virtually all trypanosomes from the 
feeder layer. Although this technique was still time consuming, 
it did overcome the problem of uneven distribution of trypanosomes 
over the well.
Results
T. congolense KETRI 2885
Bloodstream forms were isolated directly from parasitaemic 
mice and incubated in the presence of each of a range of Isometa­
midium concentrations (0, 0.01, 0.03, 0.1, 0.3, 1, 3, 10* 30 pg^ nl). 
for 48 hours at 37°C. Trypanosomes and Isometamidium were 
introduced on to the feeder layer at the same time. The results 
of two experiments are presented in Table 13* In both experiments 
counting of the untreated wells was difficult due to the large 
number of trypanosomes present and the presence of large clumps 
of trypanosomes. In experiment 1 there was a marked response 
to Isometamidium concentrations down to 0.01 jjg/ml, the lowest 
concentration used. In experiment 2, numbers of trypanosomes in 
the untreated wells and 0.01 jjg/ml treated wells were too heavy 
to count and consisted of large clumps of trypanosomes. In the latter 
trypanosome densities were heavy, but noticably less dense than the 
untreated wells. The effect of Isometamidium concentrations down 
to 0.03 Mg/ml was very marked, with very few trypanosomes in 
these wells after 48 hours.
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T. congolense KETRI 2883
Method 1; Bloodstream forms of trypanosomes were harvested 
from in vitro cultures, and were incubated in the presence of a 
range of Isometamidium concentrations (0, 0.1, 0.3, 1, 3, 10, 30 
Hg/ml) . Trypanosomes and Isometamidium were introduced on to the 
feeder layer at the same time. The effect of Isometamidium was 
determined by counting trypanosomes attached to the feeder layer 
using an inverted microscope. The percentage inhibition for each 
Isometamidium concentration was calculated in relation to untreated 
wells. The results of five experiments are shown in Table 14 •
In three tests the IC^q value, ie the Isometamidium concentration 
which resulted in a 50% inhibition of growth compared to untreated 
wells, lay between 3 and 10 pg/ml Isometamidium, while in one test 
the IC^q value lay between 0.3 and 1 |ig/ml, and in one test the value 
lay between 10 and 30 |Jg/ml.
This variation between tests could have arisen due to uneven 
distribution of trypanosomes on the feeder layer, or may have resulted 
from differences in the populations of trypanosomes harvested from the 
culture flasks, e.g. trypanosomes originating from more rapidly 
dividing populations may be more susceptible to Isometamidium.
Method 2: In these tests the basic method was varied by incubating
the trypanosomes for either 4 or 24 hours prior to addition of Isomet­
amidium and then incubating for a further 48 hours. The effect of 
Isometamidium was assessed by removing trypanosomes from each well by 
vigorous pipetting, and counting with a haemocytometer. The results 
of two tests carried out using this method are shown in Table 15 •
Incubation for 4 or 24 hours prior to the addition of Isometamidium 
does not appear to affect the outcome of the tests. In both cases 
the ICcjQ value fell between 3 and 10 |jg/ml.
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Of the seven tests carried out with this strain, in five the 
IC^q was between 3 and 10 [jg/ml.
T1_congolense KETRI 2880
Bloodstream forms of trypanosomes were harvested from 
in vitro cultures, and were incubated at 28°C in the presence 
of BAE feeder layer and one of a range of Isometamidium concentrations 
(0, 0.1, 0.3> 3»'10, 30 ((Jg/ml). Trypanosomes were incubated
for 4 or 24 hours prior to the addition of Isometamidium and the 
effect of drug was assessed by removing trypanosomes from the 
feeder layer by vigorous pipetting and estimating trypanosome 
densities by the use of a haemocytometer. The results of three 
tests are shown in Table 16.
The IC^q value lay between 3 and 10 |jg/ml in two of the 
three tests and between 1 and 3 [Jg/ml in the third. Again 
incubation of trypanosomes for 4 or 24 hours prior to addition of 
Isometamidium does not seem to have influenced the outcome of the 
test.
Even though slightly different methods were used in the 
different drug sensitivity tests performed, the basic approach 
was the same. Clear differences were demonstrated between the 
Isometamidium sensitivities of T. congolense KETRI 2885 and the 
two more resistant strains, namely KETRI 2880 and KETRI 2883.
TheIC -pjq values for T. congolense KETRI 2880 and KETRI 2883 
were both in the range 3 - -10 (jg/ml, while for T. congolense 
KETRI 2885 this value was ^ 0.01 (jg/ml.
It was not possible to differentiate between T. congolense 
KETRI 2880 and KETRI 2883 using this approach, although the MCDfs 
in cattle for these strains were 2.0 and 0.5 mg/kg respectively.
Since one of these strains could be cured by treatment at the 
manufacturers1 recommended dose of Isometamidium, and one could 
not, this degree of difference in Isometamidium sensitivity in vivo 
is of practical significance.
Discussion
An in vitro approach to the assessment of Isometamidium 
sensitivities of three strains of T. congolense has been explored. 
Although the method employed could detect broad differences in 
Isometamidium sensitivities, it was unable to demonstrate 
relatively narrow differences. Thus, a strain of T. congolense 
with a MOD in cattle of ^  0.001 mg/kg Isometamidium could readily 
be distinguished from either of two relatively resistant strains 
by the in vitro method. However the two latter strains, with 
MCD’s of 0.5 and 2o0 mg/kg respectively, could not be differentiated.
A number of problems associated with the in vitro approach 
became apparent, of which the most significant is adaptation of 
strains to in vitro culture. It is important that the population 
used in any in vitro drug experiments is a healthy, replicating 
one. Two of the three strains used in this study, namely T. 
congolense KETRI 2880 and KETRI 2883 rapidly died when introduced 
directly on to BAE feeder layer. A similar finding was reported 
by Ross et al., (1985) who found that three out of four cloned stocks 
of T. congolense died when introduced directly on to feeder layer. 
These strains therefore required more complicated and time consuming 
periods/
periods of adaptation to in vitro culture, prior to use in in vitro 
drug tests. Both T. congolense KETRI 2880 and KETRI 2885 were 
successfully adapted to in vitro culture by transformation of blood­
stream forms harvested from mice, through the insect mid-gut stages 
to metacyclic forms using a cell-free culture system, and then 
introducing the in vitro derived metacyclics on to BAE feeder layer 
where transformation back to blood stream forms occurred. In the 
case of T. congolense KETRI 2883 this adaptation phase required 
several attempts stretching over 6 months. For T. congolense 
KETRI 2880, even after the adaptation phase, in vitro cultures tended 
to replicate slowly. Of the three strains used, T. congolense 
KETRI 2880 had the longest pre-patent period in cattle, goats 
and mice, and resulted in characteristically intermittent parasit- 
aemias in mice. It therefore seems likely that both in vivo and 
in vitro this strain is inherently slow at replicating.
The difficulty of getting field isolates, or even laboratory 
strains of T. congolense to adapt to in vitro culture is clearly a 
major constraint on the wider use of this approach to drug sensitivity 
testing.
Having successfully adapted strains of T. congolense to 
in vitro culture, the question arises, how representative of the 
original trypanosome population is the in vitro adapted population?
The adaptation procedure presumably selects those individuals best 
able to survive in the in vitro conditions employed. A recent 
study has compared, in mice, the drug sensitivities of three strains 
of T. congolense both before and after adaptation to in vitro culture. 
It was concluded that the adaptation process had not altered the 
drug/
drug sensitivities of the strains used (Brown, Ross, Holmes, Luckins 
and Taylor, 1987)*
An additional disadvantage of in vitro systems for assessing 
the effects of drugs is that the influence of the host metabolism, 
and the effect of distribution and pharmacokinetics of the drug, are 
eliminated. If the metabolites of a drug play an important role 
in the in vivo activity of that drug, the results of in vitro work 
based on the use of !raw! drug may be misleading. In this context, 
it is interesting to note that Isometamidium concentrations that were 
active in the present study, are similar to calculated and reported 
values for blood concentrations soon after drug administration.
For example, the results of the in vitro experiments indicate 
that the IC^q value for T. congolense KETRI 2883 is in the range 
3 - 10 jjg/ml. The maximum calculated blood concentration for a 
250 kg steer treated at 0.5 mg/kg Isometamidium (the MOD for this 
strain) is approximately 9 Mg/ml. Currently available methods 
for estimating Isometamidium concentrations in tissues are relatively 
poor, but Braide and Eghianruwa (1980) using a spectrophotometrie 
technique report a serum concentration of 2 (Jg/ml, 24 hours after 
a single administration of 0.5 mg/kg to a goat by intramuscular 
injection.
The interaction of the hosts* immune response with 
trypanocidal treatment can also be important, and clearly such inter­
actions cannot occur in vitro. Whitelaw (1982) noted that a 
combination of diminazene aceturate treatment and maternal antibody 
provided greater protection from infection in young mice than 
either/
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either chemoprophylaxis or immunoprophylaxis alone. de Gee, 
McCann and Mansfield (1983) and Bitonti, McCann and Sjoerdsma 
(1986) both reported that an antibody response was necessary for 
the rapid elimination of trypanosomes in rodents treated with 
a-difluoromethylani thine.
\
The facilities and resources required for the in vitro 
culture of trypanosomes are relatively sophisticated and expensive, 
and are not readily available in many African countries.
Although in vivo methods tend to be expensive in developed 
countries, in developing countries where labour costs are lower, 
in vivo methods are probably more attractive, relying on locally 
available materials and labour. While the anti-vivisection 
lobby is an increasingly powerful force in Europe and America, 
with considerable pressure to use fewer animals in research, it 
is as yet, of little significance in Africa.
An alternative to using bloodstream forms for in vitro 
drug experiments is to use procyclic forms. This approach has 
the advantage that in vitro derived procyclic forms are relatively 
easy to produce from mouse harvested bloodstream forms, and also 
eliminates the need for a feeder layer. Procyclic forms of 
T.b. brucei have been used for in vitro studies of resistance to 
a-difluoromethylornithine (Phillips and Wang, 1987? Bellofalto, 
Eairlamb, Henderson and Cross, 1987). However, it remains to be 
demonstrated whether or not drug sensitivities determined in 
vitro using procyclic forms of T. congolense correlate well with 
values obtained using bloodstream forms0
In conclusion, the relevance of in vitro methods for the 
assessment of drug sensitivities of strains of T. congolense is 
limited, firstly by the difficulty of adapting strains to culture, 
and secondly, by the facilities and resources required. 
Improvements in in vitro culture techniques, e.g. the development 
of cell-free systems for bloodstream forms of T. congolense. may 
make this approach more applicable in the future, but at the 
present time an in vitro approach is not appropriate to routine 
monitoring of drug sensitivities in Africa.
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CHAPTER FIVE
STUDIES OF THE APPARENT APARASITAEMIC INTERVAL 
FOLLOWING SUBCURATIVE TREATMENT WITH ISOMETAMIDIUM
OF T. congolense INFECTIONS IN MICE
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INTRODUCTION
Treatment of animals infected with T. congolense, with an 
effective but subcurative dosage of Isometamidium results in a 
period of apparent aparasitaemia, followed by a relapse infection.
This raises the questions, what is the source of the relapse 
infection and what happens to the trypanosomes during the apparent 
aparasitaemic interval? In the case of T.b. brucei infections 
in mice, Jennings et al. (1979) demonstrated that the brain was 
the source of the relapse infection following subcurative treatment 
with diminazene aceturate. MacLennan (1973) demonstrated a 
temporary period of aparasitaemia in cattle infected with T. vivax 
and treated with diminazene aceturate, during which subinoculation 
of blood into naive cattle failed to result in the establishment of 
infection in recipients. Cattle subinoculated with blood 
collected 12 hours, or J, 6 or 9 days after treatment with 3*5 
mg/kg diminazene aceturate did not become ^parasitaemic, while, 
cattle subinoculated 6 hours or 12 days post-treatment became 
parasitaemic. He suggested this was evidence that following 
treatment with diminazene aceturate, T. vivax ’survives in treated 
animals other than in the bloodstream1.
With few exceptions, T. congolense is regarded as strictly 
vascular (Losos et al., 1973)* Two groups of workers have demonstrated 
T. congolense in the brain or CSF of cattle (Haase et al., 1981>
Masake et al., 1984) although in both cases the presence of 
intercurrent infections with T.b. brucei was a complicating factor, 
and may have facilitated the breaching of the blood-brain barrier 
by T. congolense.
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In the present study mice were examined during the aparasit- 
aemic interval following effective but subcurative treatment with 
Isometamidium of T. congolense infections.
The Relapsing Mouse Model
A preliminary experiment in mice infected with T. congolense 
82/1, indicated that 1 • 0 mg/kg Isometamidium administered on day 
21 post-infection resulted in an aparasitaemic period, as demonstrated 
by examination of tail-blood wet-film preparations, of 12 - 15 days 
duration, followed by recrudescense of parasitaemia. Increasing 
the dosage to 2.0 mg/kg resulted in all mice being cured. A 
dosage of 1.0 mg/kg administered on day 21 was therefore selected 
as a suitable treatment regime to investigate the apparent aparasit­
aemic interval following subcurative treatment with Isometamidium.
Organ Transfer Experiments 
Methods
5Donor mice were infected with approximately 1 x 10 trypanosomes, 
T. congolense 82/1, administered by ip inoculation. Twenty-one 
days post-infection donor mice were checked to confirm the presence 
of circulating trypanosomes by examination of tail-blood wet-film 
preparations, and were then treated with Isometamidium (1 mg/kg) 
administered by ip injection. Seven days after treatment mice 
were again checked to confirm absence of circulating trypanosomes, 
and then deep anaesthesia was induced using trichloroethylene. 
Approximately 0.5 ml of blood was obtained from each mouse by cardiac 
puncture using a heparinised syringe and needle. Mice were then 
killed/
Table 17. Results of the subinoculation of blood or organ macerates to 
irradiated recipient mice.
Donor
mouse
number Blood Heart Spleen Liver Kidney Brain
Reprod
organs
1 + + +
2 +i
3
4 + +
5
6 + +
7 D(17)
8 D(2) + + D(2) +
9 + + +ii
10 + + D(2) + + +
11 D(2)
12 D(10)
13 + + +
14 D(8)
15 D(3)
16
17
18
i
+ D(24)
19 +
20 +
+ infection developed in recipient.
D mouse died on day post-subinoculation indicated, without
development of infection.
i transient parasitaemia: one trypanosome per 20 fields on day 
15 post-subinoculation.
ii transient parasitaemia: one trypanosome per 20 fields on day 
24 post-subinoculation.
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killed by cervical dislocation, and heart, brain, liver, kidneys, 
spleen and reproductive organs (ovaries, Fallopian tubes and uterus) 
dissected out. Each organ was carefully macerated by forcing through 
a wire gauze with a syringe plunger, and suspended in approximately 
1 ml of sterile, isotonic saline. The blood samples and macerated 
organ suspensions were inoculated by the ip route into mice which 
had been irradiated (600 rads) 24 hours earlier, one organ per 
mouse. In the case of the liver, only half the tissue was sub­
inoculated. Recipient mice were maintained on oxytetracycline- 
treated drinking water (Terramycin, Pfizer, England) to control 
adventitious bacterial infections, and were monitored for the 
development of parasitaemia by examination of wet-films, three 
times a week. Observations were continued for 28 days. Control 
mice, which had been infected and treated at the same time as the 
donors, were retained to monitor recrudescense of parasitaemia 
after treatment.
Results
Control mice which had been infected and treated exactly 
as the donors were retained to monitor development of the relapse 
infection. Of nine control mice, eight developed relapse 
infections, with parasites first being detected in tail-blood wet- 
films between 8 and 10 days post-treatment. One mouse remained 
clear of circulating trypanosomes throughout the 35 day post­
treatment period.
The results of the subinoculation of blood or organ macerates 
are shown in Table 17. Although all donor mice were shown to 
be/
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be free of circulating trypanosomes by examination of tail-blood 
wet-film on the day the subinoculations were carried out, six of 
20 recipient mice which received subinoculations of blood developed 
parasitaemias. Heart macerates obtained from donors in which the 
blood gave rise to infection, also resulted in infection being trans­
ferred to recipient mice. In addition, a further four mice receiving 
subinoculations of heart macerate became infected, although sub­
inoculations of blood from the same donors failed to transfer 
infection.
No mice subinoculated with spleen macerate became infected.
One mouse subinoculated with liver macerate became parasitaemic.
The receipient of blood from the same donor died shortly after sub­
inoculation.
Three mice subinoculated with kidney macerate became parasitaemic. 
Of these, two mice subinoculated with blood from the same donor 
developed parasitaemias. A third mouse developed a transient 
parasitaemia, one motile trypanosome being observed on one occasion 
15 days after subinoculation. Two new irradiated mice were sub­
inoculated with 0.1 ml of blood from this mouse, 9 days after the 
single trypanosome had been observed. Both remained trypanosome- 
free throughout the 28 day observation period. Blood from the 
same donor mouse did not result in transmission of infection; 
neither did any other organ macerate.
Three mice subinoculated with brain macerate became infected.
Two of the recipients of blood from the same donors became infected.
In/
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In a third mouse the corresponding subinoculation of blood failed 
to transfer infection, although the heart macerate resulted in 
parasitaemia.
Three mice subinoculated with reproductive organ macerate 
became infected, one only transiently. Two of the matching blood 
subinoculations also resulted in infection. The recipient of blood 
from the third mouse died soon after subinoculation.
Discussion
Of the twenty apparently aparasitaemic donor mice used in 
this experiment, blood or organ macerates from 11 of them resulted • 
in the transfer of infection to subinoculated recipient mice, although 
at the time of subinoculation donor mice were aparasitaemic, as 
judged by examination of wet-film preparations. In six of the 11,
subinoculation of blood resulted in the transfer of infection to recipient 
mice, and in another mouse the recipient subinoculated with blood 
died without development of parasitaemia. Clearly if blood from a 
donor mouse caused transmission of infection, then it is impossible 
to say whether an organ macerate from the same donor has resulted 
in a parasitaemia due to a cryptic trypanosome infection, or due to 
blood incidentally subinoculated along with the tissue. In four 
donor mice however, subinoculation of organ macerates resulted in 
transfer of infection to recipients, when matching blood samples did 
not. In two cases this occurred with heart macerate, in one case 
heart and brain macerate and in one case kidney macerate resulted 
in a low-grade, transient parasitaemia. T. congolense are known 
to/
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to preferentially inhabit capillaries rather than larger vessels, 
and therefore it is possible that the latter examples can be 
explained by very low numbers of circulating trypanosomes failing 
to transfer infection in the blood, but larger numbers of 
trypanosomes inhabiting the capillaries of the heart, brain or kidney, 
resulting in transfer of infection in the organ macerates.
The finding that blood subinoculated from six of the 20, 
apparently aparasitaemic, mice resulted in establishment of parasit­
aemias in irradiated recipient mice, indicated that a more intensive 
investigation of the apparent aparasitaemia following subcurative 
treatment, was warranted.
Investigation of the Aparasitaemic Period Following Subcurative 
Treatment with Isometamidium, Using Three Trypanosome Detection Methods 
Method
honor mice (ex-breeder females, mean weight 57*3 + 2.2 g)
5
were infected by ip inoculation with approximately 1 x 10 trypanosomes, 
T. congolense 82/1, prepared from cryopreserved stabilate. Twenty- 
one days post-infection, donors were checked to confirm the presence 
of circulating trypanosomes by examination of tail-blood wet-films, 
and then treated with Is ome tami dium (1 mg/kg) administered by ip 
injection. After treatment donors were monitored by examination 
of tail-blood wet-film preparations. On the first occasion when 
trypanosomes could not be detected by the wet-film technique, Walkers* 
(1972) modification of the capillary concentration technique was 
carried out (see p 64). If the capillary concentration method also 
failed to demonstrate trypanosomes, then a recipient mouse was irradiated 
(600/
Table 18. Results of three trypanosome detection methods employed during tne apparent 
aparasitaemic period (Experiment 1.)
Donor
mouse
number
Day post- treatment
2 3 4 5 6 7 8 9 10 13
1 Wet film 4.3 4.3 4.6
Cap.conc. + +
Subinoc. - ■ K + + - +
2 Wet film 4.6 4.3 4.3 4.3 6.1
Cap.conc. + - - - - + +
Subinoc. - + + - +
3 Wet film 7.3 4.3 4.3 4.3 4.6
Cap.conc. + + - - - +
Subinoc. - + - + +
4 Wet film 6.1 4.3 4.3 4.9 6.4
Cap.conc. + - - - - +
Subinoc. + + + - +
5 Wet film 4.3 4.3 5.2 7.1
Cap.conc. + + - - - - - +
Subinoc. + + + + +
6 Wet film 5.2 4.3 4.3 5.8 7.2
Cap.conc. + - - - - - +
Subinoc. + + + + +
7 Wet film 4.3 5.2 6.1 6.7
Cap.conc. + - - - - - +
Subinoc. K + + + - +
9 Wet film 7.1 4.3 4.3 4.3 4.6
Cap.conc. - - - - - - - +
Subinoc. K + + - + +
10 Wet film 4.3 4.3 4.9 7.0
Cap.conc. + - - - - - - +
Subinoc. - + + + + +
Wet film: log trypanosomes per ml.
10
Cap.cone: + indicates trypanosomes observed
- indicates no trypanosomes observed
Subinoc. + indicates infection developed in recipient mouse
- indicates no infection developed in recipient mouse
K indicates mouse killed in extremis without developing infection
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(600 rads) and 24 hours later subinoculated with 0.1 ml of tail-blood 
collected from the apparently aparasitaemic donor mouse. Irradiated 
recipient mice were maintained on oxytetracycline-treated water 
to control adventitious bacterial infections. Observation was 
continued for up to 40 days (Experiment 1).
In Experiment 2, the same basic method was followed, except 
that new recipient mice were subinoculated each day beginning on 
day 2 post-treatment throughout the apparent aparasitaemic period. 
Recipient mice were monitored for up to 30 days.
Results
Experiment 1: The results, presented in Table 18, clearly
demonstrated the relative sensitivities of wet-film, capillary 
concentration and sub inoculation to immuno suppressed mice. In 
cases where examination of 20 microscope fields of a tail-blood 
wet-film preparation failed to reveal any trypanosomes (< log^Q 4*3 
trypanosomes per ml blood), the capillary concentration technique 
frequently demonstrated the presence of parasites (mice 1, 5> 7 and 
10 on day 2; mice 1, 2, 4> 5» 6 and 10 on day 9> mice 2, 3 and 9 
on day 10). Likewise, subinoculation of 0.1 ml aliquots of blood 
to irradiated recipients often resulted in transmission of infection 
when the capillary concentration technique showed no trypanosomes 
(mice 1, 4> 5> 6, 7 and 10 on day 5; mice 2, 4> 5> 6, 7> 9 and 10 
on day 6; mice 1, 2, 3> 4> 5> 6, 7> 9 and 10 on day 7; mice 5> 6 
and 10 on day 8; mouse 3 on day 9)«
Of 10 donor mice used in the experiment, nine developed 
a relapse infection as determined by either the wet-film or capillary 
concentration/
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concentration techniques, with trypanosomes disappearing from the 
bloodstream between days three and five post-treatment and reappearing 
on day 9 or 10. However successful transmission of infection by 
subinoculation of blood during this apparent aparasitaemic period, 
suggests that the level of circulating trypanosomes may have merely 
dropped below the limit of detection of the less sensitive trypanosome 
detection methods used. The results are incomplete due to a 24 hour 
delay from first demonstration of a negative capillary concentration 
preparation, to subinoculation of blood to an immunosuppressed 
recipient mouse, and also because some mice were killed in extremis 
without the development of parasitaemia. These individuals may 
have developed a bacterial infection in spite of being maintained 
on oxytetracycline-treated water, or they may have been affected 
by the irradiation process. Experiment 2 attempted to overcome the 
former problem by performing sub inoculations daily from day 2 post­
treatment until detection of the relapse infection by the wet-film or 
capillary concentration techniques.
Experiment 2: Of the 10 donor mice used in the experiment,
seven developed a relapse infection, as demonstrated by either the 
wet-film or capillary concentration techniques, with trypanosomes 
disappearing from the bloodstream between day 3 and 5 post-treatment 
and reappearing between days 7 and 10. The results for the three 
trypanosome detection methods are shown in Table 19 . As in Experiment 
1, the relative sensitivities of the three detection methods were 
clearly demonstrated. For the seven mice which experienced temporary 
remission of infection, followed by relapse, the mean aparasitaemic 
periods,/
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periods, as determined by the different detection methods were; 
wet-film 8.4 days, capillary concentration technique 5.0 days and 
mouse subinoculation 2.7 days. Two mice which were subinoculated 
with blood which was shown to be trypanosome-positive by the wet- 
film or capillary concentration techniques, failed to become 
infected. In both cases this occurred 2 days after Is ome tamidium 
treatment, when the number of circulating trypanosomes had already 
been reduced to a low level.
Discussion
The estimate of the duration of the apparent aparasitaemic 
period following subcurative treatment with Is ome tami dium, has been 
shown to be markedly influenced by the trypanosome detection method 
used. The most sensitive detection method used, subinoculation 
of 0.1 ml of blood into immunosuppressed mice, demonstrated the shortest 
intervals and in some mice no aparasitaemic interval could be demonstrated 
using this method.
The apparent aparasitaemic interval could be due to either 
complete elimination of circulating trypanosomes, or a reduction in 
the number of circulating parasites to below the limit of detection 
of the method used. Since a detectable relapse infection eventually 
occurs, it follows that if trypanosomes are eliminated from the 
bloodstream, a cryptic focus of infection must exist which is drug 
inaccessible, and from which trypanosomes re-emerge when circulating 
levels of trypanocide have dropped below an effective level. These 
experiments, whilst not being conclusive, suggest that numbers of 
trypanosomes may merely have dropped below the limit of detection. 
Although/
- 129 -
Although in theory, transfer of a single trypanosome is enough to 
initiate an infection, in practise it can be difficult to establish 
an infection of T. congolense from a single trypanosome, eg in 
cloning.
The relapse phenomenon described by Jennings et al. (1979) 
in which T.b. brucei infections in mice undergo a demonstrable 
aparasitaemic period following subcurative treatment with diminazene 
aceturate, during which subinoculation of brain macerates, but not 
other tissues or blood, consistently resulted in transfer of infection, 
does not seem to be paralleled in the T. congolense model used in 
the present experiment.
Is ome taintdium Sensitivities of the Parent and Relapse Population
of T. congolense 82/1
Introduction
If the apparent aparasitaemic interval is due to a reduction 
of numbers of circulating trypanosomes to a level below the limit 
of detection of the trypanosome detection method employed, then one 
might expect the trypanosomes which survive treatment and contribute 
to the relapse infection to differ from the pre-treatment population.
It was therefore decided to compare the Isometamidium sensitivites 
of the relapse population of T. congolense 82/1 with the parent 
infection.
Method
5
A group of nine mice was infected with 1 x 10 trypanosomes,
T. congolense 82/1, prepared from cryopreserved stabilate and 
administered by ip inoculation. Twenty-one days post-infection
the/
Table 20 Comparison of Isometamidium sensitivities of the parent and 
relapse population of T.congolense 82/1.
Isometamidium
(mg/kg)
Parent Relapse
0.1 4.2±1.1 a 5.0±0
0.25 7.0±1.4 7.6±2.5
0.5 12.0±1.7 2/5 b 13.0±0
0.75 11.5±2.1 3/5 13 4/5
1.0 13 4/5 5/5
2.0 5/5 ■ 4/4
a Parasitaemic by day : mean ±  S.D 
b number of mice cured/number of mice infected
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the mice were treated with Isometamidium, 1 mg/kg by ip injection.
A stabilate was prepared from the resultant relapse infection, by
pooling blood from mice close to the first parasitaemic peak.
This stabilate was called T. congolense 82R and was stored in liquid
nitrogen until required.
Later groups of five mice were anaesthetized and then infected
5 ■
via the tail vein with 1 x 10 trypanosomes of either the relapse 
infection (T. congolense 82/r ) or the parent infection (T. congolense 
82/1). Three hours post-infection mice were treated with one of 
a series of Isometamidium doses, or left untreated as infection 
controls. After infection, development of parasitaemias were 
monitored by examination of tail-blood wet-films, initially three 
times a week. Observation was continued for 100 days.
Results
The results of the Isometamidium sensitivity test are shown 
in Table 20. The minimum Isometamidium dose which cured all 
infected mice (MOD) was 2.0 mg/kg for T. congolense 82/1 and 1.0 
mg/kg for T. congolense 82R, although this difference is in fact due 
to just one mouse relapsing in the parent strain/1.0 mg/kg treatment 
group. C-DqO values for the parent and relapse infections were 
1.0 and 0.75 mg/kg respectively.
Discussion
Only minor differences were observed in the drug sensitivities 
of the parent and relapse populations of T. congolense 82/1, both 
in terms of number of cures at each dose, and in the delay in 
appearance of trypanosomes in the blood. If the period of apparent
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aparasitaemia following subcurative treatment with Isometamidium 
is due to a drop in the number of circulating trypanosomes below 
the limit of detection of the method used, then one would have thought 
that the parent and relapse populations of trypanosomes would have 
responded differently to treatment. No such differences were 
demonstrated in this experiment. The question of how some trypanosomes 
survive treatment to contribute to the relapse population remains 
unanswered.
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CHAPTER SIX
ATTEMPTS TO INDUCE CHANGES IN ISOMETAMIDIUM SENSITIVITY
BY REPEATED SUBCURATIVE TREATMENT
OP To congolense INFECTIONS IN MICE AND GOATS
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Introduction
It is frequently suggested that exposure to subcurative levels 
of trypanocidal drugs enhances the likelihood of drug resistant 
strains of trypanosomes developing, and that drug resistance is more 
likely to develop to drugs with extended prophylactic activity, 
such as Isometamidium (Whiteside, 1962). Exposure of trypanosomes 
to subcurative levels of trypanocidal drugs has been successfully 
used by many workers as a means of inducing drug resistant strains 
of trypanosomes in laboratory conditions. Although there are 
numerous examples in the literature of the production of resistant 
strains of a number of trypanosome species by this technique (Wilson, 
1949; Pulton and Grant, 1955; Hawking, 1963a), and for a range 
of trypanocidal drugs, there are very few examples of Isometamidium 
resistant strains being created. Hawking (1963a) found that 
resistance to metamidium developed more slowly than resistance to 
quinapyramine or pyrithidium, but slightly faster than resistance 
to diminazene aceturate. He passaged a me tami dium- s ens i ti ve strain 
of T. congolense through metamidium treated guinea-pigs or irradiated 
mice, and found that it took 33 months to produce maximal resistance. 
The strain was initially sensitive, with an MED of 0.005 mg/kg and 
a MOD of 0.1 mg/kg. The resistant strain he produced had a MED 
of 12 mg/kg, and the curative dose was greater than the maximum 
tolerated dose (25 mg/kg). Metamidium is a precussor of Isometamidium, 
and is a mixture of two isomers, in the proportions 55% of a purple 
isomer and 45% of a red isomer. The water soluble red isomer is the 
more active of the two, and was later given the name Isometamidium. 
Whiteside/
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Whiteside (i960) mentions that he made a strain of T. congolense 
resistant to 2.0 mg/kg metamidium, by successive treatment in cattle 
with 0.05> 0.05 and 0.5 mg/kg metamidium. Eolkers (1962) noted 
no decrease in Isometamidium sensitivity following repeated 
treatment at 0.25 mg/kg, in naturally infected cattle in Nigeria* 
Whiteside (1962) considered that drug resistant strains of 
T. congolense were difficult to produce in mice. In contrast however, 
in cattle and adopting a method of repeated subcurative treatment 
and relapse, he noted * excepting only ... berenil, resistance never 
fails to develop with astonishing rapidity1. He found that three 
to six successive treatments were all that was needed to make strains 
resistant to 40 to 80 times the median curative dose (CD^q) and 
that the procedure could be carried out in a single steer.
In view of the lack of data relating to the ease with which 
Isometamidium resistant strains of T. congolense can be produced in 
the laboratory, it was decided to attempt to induce changes in 
sensitivity by repeated subcurative treatment using mice and goats 
as hosts.
Experiments with Mice 
Methods
• 5
Groups of 10 mice were infected with approximately 1 x 10
trypanosomes per mouse, T. congolense 82/1 (parent strain), prepared
from cryopreserved stabilate. On day 7 post-infection, mice were
checked to ensure that they were parasitaemic by examination of
tail-blood wet-film preparations, and were then treated by ip
inoculation/
Fig. ■7> m Derivation of relapse populations of T.congolense 82/1
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inoculation with Isometamidium at 0.5 mg/kg. After treatment 
parasitaemias were monitored, again by examination of wet-films, three 
times per week. A stabilate was prepared of the relapse population, 
by pooling blood from mice close to the first parasitaemic peak.
This stabilate was designated T. congolense 82/R1. A new batch of 
mice was then infected with T. congolense 82/R1, and the process 
repeated to derive T. congolense 82/R2. The procedure was repeated 
several times, and in this way a series of trypanosome populations, 
designated T. congolense 82/R1 through to T. congolense 82/r6, was 
derived. A new batch of mice was then infected with T. congolense 
82/R6 and the procedure outlined above was followed, except that 
the Isometamidium dosage was increased to 1.0 mg/kg. Using this 
new dosage trypanosome populations T. congolense 82/R7, 82/R8 and 
82/R9 were derived (Eig 5 )•
The Isometamidium sensitivities of the parent, R3, R6 and 
R9 populations were then compared in a mouse sensitivity test.
Batches of mice were infected by ip inoculation of approximately 
1 x 105 trypanosomes of either T. congolense 82/1 (parent strain), 
or the R5, R6 or R9 relapse population. One week later mice were 
checked to ensure they were parasitaemic by examination of wet- 
films, and were then allocated to treatment groups receiving 0,
0.5, 0.75, 1*0, 1.25, 1.5» 1.75 or 2.0 mg/kg Isometamidium by ip 
injection. Parasitaemias were monitored for 60 days by examination 
of tail-blood wet-films and also by the capillary concentration 
method.
Table 21 .Comparison of Isometamidium sensitivities of the 
relapse populations of T.congolense 82/1
parent and
Isometamidium (mg/kg)
0.5 1.0 1.25 1.50 1.75 2.0 41.75
Parent 5/5 * 4/5 4/5 1/5 i/5 0/5 15/25
R3 5/5 3/5 3/5 2/5 1/5 0/5 14/25
R6 5/5 5/5 2/5 2/5 1/5 0/5 15/25
R9 5/5 5/5 2/4 2/5 0/5 0/5 14/24
number of mice relapsed/number of mice infected
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Results
The results of the Isometamidium sensitivity test carried 
out in mice infected with the parent or relapse populations of 
T. congolense 82/1, are presented in Table 21 .- These fail to 
show any evidence of a decrease in Isometamidium sensitivity as 
a result of up to nine exposures to subcurative Isometamidium 
treatments.
Experiments with Goats
Prior to any attempt to produce Isometamidium resistant 
strains of T. congolense using goats as hosts, basic information 
on the infectivity, course of infection and pathogenicity of a 
number of strains of T. congolense in this host species was required. 
Goats were therefore infected with one of a number of strains of 
T. congolense.
Infeotivity and pre-patent periods: All the strains of
T. congolense used, KETRI 2880, 2885, 2885 and 82/1, proved to be
goat infective. After infection by the iv route with approximately 
5
1 x 10 trypanosomes, prepared from cryopreserved stabilate, 
trypanosomes were first detected, using the capillary concentration/ 
buffy coat technique, in a mean of 15*7 + 1*6 days for T. congolense 
KETRI 2880. Corresponding values for KETRI 2885 and KETRI 2885 
were 7 + 0  and 8.1 +0.4 days respectively. Por T. congolense 
82/1, trypanosomes were first detected in a mean of 8.7 + 2.5 days.
A comparison of the pre-patent periods for T. congolense KETRI 2880, 
2885 and 2885 in cross-bred British goats in the present experiment 
and/
Table 22. Comparison of pre-patent periods in goats and cattle for three 
strains of T.congolense.
T.congolense:
KETRI 2880 KETRI 2883 KETRI 2885
n mean ±  S.D. n mean ± S.D. n mean ± S.D.
Goats 6 13.7 ± 1.6 3 7.0 ± 0 7 8.1 A  0.4
Cattle 11 . 10.6 ± 0.7 10 7.1 ± 0 . 3  12 7.0 ±  0
Table 2 5 .Effect of infection with T.congolense on PCV during first 21 days 
of infection.
T.congolense: n
Mean PCV 
Day 0
(dt_ S.D.) 
Day 21 Decrease 0-21 days
KETRI 2880 4 36.1 (3.1) 27.4 (5.4) 8.8 (4.9)
KETRI 2883 1 34 18 16
KETRI 2885 4 35.3 (2.4) 22.0 (3.7) 13.3 (4.6)
82/1 1 31 25 6
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and zebu Boran cattle determined in a previous experiment (see 
Chapter 5) » is presented in Table 22 . T. congolense KETRI 2880 
had the longest pre-patent period in both host species.
Pathogenicity: The effect of infection with strains of
T. congolense on PCV during the first 21 days post-infection is shown 
in Table 25 . The limited number of animals available, and the 
wide variation within the strains, makes it difficult to compare 
the relative pathogenicities of the strains in goats.
Goat Y98, infected with T. congolense 82/1, developed severe 
clinical signs around day 50 post-infection. Although it had a 
PCV of 22, the animal was dull and lethargic with drooping ears and 
dilated pupils, and prolonged pyrexia with rectal temperatures of 
up to 41,9°C being recorded.
Course of parasitaemia: Two goats were infected with T.
congolense KETRI 2880 and maintained without treatment. One of the 
goats remained continuously parasitaemic from first detection of 
ti^ypanosomes through to day 70 post-infection, when observation 
was discontinued. The second goat became parasitaemic on day 14- 
No trypanosomes could be detected on day 15 or day 29 post-infection, 
but otherwise it was continuously parasitaemic up to day 55, when 
treatment was administered.
One goat was infected with T. congolense KETRI 2885 and 
maintained without treatment up until day 26 post-infection. Prom 
first detection of trypanosomes on day 7, until treatment on day 
26, it was not possible to detect trypanosomes on only one occasion 
(day 12).
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Four goats were infected with T. congolense KETRI 2885 and 
maintained without treatment. In three of the goats trypanosomes
could not always be detected: goat Y97 was apparently aparasitaemic 
on four occasions during a 70 day observation period (days 40 , 44,
54 and 78); goat F185 was apparently aparasitaemic on day 24 post­
infection and goat F195 on days 22 and 24- Both F185 and F195 
were monitored up until day 27 post-infection.
A single goat, infected with T. congolense 82/1, was maintained 
until day 53 post-infection before intervention with trypanocidal 
drugs. After the pre-patent period, on one occasion (day 16) 
trypanosomes could not be detected.
Selection of Strains of T. congolense
Three strains of T. congolense were selected for attempted 
induction of changes in Isometamidium sensitivity in goats; T. 
congolense KETRI 2880, KETRI 2883 and T. Congolense 82/1. The 
former two strains had previously been used in the cattle/mouse 
sensitivity test in Kenya, and therefore Isometamidium dose rates 
likely to be subcurative in ruminants were already known: T.
congolense KETRI 2880 had a MOD in cattle of 2.0 mg/kg, and cattle 
were temporarily cleared of circulating trypanosomes by treatment 
at 0.1 (2/3 cattle), 0.5 or 1.0 mg/kg. T. congolense KETRI 2883 
had a MOD in cattle of 0.5 mg/kg, and treatment at 0.1 mg/kg 
resulted in temporary remission of infection in two out of three 
cattle. T. congolense KETRI 2885 could not be used for attempted 
production of Isometamidium resistance, because previous work in 
cattle had shown the lowest dose administered, 0.001 mg/kg to be 
curative. Comparative data for T. congolense 82/1 was only 
available from mice: the MOD in this species was 2.0 mg/kg.
Attempted Induction of Changes in Isometamidium Sensitivity in
Goats
Methods
A single goat was infected with the appropriate strain
5of T. congolense. with an inoculum of approximately 1 x 1 0  
trypanosomes being administered by iv inoculation. Rectal tempera­
ture was recorded daily at 09.00 hrs and at the same time a jugular 
blood sample was collected for estimation of PCV and parasitaemic 
status. Bodyweight was measured once a week. When trypanosomes 
were first detected, by the capillary concentration/buffy coat 
method, the goat was treated with the selected dose of Isometamidium, 
administered by deep intramuscular injection into the quadricep 
femoris muscle of the hind leg. Dosages of 0.05, 0.1 or 0.2 mg/kg 
Isometamidium were prepared as 0.25% (w/v) solutions using distilled 
water. A dosage of 0.5 mg/kg was prepared as a 1% (w/v) solution. 
Repeated treatment was administered alternately in the left and 
right leg. After treatment the goat was again monitored daily.
When a relapse infection was detected, the parasitaemia was 
monitored for 7 days. On day 7 a jugular blood sample was collected 
and 0.5 ml aliquots of blood were subinoculated into each of 
five mice which had been sublethally irradiated 24 hours previously 
(600 rads). The goat was then retreated with the selected dose 
of Isometamidium, monitoring was continued, and the above procedure 
repeated. Stabilates of the subinoculated relapse infections 
were prepared by pooling blood from the five mice close to the 
first parasitaemic peak. In this way a series of relapse populations 
was isolated and stabilated for each strain.
Table 24* The interval to relapse following treatment and retreatment with
Isometamidiurn.
Day post-infection Isoraetamidium Treatment-relapse interval
mg/kg days
KETRI 2880 (Y92)
12 0.1 9
27 0.1 6
38 0.2 8
53 0.5 15
76 0.5 38
124 0.5 >46
KETRI 2883 (Y95)
7 0.1 7
20 0.1 13
39 Killed in extremis
KETRI 2883 (Y100)
8 0.1 4
19 0.1 11
36 0.1 12
55 0.1 14
79 0.1 13
99 0.1 15
82/1 (Y91)
7 0.1 > 42
82/1 (Y197)
11 0.05 22
41 0.05 >46
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Results
T. oongolense KETRI 2880: The single goat (Y92) infected
with T. consrolense KETRI 2880 became parasitaemic on day 12 post­
infection, and was treated with Isometamidium at 0,1 mg/kg.
The interval from treatment to relapse following this and subsequent 
treatments with Isometamidium, are shown in Table 24 The results 
indicate that repeated subcurative treatment with Isometamidium 
did not result in a significant change in sensitivity.
T. congolense KETRI 2883; Goat Y95, infected with T^ 
oongrolense KETRI 2883, became parasitaemic on day 7 post-infection, 
and was then treated with Isometamidium at 0.1 mg/kg. The 
intervals to relapse following treatment and retreatment with this 
dose are shown in Table 24* Goat Y95 relapsed to repeat treatment 
with 0.1 mg/kg Isometamidium on day 33 post-infection. The relapse 
infection was accompanied by pyrexia, with a peak rectal temperature 
of 40.3°C being recorded. On day 30 post-infect ion the animal 
was stemally recumbent: although it could stand with assistance
it was ataxic. It was also noticed to be drinking more than 
normal. On day 39 the condition had deteriorated to lateral 
recumbency, with opisthotonus, paddling of the limbs, bleating 
and a sub-normal temperature (37»6°C), and the goat was killed 
by administration of an overdose of pentobarbitone. An autopsy 
was performed and the principal findings were; congested intestine, 
haemorrhage on the surface of the lung and old Kasciola lesions 
in the liver. An attempt to collect a blood-free sample of 
cerebrospinal fluid (CSK) for mouse subinoculation was unsuccessful, 
because/
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because the CSF was very viscous: this may have been a post­
mortem change. These findings seem consistent with trypanosomiasis 
with cerebral involvement (Whitelaw, Moulton, Morrison and Murray, 
1985), but without demonstration of trypanosomes in the CSF this 
can only be a speculative diagnosis. A second goat (Y100) was 
therefore infected with this strain, and became parasitaemic on 
day 7* Treatment with Isometamidium was accidentally delayed 
until day 8. The intervals to relapse following treatment and 
retreatment with 0.1 mg/kg Isometamidium are shown in Table 24. 
Relapse after initial treatment at this dose occurred in 4 days, 
but thereafter relapses occurred in 11 and 15 days. The consistent 
interval between treatment and relapse suggests that no decrease 
in sensitivity had occurred during repeated (6) exposure to sub­
curative Isometamidium doses in goats.
T. congolense 82/1: Goat Y91> infected with T. congolense
82/1, became parasitaemic by day 6 post-infection, and was treated 
with Isometamidium at 0.1 mg/kg. The dose was selected based on 
mouse data, and represented l/20th of the mouse MOD. Following 
treatment no parasites were detected during a 42 day observation 
period. A second goat was therefore infected with this strain, 
and became parasitaemic by day 11 post-infection. Treatment was 
then administered at a dosage of 0.05 mg/kg, and a relapse infection 
was first detected 22 days later. No relapse infection was 
detected following retreatment at this dosage during a 46 day 
observation period, after which the experiment was terminated.
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Discussion
The present experiment demonstrated that in both mice and 
goats, there was no significant change in Isometamidium sensitivity- 
following repeated subcurative treatment. In mice, after nine 
successive exposures to subcurative doses of Isometamidium, no 
change in sensitivity, compared to the parent strain, could be 
demonstrated. Similarly, up to six successive subcurative 
treatments in goats, failed significantly to alter the Isometamidium 
sensitivity of a number of strains of T. congolense. These findings 
are in some respects similar to those of Whiteside (1962) who 
reported that drug resistant strains of T. congolense were difficult 
to produce in mice. However, he suggested that drug resistant 
strains were much more easily produced in cattle. During the 
course of the present study a facility became available in which 
trypanosome infected goats could be housed, and so it was decided 
to attempt to induce drug resistance using goats as hosts.
The strains of T. congolense used in cattle and goats 
seemed to behave similarly in the two species in terms of infectivity, 
prepatent periods and response to Isometamidium. For example, 
cattle infected with KETRI 2880 relapsed to treatment with Isomet­
amidium at 0.5 mg/kg in a mean of 15*7 days: a goat infected
with the same strain relapsed to initial treatment at 0.5 mg/kg 
in 15 days. Similarly, cattle infected with KETRI 2883 and 
treated at 0.1 mg/kg Isometamidium, relapsed in a mean of 8.3 days: 
of three cattle, one did not experience remission of infection following 
treatment, while the other two relapsed after 11 and 14 days, 
respectively. A goat infected with the same strain, relapsed to 
repeat treatment with 0.1 mg/kg in 11 to 15 days.
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Goat Y100, infected with T. congolense KETRI 2883, was 
treated with six successive doses of 0.1 mg/kg Isometa.Tni.dium.
The intervals from treatment to first detection of the relapse 
infections were remarkably consistent. Williamson and Stephen 
(1960) suggested the use of the subcurative treatment to relapse 
interval as an index of relative sensitivity: the shorter the
interval, the more resistant the strain. On this basis it would 
appear that for this strain, repeated subcurative treatment has 
not resulted in any shift in Isometamidium sensitivity.
Goat Y92, infected with T. congolense KETRI 2880 was 
treated with successive Isometamidium dosages of 0,1, 0.1, 0.2,
0.5 and 0.5 mg/kg. On the basis of the intervals from treatment 
to relapse, no major decrease in Isometamidium sensitivity has 
occurred. Ideally the sixth relapse infection, ie the relapse 
infection which occurred after the third treatment at 0.5 mg/kg, 
would have been used to infect a new goat which would then have 
been treated at 0.1 mg/kg Isometamidium, to see if this dose was 
still effective. Demand for the fly-proof animal facility 
precluded this possibility.
The increased interval from treatment to relapse 
following successive treatment with 0*5 mg/kg Isometamidium, 
was probably due to the combined effect of the latest Isometamidium 
treatment together with the residual effect of previous treatments. 
Adoption of an experimental design similar to that used for mice 
would overcome this complication, but the increased number of 
animals required would stretch animal facilities and be prohibitively 
expensive.
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These experiments suggest that changes in Isometamidium 
sensitivity of strains of T. congolense do not readily occur as 
a result of deliberate underdosing.
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CHAPTER SEVEN
STUDIES WITH MIXED INFECTIONS OF ISOMETAMIDIUM SENSITIVE 
AND RESISTANT STRAINS OF T. congolense
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Introduction
Documented incidences of Isometamidium resistance in the 
field are relatively few in number. This is surprising in view 
of the often expressed opinion that prophylactic drugs are more 
likely to give rise to drug resistance than curative drugs (Whiteside, 
1962), and that Isometamidium has been widely used, and abused, 
for nearly 30 years. One explanation for this paradoxical situation 
is that most drug resistant strains of trypanosomes, and other 
microorganisms, are less viable than normal strains, and that in 
mixed infections the former tend to die out (Cantrell, 1956), 
possibly due to their lower replication rates.
This experiment investigates the ability of two unrelated 
strains of T. congolense, one of which is highly sensitive to 
Isometamidium (T. congolense KETRI 2885) and. one of which is 
resistant to the manufacturer* s recommended dosage in cattle 
(KETRI 2880), to become established in the face of an existing 
infection with the other strain.
Methods
Three goats were infected by the intravenous route with 
5approximately 1 x 10 trypanosomes T. congolense KETRI 2885.
Rectal temperatures were recorded three times a week and at the 
same time a jugular blood sample was obtained for measurement 
of PCV and to assess parasitaemia by the capillary concentration 
technique and examination of the buffy coat. Seven days after the 
first detection of trypanosomes two of the goats were superinfected
by/
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5by iv inoculation with approximately 1 x 10 trypanosomes T. 
congolense KETRI 2880, and an additional goat was also infected 
with the same inoculum to serve as a challenge control. Twenty 
days after the superinfection, all four goats were treated with 
Isometamidium at 0.1 mg/kg by deep intramuscular injection in 
the quadricep femoris muscle of the hind leg.
Three more goats were infected iv with approximately
51 x 10 trypanosomes, T. congolense KETRI 2880, and seven days 
after first detection of parasites two of the goats were super­
infected with T. congolense KETRI 2885. At the time of the 
superinfection an additional goat was also infected with T. 
congolense KETRI 2885 as a challenge control. Fourteen days 
after the superinfection all four goats were treated with 
Isometamidium at 0.1 mg/kg.
After treatment with Isometamdfum, all goats were monitored 
three times a week for rectal temperature, PCV and parasitaemia.
The experimental design and outcome of treatment with Isometamidium 
are shown in Table 25.
Results
For the three goats infected on day 0 with T. congolense 
KETRI 2880, parasites were first detected on day 14 post-infection.
Two of these goats were then superinfected on day 21 with a second 
strain of T. congolense KETRI 2885. An additional, previously 
uninfected, goat was also infected with T. congolense KETRI 2885 
on day 21, to serve as a challenge control, and it became parasitaemic 
8 days later. This demonstrated that the inoculum used for the 
superinfection/
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superinfection was infective. The two goats which received the 
superinfection experienced temporary remission of infection 
following treatment with Isometamidium at 0.1 mg/kg on day 35 > 
with trypanosomes again being detected 5 and 8 days after 
treatment, respectively. In contrast, the goat which received 
only the primary infection of T. congolense KETRI 2880 remained 
continuously parasitaemic following treatment. The challenge 
control, infected with the same inoculum used for the super­
infection, was cured by treatment at 0.1 mg/kg: no parasites were
detected during a 40 day post-treatment observation period, after 
which the experiment was terminated.
The three goats infected on day 0 with T. congolense 
KETRI 2885 became parasitaemic on day 8. Two of the three goats 
were then superinfected on day 15 with T. congolense KETRI 2880.
An additional, previously uninfected, goat infected at the same 
time with T. congolense KETRI 2880 to serve as a challenge control, 
became parasitaemic 13 days later, thus demonstrating that the 
inoculum used for the superinfection was infective. All three 
goats infected on day 0 with T. congolense KETRI 2885 were apparently 
cured by treatment on day 35 with 0.1 mg/kg Isometamidium irrespective 
of whether or not they had been superinfected with T. congolense 
KETRI 2880: no trypanosomes were detected during a 22 day post­
treatment observation period. The challenge control goat, 
infected with the same inoculum as was used for the superinfection 
(T. congolense KETRI 2880) remained parasitaemic after treatment 
at 0.1 mg/kg.
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The different intervals from superinfection to treatment 
with Isometamidium were selected to reflect the different pre­
patent periods of the two strains used in the experiment. In 
both cases treatment was administered approximately 7 days after 
parasites were first detected in the goats used to test the 
infectivity of the superinfection inoculum.
Discussion
The two strains of T. congolense used in this experiment 
were of different Isometamidium sensitivities. T. congolense 
KETRI 2885 was highly sensitive to Isometamidium (MOD in cattle 
^ 0.001 mg/kg), while KETRI 2880 was relatively resistant (MOD 
in cattle 2 mg/kg) (Sones, Njogu and Holmes, in press). Goats 
which were initially infected with the sensitive strain,, and were 
then challenged with the resistant strain were cured by treatment 
at 0.1 mg/kg Isometamidium, indicating that the resistant strain 
did not establish an infection. Goats initially infected with 
the resistant strain, which were then challenged with the sensitive 
strain experienced temporary remission of infection followed by 
relapse after treatment at 0.1 mg/kg Isometamidium. In contrast, 
the goat infected only with the resistant strain remained parasitaemic 
following treatment at 0.1 mg/kg. This suggests that superinfection 
with the sensitive strain resulted in the establishment of infection, 
which suppressed the resistant strain to below the limit of detection 
of the method used. Only after treatment, at 0.1 mg/kg, which 
eliminated the sensitive strain, could the resistant strain re­
establish itself.
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This experiment lends support to the theory expressed by 
Cantrell (1956) that ®most drug-resistant strains ... are less 
well adapted to life in the absence of the drug than their unmodified 
parents*. Cantrell worked with an oxophenarsine resistant strain 
of T. equiperdum and its unmodified parent strain, and demonstrated 
that the resistant daughter strain was unable to maintain itself 
in a mixture with the parent during passaging in rats. However 
in one rat passaged line the resistant strain reverted to sensitive, 
6 - 8  months after the last exposure to drug, hinting that a change 
in the sensitivity of the resistant strain may have contributed 
to its disappearance.
Oehler (1914) also reported that an arsphenamide resistant 
strain of T.b. brucei was displaced by the parent strain during 
mouse passage in the absence of drug, and he attributed this to 
differences in growth rates of the two strains. Other workers 
however have found the resistant strain to displace the sensitive 
parent (Laveren and Roudsky, 1912), or the results to be variable 
(Teichman, 1918).
More recently several workers have reported an interference 
phenomenon operating in the establishment of superinfections of 
T. congolense in ruminants, whereby the presence of an active 
infection of one serodeme inhibited the establishment of a second 
infection with a different serodeme (Morrison, Wells, Moloo, Paris 
and Murray, 1982; Dwinger, Luckins, Murray, Rae and Moloo, 1986).
The interference phenomenon appeared to be independent of specific 
antibody/
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antibody and required the presence of an active infection, and occurred 
whether infection was brought about by inoculation of bloodstream 
forms, or by the bite of infective tsetse flies. With different 
combinations of serodemes the interference effect observed varied 
from insignificant to marked. Morrison et al. (1982) postulate 
that competition between the trypanosome populations may be implicated, 
and it is possible that the relative competitive advantage of a 
strain is related to its drug sensitivity. Dwinger et al. (1986) 
found the interference phenomenon to be dependent on the interval 
between the primary and secondary infections, both being administered 
by the bite of infective tsetse flies. The interference phenomenon 
was maximal at day 7> and diminished from day 14 onwards, and no 
interference was demonstrated when infection with the two unrelated 
serodemes occurred simultaneously. However, Morrison and co­
workers were able to demonstrate a marked interference when 
superinfection was administered by either needle challenge with 
bloodstream forms or by infective tsetse flies, 35 days after 
the primary infection. The intervals between the primary and 
secondary infections in the present experiment were dependent on 
the prepatent period of the primary infection: superinfection was 
carried out approximately seven days after trypanosomes of the 
primary infection were first detected. Although it is possible 
that the observed differences were due to the timing of super­
infection, this seems unlikely, in view of the fact that Morrison 
et al. (1982) observed interference when superinfection was delayed 
to/
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to day 35 using needle challenge of bloodstream forms, a similar 
protocol to the present experiment in which superinfection was 
carried out by this method on day 15 (primary infection sensitive; 
secondary infection resistant) or day 21 (primary infection 
resistant; secondary infection sensitive).
In contrast to the findings of Morrison et al. (1982) 
and Dwinger et al. (1986), in which interference was solely 
restricted to the development of a superinfection, in the present 
study the sensitive strain was dominant, regardless of whether it 
was the primary or secondary infection.
It is possible that the observed differences in viability 
of the two strains in mixed infections is incidental to the 
differences in Isometamidium sensitivity, and may, for example, 
simply reflect differences in replication rates. In some respects 
it would have been preferable to perform the experiment using a 
laboratory produced, resistant daughter strain, and the unmodified 
parent strain. Attempts to produce such strains by a process of 
repeated subcurative treatment of strains of T. congolense in both 
mice and goats failed to induce any change in sensitivity to 
Isometamidium. It should be borne in mind however that antigenic 
similarities between parent and daughter strains may influence the 
results of such an experiment because of immunological responses.
If drug resistant strains which arise in the field tend 
to be less viable than normal strains, this could explain the relative 
scarcity of Isometamidium resistance. Following treatment with 
Isometamidium,/
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Isometamidium, the period of prophylaxis against drug sensitive 
strains can extend to six months (Whitelaw et al., 1986).
However during this period, as the level of circulating trypanocide 
declines, challenge with Isometamidium resistant strains may 
result in successful establishment of infection. It has been 
suggested that drug resistant strains may be of low pathogenicity 
(Stephen,i960) and they may also have low replication rates 
(Hawking, 1963a), and therefore this infection may be of little 
clinical significance. As the level of circulating trypanocide 
continues to wane, treated animals will eventually also become 
susceptible to challenge with drug sensitive strains. It is possible 
that at this stage, infection with trypanosomes of normal sensitivity 
could overgrow, and eventually eliminate, the resistant trypanosomes.
The results of this experiment may have interesting 
practical implications for the control of drug resistance, and may 
even indicate that complete prophylaxis is not always necessary 
or desirable. Further work in this interesting field is clearly 
warranted.
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CHAPTER EIGHT
GENERAL DISCUSSION
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Bovine trypanosomiasis is acknowledged to be one of the 
major constraints limiting livestock production in sub-Saharan 
Africa (Trail et al. 1985)* In the absence of an effective 
vaccine and lacking a coherent strategy for controlling the insect 
vectors, the livestock industry is highly dependent on the small 
number of drugs currently available for the treatment and 
prevention of the disease. Amongst that limited range of drugs, 
Isometamidium is perhaps the most widely used trypanocide.
Although examples do occur in the literature of demonstrable 
field resistance to Isometamidium, and indeed to the other trypano­
cidal drugs, the term *drug resistance* is frequently used to 
explain any therapeutic or prophylactic failure, often with little 
or no supporting evidence. The existence of drug resistance 
strains, though important, is only one of many possible explanations 
for such failures. This makes it particularly important to be 
able to investigate reported incidences of drug resistance from 
the field, and ideally to be able to evaluate the sensitivities 
of the strains of trypanosomes implicated.
Three basic approaches to the assessment of drug sensitivities 
of strains of T. congolense have been explored in the present studies; 
tests conducted using mice or cattle as hosts and tests carried 
out using an in vitro system. The mouse sensitivity test has the 
advantage of being inexpensive in terms of experimental animals, 
animal housing and maintenance. Laboratory mice are widely 
available, and the method has the additional advantage of being 
low/
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low tech, not reliant upon imported facilities and supplies, and 
therefore is capable of being carried out on the spot in Africa.
This is important because disease control regulations: make it 
difficult to export isolates of trypanosomes, for example to the 
UK, and therefore tests need to be applicable to local African 
conditions. The mouse model, however has been shown to have 
limitations in the degree of correlation between mouse and cattle 
results, and can therefore only give a broad indication of the 
sensitivity of a strain, and cannot be relied on to predict curative 
doses for cattle.
Sensitivity tests carried out using in vitro systems have 
the potential advantages of being quick, and of eliminating much 
of the biological variation encountered in animal experiments. 
However, with the present state of the art, the approach has the 
major disadvantage that most strains of T. congolense need to undergo 
adaptation to in vitro culture before an in vitro sensitivity 
test can be 'carried out. This adaptation procedure can take several 
months for some strains, and it is possible that the in vitro adapted 
population varies from the initial population in important respects, 
such as drug sensitivity. A similar criticism can also be levelled 
at mouse sensitivity tests: the population which becomes established
in mice may vary from the population which occurred in the original 
bovine host. An in vitro approach requires sophisticated, imported 
equipment, such as microbiological cabinets and incubators, all 
of which need regular, expert servicing, and regular inputs of
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media, sera and sterile laboratory ware are also required. The 
equipment, servicing and supplies are all expensive and are 
unlikely to be locally available in most African countries.
The most appropriate and meaningful approach to sensitivity 
testing of strains of trypanosomes in an African context is 
undoubtedly tests using the definitive host, cattle. Such tests 
are more expensive to conduct than mouse tests in terms of animals 
and feedstuffs, but there is no reason why the animals used cannot 
be cured by chemotherapy at the end of an experiment and disposed 
of through commercial outlets for slaughter, thus recouping some 
of the expenditure. A possible problem in some locations may 
be the supply of trypanosome-naive cattle. In Kenya, for example, 
there are tsetse-free areas from which trypanosome-naive cattle 
can readily be obtained, but in some African countries this may 
not be the case. The provision of fly-proof accommodation for 
experimental cattle is a prerequisite. Such housing is relatively 
expensive to build, and is difficult to maintain intact, but is 
important, even outside the tsetse-infested areas. Biting flies 
could transfer infection from infected to uninfected cattle, which would 
confuse the outcome of an experiment, and there is also the risk 
of biting flies carrying the infection to neighbouring cattle.
The consequences of the latter could be especially serious if drug 
resistant strains were involved.
Probably the best, most practical approach to the assessment 
of drug sensitivities in most circumstances is to collect blood 
from/
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from animals naturally infected with the trypanosome strain of
interest; transfer the blood to the laboratory and expand the
primary isolate by infecting a trypanosome-naive calf to provide
sufficient trypanosomes to infect the required number of cattle,
and to prepare a stabilate for future use; infect a minimum of
5three cattle with approximately 1 x 10 trypanosomes per head by 
intravenous inoculation; treat some animals at first detection 
of trypanosomes and retain others as untreated controls; and 
monitor cattle for response to treatment and occurrence of 
relapse infections. If the minimum of three cattle are used, one 
should be left untreated and the other two treated with the dosage 
of drug used in the field. Isometamidium is usually used at 0.5 
or 1.0 mg/kg, so treatment at either of these doses would allow 
the sensitivity to the recommended dosage to be assessed using a 
therapeutic protocol. This range covers the level of sensitivity 
of practical significance.
The duration of the observation period following treatment 
is a contentious issue. In the present study cattle were observed 
for 100 days post-treatment. The longer the period selected, the 
more confident one can be that all potential relapse infections 
have occurred, but excessively long periods increase the cost of 
an experiment and limit the throughput of strains in a given 
facility. A 100 day post-treatment monitoring period is probably 
a reasonable compromise between experimental design and more 
practical considerations.
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Another practical problem is the delay between collecting 
blood samples from naturally infected cattle in the field, and 
subinoculating the material into a naive calf in the laboratory.
In the past Jones-Davies and Folkers (1966) overcame this problem 
by transporting calves by lorry to cattle treatment camps, and 
subinoculating blood samples as they were collected. Up to 80 
blood samples were subinoculated into a calf, and animal welfare 
considerations apart, it would be difficult to ensure that the 
calf was not bitten by tsetse infected with other strains.
Ilemobade et al. (1975) collected blood from T. vivax 
infected cattle, with 20 ml samples being collected into chilled, 
heparinised Universal bottles, which were then stored in ice.
Samples kept under these conditions for up to 4 hours retained 
their infectivity. Although it would be possible to prepare 
stabilates of infected blood in the field, and transport them back 
to the laboratory in liquid nitrogen or solid carbon dioxide, this 
is unlikely to be practicable in most circumstances.
All the drug sensitivity work carried out in this thesis 
was performed adopting a curative protocol. Isometamidium is 
most often used as a prophylactic agent, but it has generally been 
considered in the past that drug sensitivity assessed by a therapeutic 
protocol would be a reasonably good indicator of sensitivity to 
the prophylactic activity of a tzypanocide. Recent work by 
Peregrine, Moloo and Whitelaw (1987)> however, brings this assumption 
into doubt, at least for T. vivax. They found that, whereas 
treatment of a clone of T. vivax with 0.5 mg/kg Isometamidium 
resulted/
Table 26. Some examples of the duration of Isometamidium prophylaxis.
Cattle Challenge Isometamidium
(mg/kg)
Mean period 
of
protection
(days)
Ref:
Cattle - 1.0 186.5 Boyt (1963)
Steers raed./high 0/5 99.4 Fairclough (1963)
Zebu cattle high 1.0 97.0 Kirkby (1964)
Zebu steers - 0.5
1.0
a
168
a
217
Wiesenhuetter (1968)
Grade dairy 
cattle - 0.5 66.5 Wiesenhuetter (1968a)
- 1.0 87.5
Work oxen high 1.0
b
35 Scott & Pegram (1974)
Boran cattle high
c
0.5/1.0 79.3 Trail et al., (1985)
Zebu cattle - 1.0
d
14-42 Pinder & Authie (1984)
a
10% infection rate.
b
66% infection rate.
c
See pp. 19-20;
d
Some animals trypanosome positive by 14 days; many by 42 days.
— 160 —
resulted in cures in all five cattle, the same dosage resulted 
in less than one month* s prophylaxis. They concluded that the 
level of sensitivity of a T. vivax population to the prophylactic 
activity of Isometamidium, could not be derived from sensitivity 
tests conducted using a therapeutic protocol, and suggested that 
investigations of putative Isometamidium resistant trypanosomes 
should he conducted using prophylactic protocols.
Adoption of prophylactic protocols to test drug sensitivity 
will he more difficult than therpaeutic tests. The tests are 
likely to take longer, and the point at which it is decided a 
prophylactic dose is ineffective depends on the expectation of the 
experimenter. Duration of prophylaxis achieved under laboratory 
or field conditions varies considerably. Some examples of the 
duration of protection achieved using Isometamidium under different 
field conditions are shown in Table 26. The range is wide, varying
from less than 14 days to more than 200 days.
Recently a number of laboratory studies have examined the 
influence of various factors on the duration of Isometamidium 
prophylaxis. Complete protection from either single or monthly 
challenge with five infected tsetse flies, of at least five months
duration, was reported by Whitelaw et al. (1986) following treatment
of cattle with 1 mg/kg. The serodeme used was T. congolense 
IL Nat. from which KETRI 2885, used in this thesis, was
derived. Two thirds of the cattle also resisted challenge with 
up to 500,000 in vitro derived metacyclics, or multiple tsetse 
challenge at six months. Peregrine et al. (in press) found 
treatment/
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treatment at 1.0 mg/kg, followed by challenge with the same serodeme, 
or a second unrelated serodeme, provided complete protection for 
three months. Significant differences between serodemes were 
demonstrated by Peregrine et al. (1987)• They showed that whereas 
for a serodeme of T. vivax from Nigeria, treatment at 0.5 mg/kg 
provided at least two months protection against challenge, for a 
serodeme originating in Kenya, complete protection was afforded 
for less than one month.
Any period of prophylaxis which is selected as being fnormalf 
for the purposes of a sensitivity test will be an arbitrary choice, 
but protection of less than one month would generally be considered 
suboptimal, and more than two months would be desirable. One 
possible protocol for the routine testing of the prophylactic 
sensitivity of isolates of trypanosomes would be to treat a minimum 
of two cattle with 1 mg/kg Isometamidium and challenge them 50 days 
later with, ideally, tsetse infected with the trypanosome strain 
under investigation. Less satisfactory, but easier, would be 
needle challenge with bloodstream forms. At the same time, an 
untreated steer would also be challenged in a similar manner to 
act as a challenge control. If challenge was successfully resisted, 
and no trypanosomes were detected in treated animals during the 
next 30 days, challenge would be repeated on day 60 post-treatment, 
again including an untreated animal. If challenge at 30 days 
resulted in establishment of parasitaemia, then the strain in question 
could be considered, for practical purposes, resistant to the 
prophylactic/
- 162 -
prophylactic activity of Isometamidium. Complete protection 
at 60 days would indicate sensitivity, and resistance to challenge 
at 30 days, but not 60 days, would indicate intermediate 
sensitivity.
In summary, to obtain a complete picture of the Isometamidium 
sensitivity of a strain of trypanosome, tests in cattle adopting 
both therapeutic and prophylactic protocols should be performed.
The minimum effective dose (MED), ie the minimum dose which 
will cause a temporary clearance of circulating trypanosomes, is 
a parameter of drug sensitivity commonly reported in the past. 
Consideration of MED1s prompted studies of the apparent aparasitaemic 
interval following subcurative treatment with Isometamidium of 
T. congolense infections in a mouse model. Though inconclusive, 
these studies suggested that trypanosomes survive in the bloodstream 
in low numbers, rather in cryptic foci, such as has been described 
for T.b. brucei infections in mice. Further work would be of 
value in this field, using both the mouse model and ruminants, to 
improve our understanding of host-parasite and parasite-tiypanocide 
interactions.
Drug resistance is frequently considered to be the major 
problem associated with the use of trypanocidal drugs. The use of 
some drugs has undoubtedly been influenced by the emergence of 
drug resistant strains. In 19&5* f°r example, the use of homidium 
was discontinued in Nigeria in favour of diminazene aceturate, due 
to the discovery of homidium resistant strains of T. congolense 
(Na*Isa, 1967)« Reported incidences of resistance to Isometamidium 
are/
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are relatively scarce, with, only a handful of documented accounts 
in the literature. This is surprising since Isometamidium has 
been in use for approaching 30 years, and is frequently misused, 
and also in view of the often expressed opinion that drugs with 
prophylactic activity are more likely to induce drug resistance 
in the field than those with only curative activity. Two aspects 
of resistance to Isometamidium, studied as part of this thesis, 
may help to explain this situation.
First, deliberate attempts to induce changes in sensitivity 
by repeated, subcurative treatment, failed to alter significantly 
the Isometamidium sensitivities of strains of T. congolense, both 
in mice and goats. The ease with which Whiteside (1962) reportedly 
produced marked decreases in sensitivity by a few sub curative 
treatments in cattle, could not be repeated for Isometamidium in 
goats in the present studies. Secondly, a relatively Isometamidium 
resistant strain of T. congolense was apparently unable to establish 
an infection in the face of an existing infection with a sensitive 
strain, although in the reverse situation the sensitive strain 
established an infection and suppressed the resistant strain.
More work in this important and interesting area is clearly indicated, 
but these early observations suggest that at least some Isometamidium 
resistant strains of T. congolense cannot compete in mixed infections 
with sensitive strains.
Although the importance of drug resistance may sometimes 
have been overstressed, this does not mean that reasonable steps 
should not be taken to reduce the likelihood of resistant strains 
from/
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from arising. In particular the use of an effective sanative, 
ie a drug which is effective against strains resistant to the 
trypanocide in use, should be central to any chemoprophylactic 
regime. The narrow range of trypanocides available makes the 
choice of a trypanocide to fulfil this role difficult. Until 
recently, cross-resistance between Isometamidium and diminazene 
aceturate was thought not to occur, but Authie (19^4) reported 
strains of T. congolense resistant to both these trypanocides, 
and in the present studies a strain of T. congolense isolated 
from the same area was shown to be resistant to the manufacturer’s 
recommended doses of the two trypanocides. In spite of this, 
diminazene aceturate is the sanative of choice for most prophylactic 
regimes based on Isometamidium. For example the regime currently 
in use at Mkwaja Ranch, Tanzania consists of all animals in a herd 
receiving diminazene aceturate at 3*5 mg/kg, when monitoring of 
a herd indicates relapse or reinfection has occurred, followed 
one week later by Isometamidium at 1 mg/kg.
Isometamidium is likely to continue to play a major role 
in the control of African bovine trypanosomiasis for the foreseeable 
future. Even if alternative control strategies which seem to 
have considerable potential, such as increased use of tiypanotolerant 
cattle, or the deployment of insecticide treated, tsetse attractant 
targets, fulfil their promise, trypanocidal drugs will still have an 
important part to play. Novel trypanocidal drugs are unlikely to 
become available within the next few years, indeed no new trypanocides 
have/
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have been introduced since Isometamidium in the early 1960*s, 
and therefore it is important that the maximum benefit is derived 
from the available products. Monitoring the incidence of drug 
resistance is an important element of any trypanosomiasis control 
programme which includes the use of trypanocidal drugs, and at the 
present time there is.no substitute for sensitivity tests carried 
out in cattle. Although drug resistance is potentially an 
important constraint on the use of trypanocidal drugs, its impact 
on some products, including Isometamidium, may have been over­
emphasised in the past. For a variety of reasons, widespread 
surveys to determine the extent of drug resistance have not been 
carried out in post-colonial Africa. There is clearly a need 
for more work to be done in this area, so that an accurate appraisal 
of the current situation can be made. The facts that in the present 
studies repeated, deliberate underdosing did not result in decreased 
sensitivity to Isometamidium of strains of T. congolense. and that 
some Isometamidium resistant strains appear to be less viable than 
strains of normal sensitivity, may help to explain why Isometamidium 
remains effective in most field situations after nearly 30 years use.
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